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ABSTRACT
Investigating Determinants of 
Macular Pigment Optical Density and Distribution 
in Adults aged 45-73:
Can enhanced analytical techniques improve the ability to predict 
macular pigment status?
By
Joanne Delaney Burke 
University of New Hampshire, December, 2001 
This research assessed the relationships of dietary, sex, and biochemical factors to 
macular pigment optical density (MPOD) and macular pigment (MP) distribution in 108 
adults. Dietary assessment tools were evaluated for their ability to predict MP status. 
Macular pigment was assessed at four foveal sites and one parafoveal site. An average 
composite macular pigment value (CMPV) was calculated based on the MPOD results. 
Group mean MPOD results from most to least central retinal locations, were 0.43 
(SE ± 0.017), 0.36 (SE ± 0.013), 0.28 (SE ± 0.012), and 0.13 (SE ± 0.008), respectively. 
The CMPV was 0.26 (SE + 0.011). Those with blue iris color were found to have higher 
MPOD at the 1.00° (p= 0.008), and 2.00° (p= 0.01) sites and CMPV results (p=0.02) 
compared to those with hazel eyes.
Significantly lower MPOD were evident at the 1.00° (p= 0.02) and 2.00° (p=
0.001) sites and for CMPV (p= 0.02) when BMI > 27 compared to BMI < 27.
Higher MPOD were associated with higher intakes of fruits and vegetables using average 
consumption estimations derived from a seven item fruit and vegetable
xv
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
screening tool, while a 24-hour carotenoid guided food recall did not predict MPOD. 
Multiple significant linear relationships were detected for dietary intakes of the 
carotenoids lutein and beta-cryptoxanthin based on FFQ results Additional nutrients with 
multiple significant associations were vitamins A and C, and iron.
Mean serum lutein and lutein/zeaxanthin concentrations for the sample were 
significantly associated with MPOD at the 0.167°, 0.50°, 1.00° sites, and CMPV results. 
Cholesterol, LDL-C, and HDL-C were not associated with MPOD while triglycerides 
were significantly associated with MPOD at the 0.167° (p= 0.03) and 1.00° (p= 0.02) 
sites. Fasting serum lipoproteins of total cholesterol and triglycerides concentrations were 
significantly associated with some serum carotenoid concentrations, while LDL-C and 
HDL-C were not significantly associated with serum carotenoid concentrations.
xvi
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I. INTRODUCTION
A. Overview
Presently, there is limited information on the usual amount and distribution of 
macular pigment (MP) found in the retina of individuals, although its presence may 
confer health benefits (1-9). Ideal pigment density has not been determined since the 
ability to take routine measurements of this pigment has been typically limited to 
research facilities (10). Optimal MP and factors that appear to influence its status need to 
be more completely identified. A direct link between macular pigment optical density 
(MPOD) and development of age-related macular degeneration (AMD) has not been 
unequivocally established. However, the frequent association between the risk of 
developing AMD and factors which appear to influence MP suggest there may be a 
relationship between them (1, 2, 11-16).
Age-related macular degeneration is the leading cause of irreversible vision loss 
in the United States among persons older than 65 years of age (17-19); approximately 1.7 
million Americans have AMD (20). The Census Bureau projects that between the years 
2000 and 2020, the number of persons 65 years and older in the United States will 
increase from 35 to 53 million, comprising over 16% of the entire population (17, 21). 
With this increase in an aging population, the incidence of AMD is projected to rise to 
6.3 million by the year 2030, when an even greater percentage of the American 
population will be over the age of 60 (20). If dietary interventions and practices could 
delay or prevent some of these changes, enhanced quality of life and substantial savings 
in health care costs could be realized for those at risk of macular eye disease.
1
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In addition to hypothesized macular disease prevention, additional putative benefits have 
been linked to the presence of MP. These include its ability to filter out harmful 
wavelengths of light (7, 22-24), to engage in antioxidant reactions (1, 7, 13, 25, 26), to 
contribute to the preservation of visual sensitivity and resolution (3) (14, 27), to enhance 
cellular gap junction communication (13), and to serve as a potential biological marker of 
nutrient and health status (7, 9, 14, 28-30).
B. Study design
This research was designed to examine the ability to predict the MP 
concentrations in the retina, by determining MPOD and comparing these results to 
dietary and biochemical assessments. Measurement of MPOD at four sites in the foveal 
region (and one site in the parafoveal region) provided information on the distribution of 
the MP. The carotenoids lutein (L) and zeaxanthin (Z) were of particular interest, since 
they are considered the principal carotenoid components comprising the MP (31-36) and 
their presence in the diet and serum has been linked to MPOD. Previously published 
research demonstrated a relationship between carotenoid intake and serum carotenoids 
(37-42); between lutein and zeaxanthin (L/Z) intake and MP, (5, 28, 43) and between 
serum L and Z and MP (5, 44,45). In those cases in which L and Z are reported as a 
combined value, such as in food composition databases or from serum, their combined 
value is typically denoted as ‘L/Z’.
The reported relationships between carotenoid intake, serum concentrations and 
deposition are generally not robust, nor are the results consistent from study to study (1,
4, 5, 37, 38, 40, 44,46, 47). Differences in research results are, in part, indicative of the 
many factors
2
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which influence carotenoid status such as bioavailability (48-50) absorption (51-53), 
transport (54), gender (55, 56), body mass index (BMI) (37, 39), cigarette use (6, 56), 
alcohol use and lipoprotein status (39). Additionally, these differences in results may also 
be due to assessment limitations.
In this research project, enhanced analytical methods were utilized in an attempt 
to minimize some of these measurement restrictions. Indicators of carotenoid ingestion, 
transport, and deposition were assessed via dietary, serum, and ocular assessments 
respectively. A summary of the major research components is depicted in Table 1. Fruit, 
vegetable, carotenoid intake, and dietary habits were assessed using multiple instruments. 
These included a seven item fruit and vegetable screening tool (7-FVST: Appendix F)
(57, 58), a 24-hour carotenoid guided food recall (24hr-CGFR: Appendix G) (59, 60) and 
multiple food frequency questionnaires (FFQ’s: Appendix G).
The 7-FVST was administered to place eligible study participants into low, 
medium, or high fruit and vegetable consumer categories. The 24hr-CGFR captured data 
on recent dietary carotenoid intake (59) and was used to compare recent carotenoid intake 
to semm carotenoid concentrations and MPOD . Data from the 24hr-CGFR were 
analyzed using the University of Minnesota Nutrient Database System (NDS) diet 
analysis software (61).
In addition, to assess typical total dietary intakes consumed over the previous 
year, multiple national FFQ’s, (38, 62, 63) were completed by most participants. These 
included those developed by Block (B-FFQ) (62, 64, 65) the Fred Hutchinson Cancer 
Research Center (FH-FFQ), and the Tufts USDA Center on Aging, Human Nutrition 
Research Center (T-FFQ) (38). The developers of each FFQ analyzed their own
3
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respective questionnaire. These FFQ’s utilize different questions and database 
configurations. Comparisons of estimated dietary and carotenoid intakes to serum 
carotenoid concentrations and MP status provide valuable information regarding the 
ability of these instruments to predict serum carotenoid and MP status. The availability of 
expanded databases, which include extensive information on specific carotenoids and 
their content in foods and supplements, enhances the ability to conduct comprehensive 
dietary analyses (63, 66-69).
Reverse phase high performance liquid chromatography (HPLC) was utilized for 
serum carotenoid determinations (34, 37, 70). Comparisons of diet and blood carotenoids 
were explored. Since carotenoids may be influenced by lipoprotein concentrations, 
fasting plasma lipoproteins were also evaluated (37, 71-75). Lipids were analyzed at 
Tuft’s Nutrition Evaluation Laboratory at the USDA Center on Aging, Boston.
Enzymatic reactions were conducted for total cholesterol (TC), high density lipoproteins 
(HDL-C), and triglycerides (TRIG) analysis; calculations were used to determine low 
density lipoprotein (LDL-C) and very low density (VLDL-C) concentrations. Since the 
transport of carotenoids occurs via the various lipoprotein carriers (54), the potential for 
lipid carriers to influence MP was examined by comparing TC, HDL-C, LDL-C, VLDL- 
C and TRIG results to MPOD and MP distribution.
Carotenoid deposition in the retinal macula was measured psychophysically using 
heterochromatic flicker photometry (HEP). Macular pigment was determined using a 
Macular Metrics ® free view HFP unit which yielded MPOD. The MPOD measurements 
represent carotenoid pigment deposition at multiple sites across the macula, thus 
providing data on the density and distribution of the MP (10). Subjects were presented
4
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centrally fixated stimuli 20 minutes, 1.00°, 2.00° degree and 4.00° from the central retina, 
and one parafoveal stimulus, 7 degrees to the right of a fixation point. To ensure that the 
subjects enrolled in the study were free of significant ocular impairment, particularly 
macular function, vision screening tests used to assess visual acuity, contrast sensitivity, 
and macular function were administered to all subjects (76). In addition, an interactive 
computer simulation program was developed to allow each subject to become familiar 
with the tasks associated with the MPOD evaluations before the actual test (77).
Factors previously associated with carotenoid status, MP and/or AMD were also 
considered during the analysis. These include gender (5), age (14, 27, 78, 79), iris color 
(80, 81), body mass index (BMI) (5, 37, 39), tobacco use history (6, 39, 56, 82, 83), as 
well as education and income levels (84).
To our knowledge, no research to date has compared dietary practices as 
measured by multiple food frequencies and serum nutrient concentrations to MPOD and 
distribution in a select group of men and women between the ages of 45-75 years. In 
addition, little information exists on the ability to predict MPOD status based on FFQ 
results. Advances in instrumentation, biochemical detection, and expanded nutrient 
databases have resulted in increasingly sophisticated tools for such an investigation. The 
urgency of identifying diet and/or lifestyle habits that promote macular health has 
become increasingly apparent since macular disease is now the leading cause of visual 
impairment and blindness in the United States (1, 85).
C. Objectives and Hypotheses
The goals to assess carotenoid intake, to determine nutrient absorption and to 
quantify MP density and deposition in adult females and males shaped the design of the
5
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study. Six specific research objectives and related hypotheses were developed. They 
included the evaluation of dietary intakes (including the comparison of food and nutrient 
analysis tools), analytical determinations of biochemical markers, and assessment of 
MPOD and distribution. The specific objectives and related hypotheses related to intake, 
absorption, and deposition are considered below.
#1. To determine MPOD and MP distribution patterns and total foveal carotenoid 
deposition in the study population and to assess if these results differed by age 
and/or between females and males.
It was hypothesized that this New England population would have higher MPOD 
than those reported from a Midwest (44) and Southwestern (45) population based on the 
higher reported values from the New England area as reported in 1996 (5). It was also 
hypothesized that men would demonstrate a greater amount of carotenoid deposition 
throughout the foveal region. In studies using HFP, research by Hammond et al. showed 
greater MPOD in men than women when assessing one site (0.50° degree) in the retina of 
subjects residing in NH and MA (5) as well as in a Southwestern population (45). No 
difference in MPOD using HFP was found by Ciulla et al. in a study of 280 Midwestern 
males and females aged 18-50 (44). Beatty found lower MP in older versus younger 
subjects (1). In addition, research by Eisner et al. using reflectometry with a scanning 
laser ophthalmoscope (SLO) on eleven subjects in New England indicated a decrease in 
peak MP in older individuals and in women (78). The subjects in Elners studies were 
under the age of sixty.
6
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#2. To compare serum carotenoid concentrations and MPOD of low, medium and 
high consumers of fruits and vegetables as determined through a brief seven-item 
fruit and vegetable-screening questionnaire.
The 7-FVST was designed to categorize subjects into low, medium, and high fruit 
and vegetable consumers, considering ingestion during the past year. It was hypothesized 
that average serum carotenoid concentrations would increase as the reported number of 
fruit and vegetables increased. Since this survey assessed common fruit and vegetable 
consumption, this instrument indirectly captured carotenoid as well as antioxidant and 
phytochemical intake. Consumption of nutrient dense diets and participation in health 
promotion behaviors are common in subjects who report high fruit and vegetable intake 
(7, 9, 28-30). A 40% lower estimated risk for the development of AMD was reported in 
individuals eating more than seven fruits and vegetables rich in vitamin A per week (30). 
However, fruit and fiber consumption explained only 2.0% of the MPOD variance in a 
study of 280 men and women between the ages of 18-50 years (44). Reported fruit and 
vegetable consumption did not appear to serve as an indicator of L/Z serum 
concentrations in a study reported by Tucker et al. (38). It was also hypothesized that the 
mean MPOD as assessed for the 0.167°, the 0.50°, the 1.00°, and the 2.00° sites would be 
higher in those who reported higher intakes of fruits and vegetables.
#3. To determine if the current FFQ’s which have expanded their carotenoid 
databases would generate higher estimates of daily carotenoid ingestion than 
estimates generated from previous analyses.
It was hypothesized that calculated dietary estimates of carotenoid ingestion for 
both male and females would be higher compared to estimates derived from previous
7 .
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databases that had utilized vitamin A activity to estimate carotenoid values (63). The six 
carotenoids, a-carotene (AC), P-carotene (BC), (3-cryptoxanthin (BCX), lycopene (LY), 
lutein (L) and zeaxanthin (Z) account for most of the carotenoids circulating in humans 
(86).
#4. To determine if the FFQ ’s which use expanded carotenoid databases, would 
have an enhanced ability to predict serum carotenoid concentrations and MPOD as 
compared to earlier studies.
It was hypothesized that calculated dietary estimates of carotenoid ingestion for 
both male and females would enhance prediction of their respective serum concentrations 
compared to previous studies that relied on databases that utilized vitamin A activity to 
estimate carotenoid values. Michaud et al. used the expanded USDA-NCI carotenoid 
database, as well as updated values for tomato products (63). For females, adjusted diet- 
plasma carotenoid associations were 0.48 for AC, 0.32 for BCX, 0.27 for BC and L, and 
0.21 for LY; for males, adjusted values were 0.47 for AC and LY, 0.43 for BCP, 0.35 for 
BC and 0.40 for L.
Ciulla et al. found that reported dietary L/Z intake predicted 4.6% of the MP (44). 
Hammond et al. found that MP was significantly related to dietary L and Z for males (5). 
Improvements in dietary assessment tools should enhance the ability to determine diet 
and tissue deposition relationships (67).
It was hypothesized that the FH-FFQ would be the best instrument able to predict 
MP since this FFQ had been previously used for carotenoid research. However, since the 
T-FFQ and the B-FFQ also use expanded carotenoid databases and capture detailed
8
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information on fruit and vegetable intake, all could be similar in their ability to predict 
MP status.
#5. To compare serum carotenoids to MPOD and MP distribution.
Absorption of carotenoids is affected by a number of factors (49, 50). Serum 
concentrations of absorbed carotenoids may be more indicative of carotenoid 
bioavailability than those estimated from dietary recalls. It was hypothesized that higher 
serum carotenoid concentrations would be predictive of higher mean MPOD, 
relationships which have been previously reported by Ciulla, Landrum, and Hammond (5, 
44, 87).
#6. To compare plasma HDL-C and LDL-C, to MPOD and MP distribution in 
males and females.
The hydrocarbon carotenoids are transported primarily via LDL lipoproteins, 
while oxygenated (xanthophyll) carotenoids such as L and Z are more evenly transported 
via HDL and LDL. Since LDL is considered the delivery lipoprotein to the cell, and HDL 
is responsible for lipoprotein return to the liver, it was hypothesized that lipoprotein 
status would influence MP. Elevated LDL-C was predicted to enhance MP, while higher 
HDL-C concentrations were predicted to be associated with lower MP concentrations. In 
some studies (5, 45) males have been shown to have a higher MP than females. Other 
studies have not demonstrated this sex difference (44). Men tend to have relatively higher 
LDL-C concentrations while women tend to have relatively higher HDL-C 
concentrations, particularly during the premenopausal period.
The preceding summary of the research project demonstrates the complexity of 
this human research project. It was anticipated that a greater understanding of the
9
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determinants of MP status could emerge by investigating key components indicative of 
carotenoid intake, absorption and deposition.
10
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II. REVIEW OF THE LITERATURE
A review of the critical issues inherent in understanding the carotenoids, dietary 
sources, assessment of intake, transport, and deposition in the macular region is 
presented. In addition, information on macular disease and MP is reviewed. Factors that 
may influence carotenoid or MP are considered. The rationale for vision screening 
concludes the review.
A. Carotenoids
Carotenoids are naturally occurring colorful compounds that are very abundant in 
plants, but which also occur extensively in animals and microorganisms (88). Over 600 
carotenoids have been identified in nature (89, 90). However, if isomers of carotenoids 
were included, this number could be in the hundreds of thousands (90). Carotenoids are 
essential for photosynthetic reactions (91, 92) and perform essential photoprotective 
functions in photosynthetic organisms (91, 93, 94). Without carotenoids, life in an 
oxygen environment would not be possible (88). Photosynthetic organisms as well as 
non-photosynthetic bacteria and fungi may produce carotenoids (89). Humans do not 
synthesize these compounds and therefore need an external source.
Although much of the initial research examined the conversion of carotenoids, 
such as BC to vitamin A, research during the past 30 years has suggested a greatly 
expanded role for carotenoids. Their ability to act as antioxidants (26, 95, 96), to function 
as prooxidants (91), to provide protection to the visual system (2, 13), to influence cancer 
cell growth (97-99) and to interact in a number of biological pathways (89, 100) have 
brought carotenoids into the forefront of the research arena.
11
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Despite the recent surge in carotenoid research, an extensive review by Armstron 
and Hearst, (89) revealed carotenoid investigations have been carried on for at least 170 
years. The term ‘carotene’ was coined by Wackenroder in 1831 to describe the pigment 
he had extracted and crystallized from carrot roots. In 1837, Berzelius called the yellow 
pigments extracted from senescent leaves as a ‘xanthophylls’. By 1911, Tswett 
determined through chromatography experiments (91) that the ‘carotenes’ and 
‘xanthophylls’ were chemically related; he proposed the term ‘carotenoid’ be used to 
encompass both classes of pigments.
Although there are over 600 carotenoids in nature, 50 that are largely in the all- 
trans configuration have historically received the most attention from the scientific 
community (91). However, increasing advances in technology are contributing to the 
ability to investigate the role of cA-isomers of some of the more common carotenoids as 
well. Presently, the carotenoids are classified as carotenes (hydrocarbon carotenoids), 
xanthophylls (to classify a carotene derivatized with one or more oxygen-containing 
functional groups) and lycopene (89, 101). The carotenoids which have been receiving 
the significant attention in human research include the carotenes (AC, BC, and gamma- 
carotene), which consist of an 18-carbon chain of conjugated bonds with a six carbon 
ring at each end; the xanthophylls (L, Z, BCP, astaxanthin, and canthaxanthin) which 
have one or more oxygens added to their carotene structure; and LY which consists of a 
30-carbon chain of conjugated bonds, but without the ring structures on either end of the 
chain (101). The structures of the most common carotenoids found in the human serum 
and macula are depicted in Figure 1.
12
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Much of the initial research on carotenoids in humans focused on the role of BC 
and the carotene precursors of vitamin A (102, 103). Additional putative functions were 
proposed for BC in the early 1980’s (104). An article appearing in the prestigious Nature 
Magazine hypothesized that BC might be the protective factor associated with lower 
cancer rates in individuals consuming diets rich in fruits and vegetables (105). An 
independent antioxidant function for BC was hypothesized. For the next 15 years it was 
assumed ‘the more the better’ (105). In 1994, the Finnish Alpha-Tocopherol Beta- 
Carotene (ATBC) trial put a damper on enthusiasm since the data suggested carotenoid 
supplementation increased cancer rates in smokers given beta-carotene supplements 
(106). Results from this joint project of the Finnish National Public Health Institute and 
United States National Cancer Institute indicated a 34% lower rate of prostate cancer in 
the Vitamin E supplemented group. However, there was an 18% higher incidence of lung 
cancer in those receiving BC; deaths were 8% higher in supplement users due to lung 
cancer and ischemic heart disease (p= 0.02). Besides lung cancer, BC did not appear to 
have an effect on other types of cancer. No interaction between vitamin E and BC were 
observed. Additional results from the beta-carotene retinol efficiency trial ‘CARET’ 
revealed a 28% higher incidence of lung cancer, and a 26% higher mortality from 
cardiovascular event with intervention of carotenoids and vitamin A (107). Overall 
mortality rate was 17% higher in the BC and vitamin A treatment group compared to the 
placebo group (p= 0.02). The results were so distressing that the CARET intervention 
trial was halted. Since smokers and asbestos workers had comprised part of the 
intervention populations, it was unclear the role of previous exposure to these known 
carcinogens played in cancer development. These unexpected results led to a call for
13
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more in-depth but cautious research endeavors given the potential risks associated with 
BC supplementation (108,109). Subsequent results from the Physician’s Health Study 
found no significant effect of BC, either positive or negative, on the primary endpoint of 
all cases of malignant neoplasm, or cancer of the lung, cardiovascular disease, or all 
cause of mortality in well nourished men (108).
Studies designed to determine carotenoid recommendations are critically needed, 
yet must be designed carefully given the experience with BC supplementation (86). 
Determining optimal carotenoid intake continues to be of research interest, and is surely 
not limited to BC recommendations. Lycopene ingestion has been linked to a lower rate 
of prostate cancer (99). As discussed throughout this review, and evident in the present 
research project, data which provide more specific information on optimal 
concentrations of L and Z are desired since these carotenoids are linked, but not limited 
to ocular health (4, 9, 23).
B. Dietary sources and bioavailabilty of carotenoids
Significant sources of carotenoids in the American diet are fruits and vegetables. 
Eggs (110, 111) and products made from tomato products such as pizza also contribute to 
daily carotenoid consumption. While BC and LY are found in concentrated amounts in 
carrots and tomatoes respectively, food sources of L/Z include a more diverse array, 
including spinach, com, peppers, and a variety of other fruits and vegetables.
Difference in the bioavailability of carotenoids can translate into varying amounts 
of carotenoid actually being available for utilization or storage in the body. Castenmiller 
(50) developed the mnemonic ‘SLAMENGHT to identify the many factors that are 
known to influence the bioavailability of carotenoids. These factors include Species of
14
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carotenoids, Linkage of the molecules in the carotenoids, Amount of carotenoids 
consumed in a meal, Matrix in which the carotenoid is incorporated, Effectors of 
absorption and bioconversion, Nutrient status of the host, Genetic factors, Host-related 
factors, and Interactions. The food matrix and the type and extent of processing have 
begun to receive more attention from carotenoid researchers (50, 112, 113) and those 
designing related nutrient databases.
C. Dietary recommendations
Estimates of current carotenoid intake in the United States suggest that Americans 
are consuming between 6 and 7 mg (68) total of the six most prevalent carotenoids per 
day. Although carotenoids are considered to be important components of a nutrient-dense 
diet, no specific recommendations were established for BC and other carotenoids in the 
Institute of Medicine’s Food and Nutrition Board report “Dietary Reference Intakes for 
Vitamin C, Vitamin E, Selenium, and Carotenoids released in the Spring of 2000 (86). 
The Panel on Dietary Antioxidants and Related Compounds of the Food and Nutrition 
Board maintained that insufficient data and inconsistent research results precluded the 
development of dietary guidelines at this time. This comprehensive review considered the 
many studies that suggest higher blood concentrations of BC and other carotenoids are 
associated with lower risk of several chronic diseases. However, since carotenoid blood 
concentrations are the best biological markers for fruit and vegetable consumption, the 
observed positive effects may be due to other substances found in carotenoid-rich foods 
or to other behavioral correlates of increased fruit and vegetable consumption (86). The 
panel sited the critical need for more research on the potential influence of all carotenoids 
on health, including research on MP and macular degeneration.
15
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Despite the lack of an official recommended intake, a number of Americans have 
begun to increase use of L supplements with the hopes of improving their vision (114). 
This may in part be explained by the hope to stave off serious diseases such as AMD and 
to treat conditions already affected by various eye diseases. Hammond notes that 
anecdotal reports support the hypothesis that L intake may improve ocular function (3). 
For instance, 16 patients with congenital retinal degenerations noted an improvement in 
vision acuity using L supplements (40 mg/day for 2 months followed by 20 mg/day for 4 
months) (115). In another study, 14 AMD patients supplemented with 5 ounces of 
spinach (each serving contains about 10 mg L) four to seven times per week observed 
improvements in a number of visual function tests (116). Although studies such as these 
offer hope, extensive double blind, placebo controlled studies are needed to provide 
credence to these promising results and to establish dietary and therapeutic 
recommendations.
D. Dietary assessment strategies
Numerous strategies have been used to evaluate the dietary habits of Americans. 
The most common methods include 24-hour dietary recalls, diet histories, single or 
multiple food records, food frequency questionnaires (FFQ’s), targeted food and nutrient 
screeners, telephone surveys, metabolic ward studies, duplicate portion studies, 
distribution of prepared food items, or a combination of one or more of the above 
strategies. No assessment method is considered to be perfect; no gold standard exists. 
Each method has strengths and weaknesses (42, 117-119). More ‘accurate’ measurements 
of food intake are typically more intrusive of the subject’s typical eating patterns, and 
therefore do not reflect ‘usual’ food consumption by free-living subjects. Being observed
16
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or being asked to record food intake may influence subjects’ food selection and /or 
documentation. A 24-hour recall, administered by a trained interviewer, can provide 
accurate, quantitative information on recent food intake, but may not reflect usual food 
intake throughout the year (119).
Food records and histories (typically one-day, three-day, and seven-day records) 
are conducted to determine recent food intake. Multiple-day food histories recorded 
typically over 3 to 7 days may contain accurate reporting, yet not really capture ‘typical’ 
food intake over time and during various seasons. However, food records do not depend 
on memory and estimation to the same extent as that required for completion of FFQ’s. 
Current multiple day food records are often more closely related to serum concentrations 
of carotenoids than FFQ’s since serum also measures more recent exposure to 
carotenoids (5, 40). Bone suggested that serum concentrations of carotenoids might be 
more closely captured by a 24-hour recall but that MP is more influenced by the long­
term exposure to carotenoids as captured in a FFQ type questionnaire (4).
A variety of health and nutrition survey instruments have been used to assess 
dietary intake in nutrition as well as vision research studies. The most nationally 
recognized food frequencies include the Block (B-FFQ), Willett (W-FFQ), Fred 
Hutchinson Cancer Research Center (FH-FFQ), and the Tufts Human Nutrition Center 
(T-FFQ) FFQ’s (5, 9, 44, 46, 120, 121).
Food frequency questionnaires direct respondents to quantify food intake over a 
long period of time, typically six months to one year. Although designed to gather 
information on the seasonal as well as daily consumption of food items, respondents 
report difficulty in estimating food items consumed irregularly (seasonally). Despite their
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limitations, FFQ’s are designed to quantify nutrient intake over an extended period of 
time and can be administered to large populations since they are typically scored via 
computer software programs.
An analysis by Ajani et al. concluded that the 60 item Willett FFQ (W-FFQ) 
provided ‘reasonably reproducible dietary information’ for ocular research (122). 
Recently, the relationship between fat intake and AMD development was evaluated using 
data from multiple FFQ’s administered to participants in the Nurses Health Study and the 
Health Professionals Follow-up Study over a four to six year period (123). Utilization of 
the 130 item FFQ provided information on the dietary habits of individuals prior to their 
diagnosis of AMD development. Dietary results from this study of over 42,000 women 
and 29,000 men indicated that the total fat intake was positively associated with risk of 
AMD. Upon further analysis, the researchers hypothesized the association may have be 
due to the intake of individual fatty acids, such as linolenic acid, rather than total fat 
intake per se. In these same samples, a high intake of fish, particularly tuna, was 
associated with a lower risk of AMD development. The dietary data was collected prior 
to the individuals’ diagnosis of AMD.
In a recent analysis, Schaefer et al. compared the efficacy of the W-FFQ to food 
records to estimate the macronutrient intake of 19 subjects fed diets of various known 
compositions (117). For those on the high-fat diet, the FFQ significantly underestimated 
fat and protein intake. The percent of energy from fat was significantly underestimated on 
the high-fat diet, and significantly overestimated for the very-low-fat diet. Estimates from 
the diet records better agreed with actual intakes for most of the other nutrients evaluated.
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In an assessment of the 126 item expanded W-FFQ, Tucker et al. reported that the 
estimated intakes of fruits and vegetables correlated most strongly with plasma BCP and 
BC among women and with plasma AC and BC among men (38). However, correlations 
were lowest (and not even significant for the male subset) for L/Z. It was concluded that 
the W-FFQ did not provide a reliable estimate of L/Z status. These researchers suggested 
that further work was needed to improve specification of foods containing these 
carotenoids or in understanding the reasons for the low correlation (38). An analysis of 
the B-FFQ and W-FFQ found that in comparison to an interviewer -administered food 
history, both generally provided lower estimates of nutrients (64). The B-FFQ was lower 
than the dietary assisted recall for BC and vitamin C. Since the W-FFQ measured total 
carotenoids, comparison of individual carotenoid estimates between the W-FFQ and B- 
FFQ could not be made. Both contain between 60-126 food items, depending upon the 
version selected.
Since FFQ’s are used in numerous nutrition studies, demonstration of their ability 
to capture carotenoid status or predict MPOD could prove valuable. Each of the FFQ’s 
results will be compared to serum carotenoid concentrations and MP data to determine if 
a particular FFQ is more likely to predict carotenoid and/or MP pigment status. Since 
none of the assessment instruments are designed to account for digestive losses, lack of 
absorption, competitive absorption of a mixed diet, and recall error (38, 44), the 
relationship between reported intake and measured concentrations is attenuated.
E. Nutrient analysis of dietary data
The most comprehensive food frequency questionnaires or dietary assessment 
tools are ultimately dependent upon database analysis. Accuracy in dietary assessment is
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extremely important since errors in food data composition can cause misclassification of 
dietary intakes and limit the power of epidemiological studies to detect potential diet- 
disease relationships (67). Carotenoid analysis has been greatly enhanced with the 
development of more comprehensive analytical tools, extensive database development, 
and improved access to these databases (40, 66, 67, 69).
Historically, carotenoid values were reported in food composition tables in terms 
of their vitamin A activity. As the ability to detect individual carotenoids has improved, 
typically through the use of HPLC, quantification of concentrations for AC, BC, BCP, 
LY, and L/Z (68) have become more available. In 1993, extensive analytical data of the 
carotenoid content of more than 2,400 fruits and vegetables was published and utilized in 
the development of the expanded United States Department of Agriculture-National 
Cancer Institute (USDA-NCI) carotenoid database (68 , 69). Since then, data on the 
specific content of carotenoids have continued to expand. A recent study by Michaud et 
al. determined that an expanded carotenoid database provided valuable information on 
specific carotenoid intake, and could be useful in epidemiological studies designed to 
examine an association between fruit or vegetable intake and disease (63). In addition, 
LY, BCX, L/Z, AC and BC intake values calculated from the new database were 
substantially better at predicting their respective plasma concentrations than total 
carotenoid vitamin A activity used in earlier databases (63).
The opportunity to access these comprehensive databases continues to improve. 
For instance, the Nutrition Coordinating Center (NCC) of the University of Minnesota 
has developed an extensive food and nutrient database (124). This Nutrition Data System 
(NDS) has incorporated the latest USDA values as well as additional data from
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professional journals, researchers, and manufacturers’ analyses. Nutrition Data System 
for Research includes information on the six major carotenoids, with values for L and Z 
represented as a combined L/Z value. Over 19,000 foods, including specific carotenoids, 
brand names, and supplement composition are included.
Many research institutions, as well as some of the nationally promoted FFQ’s use 
or will be using this or other expanded carotenoid database systems. However, 
differences in the calculations of the contributions of specific foods to total nutrient 
intake, the availability of numerous data sources, and uniqueness in survey designs 
contribute to different nutrient estimations derived from the various FFQ’s.
F. Carotenoid intake, absorption, transport and deposition and their relationship to 
macular pigment
Combined with the dietary and ocular data, biochemical analysis provides 
additional data to provide a more complete understanding of the relationships among 
reported dietary intakes, circulating blood concentrations of carotenoids and lipids, and 
MP density and distribution. Given the inherent difficulties in reporting and estimating 
dietary nutrient intake, serum carotenoids indicate the circulating concentrations of these 
plant pigments. The serum concentrations may be different than those estimated by 
dietary intake, but do reflect post-absorption concentrations.
Numerous research studies that have examined carotenoid intake and serum 
concentrations generally show a relationship between reported intake and serum 
concentrations. A number of variables such as digestion, absorption, lipoprotein profiles, 
food and nutrient interactions, sample extraction methods and database information 
influence reported serum carotenoid concentrations (37, 39, 125-127). Researchers have
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shown that serum concentrations of carotenoids often appear to be biomarkers not only 
for carotenoid intake, but fruit and vegetable consumption as well (41, 63,127, 128). 
Carotenoids are stored in body tissue, including but not limited to adipose tissue, the liver 
and as this study indicates, retinal tissues (129, 130).
For many individuals, dietary and serum concentrations of the oxygenated 
carotenoids L and Z are related to MP deposition (5, 28, 131). Hammond et al. found that 
plasma carotenoids were significantly related to dietary L/Z for males (r= 0.70, 
p<0.0005), and females (r= 0.56, p<0.005). Ciulla et al. found that reported dietary L/Z 
intake predicted 2.01% (p= 0.01) of the MPOD variance and that serum concentrations of 
L and Z predicted 7.05% (p <0.0001) (44) of MPOD variance. MPOD was also 
significantly related to plasma L and Z for males (r= 0.62, p<0.Q05), and females (r=
0.30,p<0.05) (5).
Hammond et al. found that MPOD could be increased in some, but not in all test 
subjects, after increased consumption of Z- and/or L- rich foods (28). Landrum et al. 
found that two subjects given L supplements for 140 days experienced a mean increase in 
the peak MP density of 39% and 21 % respectively (87). For most, an increased intake of 
carotenoids translated into increased MP deposition as determined by MPOD. However, 
in some individuals, there was no apparent change in MPOD, while in a small percentage 
of subjects, an increase in L and Z intake resulted in apparently lower MPOD scores (28). 
This surprising decrease in MPOD puzzled the investigators as reported in the original 
research and has yet to be explained in subsequent MP research. Differences in 
deposition patterns may play a role in these results. If excess dietary or supplemental L 
and Z were deposited in higher amounts in the parafoveal than the foveal region, the
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resulting calculations for MPOD would be lower (15). However, based on three 
individuals with widely different peak macular densities, Hammond calculated that these 
differences would only underestimate MP by approximately 4%. Typically, this small 
underestimation would affect data from subjects with a higher than average MP since 
their distribution pattern tends to be wider than those with low pigment measurements 
(15).
In addition to ingestion, a number of factors influence serum carotenoids.
The fat-soluble carotenoids are dependent on the presence of lipids for absorption and 
transport (74, 132). Lipoprotein carriers demonstrate selectivity for specific carotenoids. 
For instance, Forman et al. determined that the hydrocarbon carotenoids AC, BC and LY 
were highly concentrated in LDL lipoproteins, while the xanthophyll carotenoids (L and 
Z) were more evenly distributed between LDL and HDL (55). Traber also determined 
that BC was carried predominately by the LDL (133). The other carotenoids, including 
the more polar xanthophylls L and Z are transported preferentially in the HDL (53%) and 
to a lesser extent by the LDL (31%) and VLDL (16%) lipoproteins (54, 86,134). It is 
hypothesized that BC and the other hydrocarbon carotenoids are found in the 
hydrophobic core of the lipoprotein, while the more polar xanthophylls probably reside 
closer to the lipoprotein surface (54). In the HDL subclasses, L/Z were more concentrated 
in the HDL 3 than in the HDL2 fractions (135).
G. Body mass index, sex, age, dietary practices and tobacco use: relationship to 
carotenoid and macular pigment status
Research results have indicated that a greater body mass index (BMI) may 
be associated with lower concentrations of circulating carotenoids (39, 132). In a recent
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abstract by Hammond and Cuilla, an inverse relationship was reported between MPOD 
and BMI in 680 subjects (r=0.12, p< 0.008) (136). These results were largely attributed to 
those whose BMI was > 29. The measured MP were 29% lower in those with a BMI over 
29, and 27% lower in those whose percent body fat was over 30%. In addition, reported 
dietary intake and serum carotenoids were lower in those with higher BMI in the subset 
of 280 subjects for whom dietary and serum concentrations data were available. Results 
from the Age-Related Eye Disease Study Group revealed a higher BMI was associated 
with the development of neovascular AMD (17). However, in the Beaver Dam Eye 
Study, greater BMI was associated with the prevalence of early age-related maculopathy 
(ARM) but not neovascular AMD (73). Age-related maculopathy (ARM) refers to those 
early signs of macular demise and change. This frequently mimics changes associated 
with normal aging, without the full complement of symptoms and change that 
characterize the more debilitating AMD (137).
In addition to the dietary intake differences noted by Hammond (136), obese 
subjects have been shown to demonstrate insulin resistance (138) and impaired glucose 
tolerance (139). Insulin resistance has been linked to increased plasma concentrations of 
lipid peroxides, and decreased concentrations of some carotenoids and tocopherols (140). 
Gender (141), phase of the menstrual cycle (55), age (142), fiber intake (143), alcohol 
(144), as well as tobacco use (6 , 83, 145), may also influence serum carotenoid 
concentrations and MP status.
H. Macular pigment
The presence of MP is unique to primate retinas. According to an extensive 
review by Nussbaum et al. (146), Buzzi noted a yellow color in the retina in 1782 (147);
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by 1795, it had been identified as the “foramine centrali limbo luteo” by Soemmering 
(148). Debate on whether it was a post-mortem artifact (149, 150) or a part of the living 
eye (151, 152) continued throughout the 1800’s and into the 1900’s. According to 
Nussbaum (146) part of this debate may have been due to the variability of the lights used 
to examine the retina. For example, investigators using illumination with a high blue- 
green content would have been more likely to see the yellow pigment compared to those 
using light at the yellow-red end of the spectrum. Between 1918 and 1937, Vogt 
published work that he felt supported the in-vivo existence of pigment in the macula 
(153). Determination of the chemical structure of the MP was significantly advanced by 
Wald’s research (154) published in 1945. Wald determined that the pigment absorbed 
wavelengths between 430nm and 490nm, with maximum absorption of 60% at 465nm, 
and that the shape of the absorption curve was consistent with this pigment’s being a 
carotenoid. He then isolated the pigment from human maculae and identified it as a 
xanthophyll.
However, it has been during the past fifty years that research into the retinal 
macula has expanded tremendously. The distribution of MP has been studied in monkeys 
(34, 155) and in human eyes that have become available via autopsy (2, 34). Lutein and 
zeaxanthin are the dominant dietary carotenoids found in the macular region of the eye; 
they are present in sufficient quantity to impart a yellow, ‘lutea’ color to this area (7, 28, 
156, 157). Landrum and Bone identified a third significant macular carotenoid, meso- 
zeaxanthin a stereoisomer of zeaxanthin (130). It is now estimated that the three isomeric 
carotenoids lutein, zeaxanthin, and meso-zeaxanthin comprise 36%, 18%, and 18% of the
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MP respectively (22). Several additional minor carotenoids have been identified in retinal 
tissue using HPLC analysis (22).
The distribution of MP varies by eccentricity around the fovea. The fovea is the 
depression in the retina where the inner retinal layers are absent. It is estimated that the 
human fovea is about 1500 pm (5°) in diameter and has only cones in its center. (158). 
The retina is organized around the point of maximum cone density, and most measures of 
visual performance vary relative to the fovea (158).
According to Landrum et al., Z is about twice as abundant as L in the center of the 
fovea (16). The concentration of both isomers diminishes radially away from the center 
of the macula. Lutein becomes increasingly more dominant in the outer region; it 
becomes about two-to-three times more concentrated than zeaxanthin. Despite the highly 
ordered distribution of these carotenoids, there is limited research on specific receptors or 
other factors, which may selectively influence L and Z deposition in the macula (159). 
These carotenoids are also found outside the foveal region, but not nearly in the same 
concentration (12, 14). Much remains to be understood about the major and minor 
carotenoids, their relationship to one another and their specific functions as components 
of the MP.
I. Macular pigment assessment
Macular pigment has been assessed using a variety of techniques based on 
properties unique to the visual system (160). These include but are not limited to autopsy 
analysis (161, 162), fundus reflectometry, color matching (163), Raman detection (164), 
scanning laser ophthalmoscope (SLO)(78) and heterochromatic flicker photometry
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Assessment by HFP of the MP is a non-invasive psychophysical measurement of 
the carotenoid pigments deposited in the foveal region of the retinal macula (10, 165). 
This methodology takes advantage of the fact that the MP is located anterior to the 
photoreceptors (15, 167). The smaller the amount of light that is transmitted, the greater 
the optical density (OD) of the tissue. The density measured is the sum of the carotenoids 
present in the fovea (i.e. L, Z, and meso-zeaxanthin)( 131). Macular pigment density is 
determined by subtracting the spectral sensitivity values of the parafovea, where MP is 
considered to be negligible, from the spectral sensitivity values of the fovea, where MP is 
most highly concentrated (5). Macular pigment optical density assessment bypasses some 
of the uncertainties inherent in just using carotenoid blood samples as potential indicators 
of the tissue status of the macular region. Though blood samples provide an indication of 
nutrient transport, they do not necessarily indicate retinal carotenoid deposition. Macular 
pigment optical density determinations may be more precise and indicative of long-term 
ocular nutrient status (131).
There is limited research on MPOD status in live subjects. MPOD as measured 
using HFP has been reported for approximately 800 subjects during the past 14 years. 
These studies are summarized in Table 2. Results range from non-detectable to 
approximately 1.00 optical density (OD), with many studies recording between 0.20-0.40 
OD when using a one-degree central retinal stimulus (1). In studies conducted on 
populations in the Midwest (44) and the Southwest (45) mean MPOD ranged between 
0.21 OD for both males and females, and 0.24 OD and 0.21 OD for females respectively 
in these two studies that collectively examined approximately 500 individuals aged 17- 
51. In a study in the Northeast MPOD were reported to be higher; 0.38 for males and 0.24
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for females aged 19-83 (5). Note that comparisons of within-laboratory results are more 
meaningful than between-laboratory results since slight variations in assessment 
procedures and equipment can potentially yield differences in the relative value of the 
MPOD scores (168).
Most studies, including the ones cited above, have typically measured MP using a 
one-degree stimulus, which assess approximately 0.50 degrees eccentricity from the 
center of the macular retina. The site measured in the fovea, combined with one 
parafoveal measurement is used to calculate MPOD (5, 27, 165). Multiple foveal loci 
may be assessed using a series of optical disks and rings, which provide information on 
both MPOD and distribution.
Hammond et al. compared the spatial distribution of MP from multiple sites in 32 
subjects (18 females and 14 males) aged 21-63 (15). The spatial distribution of the 
reported MP varied by no more than 16% at the horizontal and vertical meridians 
indicating a fairly symmetrical pattern of MP distribution in most of the 32 individuals 
investigated (15). Data were analyzed using both Gaussian and exponential functions.
The exponential decay with eccentricity explained more variance than a Gaussian 
function. Upon further analyses of the results, approximately 13 (40%) subjects exhibited 
small deviations, described as small valleys or flanking peaks. In four of these subjects 
repeat measurements were taken and similar results were obtained, indicating these peaks 
were a fairly stable feature for these individuals. The researchers acknowledged that the 
absolute magnitude of these deviations was small, and would require further research to 
determine the frequency of MP deviations from the smooth curve. Additional research 
results from this study indicated that at higher MP peak densities the distribution of
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carotenoids was wider, resulting in higher carotenoid concentration in the parafoveal 
region of the retina. This could result in an underestimation of the peak macular density, 
because the calculation of density is based on the assumption that there is limited or no 
significant pigment in the parafoveal region. Thus the under estimation would most likely 
be limited to those individuals with high MP (13, 15).
Werner et al. suggested there may be a slight decline in MPOD as people age, but 
proposed this would not be significant. Age was calculated to represent about 4% of the 
variation in MPOD (27). Aging has not been consistently linked to a decline in MP, 
although advanced age has, as the name implies, been strongly associated with the 
development of AMD (137,169,170) (85). Beatty et al. (1) and Hammond et al. (14) 
suggested that there might be a trend towards a reduction in MP as individuals age, 
particularly in those over 60. Hammond’s results did not demonstrate an age-related 
decrease in MPOD when data from the entire sample of individuals aged 24-84 were 
analyzed together. There was an average MPOD level of 0.40 OD in those aged 24-36 
and an 0.46 OD in those aged 60-84 (a higher but not significant difference). However, 
there was a significant rate of decrease in MPOD when the subset of subjects (those aged 
60-84) was considered. It was noted that the decline of MP paralleled an accelerated loss 
in visual sensitivity (14).
Macular pigment optical density was found to be higher in men than in women 
aged 19-83 years in New England using the standard one-degree stimulus: male 
measurements averaged 0.38 OD while those in females averaged 0.24 OD (5). However, 
MPOD for men and women aged 18-51 in Indianapolis were lower: 0.21OD for both 
males and females (44). Similarly low results for both females and males were also found
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in a Southwestern population (45). Differences in MPOD have been partially explained 
by possible variations in the populations studied. Dietary habits, gender, age, health 
status, genetics, hormones, and lifestyles of the subjects evaluated, as well as equipment 
design and assessment techniques are some of the factors that may influence MPOD (14, 
15, 27, 28, 44, 168).
J. Macular pigment and vision
Loss of central visual acuity is one of the classic symptoms associated with AMD. 
The foveal region has the highest concentration of cones and is the site responsible for 
fine vision and central vision tasks such as reading, sewing, and facial recognition. In 
1988 it was hypothesized that MP may help to protect the fovea from neural damage 
caused by visible-light exposure over a lifetime (24). The sensitivities of the short-wave- 
sensitive-cones and long-wavelength pathways were assessed in a group (n=17) of 
younger age subjects (mean age, 23 years) and a group (n=12) of older subjects (mean 
age, 67 years). There was no statistically significant difference found at any of the retinal 
locations between the groups for measurements of long-wavelength sensitivity. However, 
the older group did demonstrate a significant decline in short-wavelength sensitivity 
across the retina, compared to the younger group, with more of a loss at the non-foveal 
locations than at the fovea. It was concluded that these results demonstrated a potentially 
protective role of the MP in the fovea.
Hammond et al. (14) evaluated vision sensitivity using threshold sensitivity 
methods developed by Wooten and Wald (171). Non-smoking subjects (n=37) were 
evaluated. Vision sensitivity in the older subjects (n=27) with a high MP did not differ 
from that of the younger subjects (n=10). However, in those older subjects with low MP
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densities, vision sensitivity was lower than their younger counterparts. The effect of MP 
was age dependent, since no significant relationships were found between MP density 
and visual sensitivity measurements in the young subjects.
Vision function tests used in the present study included those designed to assess 
visual acuity, contrast sensitivity, and macular function (76). These tests also help to 
ensure that the data used in MP analysis was from subjects free of significant functional 
ocular impairment.
K. Age-related macular degeneration (AMD)
As the name implies, age-related macular degeneration is a disease associated 
with aging along with a significant decline in the structure and function of the macular 
region. Age-related macular degeneration is the leading cause of permanent visual 
impairment and blindness among the elderly in Western countries (172). Based on 
slightly more than 20,000 subjects from nine AMD prevalence/incidence studies 
conducted in a variety of countries (including the United States), it has been estimated 
that AMD affects close to 30% of those over age 75 (13, 172). Genetics has been 
identified as a risk factor in the development of AMD (173, 174).
Researchers from Switzerland and the United Kingdom reported a greater 
incidence of macular degeneration in women than in men (13, 137). In 1997, the National 
Eye Institute (NEI) declared macular degeneration the leading cause of severe visual 
impairment and blindness in Americans 60 years of age and older. In addition, women 
were identified as being at slightly greater risk for development of the disease than men 
(85). Neither the US Center for Disease Control and Prevention, nor the NEI of the
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National Institutes of Health (NIH) has national statistics. It remains to be determined if 
American women are at greater risk for AMD than men.
Data from the United States suggest that over 640,000 Americans are affected by 
the late stages of AMD (175, 176). As documented in the international studies, age is the 
primary risk factor for this disease. Data from the Framingham Eye Study suggested that 
only about 1% of the subjects suffered from macular degeneration between the ages of 
55-64. Rates increased to 6.4% and 19.7% for those between the ages of 65-74 and 75-85 
respectively (177).
The two major classifications of AMD are "dry" (geographic atrophy) and 
”wet"(neovascular/exudative). The dry form is the most common, occurring in 
approximately 90% of those diagnosed with the disease (178). This type of AMD tends to 
develop slowly and is characterized by the presence of soft, confluent deposits known as 
drusen. The accumulation of drusen in the retinal pigment epithelium layer of the retina 
eventually appears to increase the rate of decline of the photoreceptor cells in the macula. 
In the wet form, which makes up the remaining 10% of the cases, new blood vessels 
infiltrate the retinal pigment epithelium and progress into the neuronal layers of the 
macula. These very thin blood vessels frequently leak fluid and blood, causing demise of 
the photoreceptor cells in the vicinity of the infiltration. Although only a small percentage 
of those individuals with macular degeneration are diagnosed with the wet form, they 
make up the majority of patients with the most severe vision loss (178). Epidemiological 
results from the Beaver Dam Eye Study (BDES) indicated that a high intake of saturated 
fat and cholesterol was associated with an increased risk of early AMD in this population 
(8). Persons with intakes of saturated fat and cholesterol in the highest quintile had 80%
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and 60% higher odds for early ARM than those in the lowest quintile. Researchers 
offered the following three possible mechanisms influencing the association of saturated 
fat and cholesterol with macular disease. First, these dietary factors increase the risk for 
systemic vascular disease. Second, higher concentrations of saturated fat or cholesterol 
may enhance direct deposition of fat in Bruch’s membrane, which may subsequently 
interfere with the flow of metabolites in and out of the retinal pigment epithelium. Third, 
high intakes of dietary saturated fat or correlates such as high butter intake may reflect 
other unmeasured behaviors that increase risk for AMD (8). In contrast to this research, 
Sanders et al. did not show a relationship between cholesterol and AMD (179). Results 
from human studies that evaluated diet and/or supplement use for their potential role in 
MPOD status and macular disease risk factors and/or AMD development are summarized 
in Table 3; data on vitamin A and the carotenoids are presented in Table 4.
L. Age-related macular degeneration and macular pigment status
To date a direct link between the development of AMD and reduced MP has not 
been unequivocally established. Evidence from animal and human studies indicates that 
diminished MP and retinal damage may be related (2,175). In studies on monkeys, those 
fed a diet devoid of plant pigments for six years developed retinal damage similar to that 
seen in human age-related macular degeneration (180). Animal and clinical studies of 
supplementation and deficiencies indicate that nutrient exposure can influence macular 
tissue. Diet and epidemiological evidence, as summarized in Tables 3 and 4, indicate that 
in some studies there is evidence of a relationship between MP and retinal status. 
Epidemiological evidence is inconsistent regarding the potential relationships among diet, 
genetics, and environment and the development of AMD (175,181). According to
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Mares-Perlman, the inconsistencies of these results may be due, in part, to the complex 
relationship of diet to age-related macular degeneration as well as limitations in the 
studies’ designs (175). Although modification of diet may represent one of several 
lifestyle choices that could serve to enhance retinal health and possibly delay the onset or 
progression of AMD, specific guidelines have not been developed because of the 
uncertainty surrounding diet and AMD (175).
There are many factors that may influence carotenoid status and MP. The 
methods used in the present study include assessment strategies designed to determine 
carotenoid intake, transport and deposition. Although further discussed in the methods 
section, their selection reflects the realization of the need to assess multiple factors that 
may influence MP status.
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III. SUBJECTS AND METHODS
A. Subject recruitment
Participants were recruited primarily from southeastern NH and southern Maine 
after the research protocol had received approval from the University of New Hampshire 
Institutional Review Board (Appendix A). The tenets of the Declaration of Helsinki (182) 
were utilized as the basis for the guidelines followed for human subject involvement at 
UNH.
Recruitment strategies included advertisements in campus newspapers and a 
regional newspaper, announcements at professional and community organization 
meetings, a presentation to an association of retired individuals, and personal outreach. In 
additional, brochures and flyers (Appendix B) were also made available through an area 
optometric association, posted on campus, and distributed through a campus-based 
restaurant. Some participants referred additional subjects via personal contact. Subjects 
were recruited from April 2000 through January 2001.
Upon expressing interest in the study, additional information regarding the design 
of the study and key tasks associated with participation were provided to potential 
subjects. A participant information questionnaire (Appendix C) was administered to 
ensure that the participant met the study criteria, including being free of macular eye 
disease and not having a diagnosis of diabetes. Participants were provided a copy of the 
informed consent (Appendix D) in an information packet sent prior to their appointment 
to allow time for review; the informed consent was signed in the presence of the principal 
investigator or other members of the nutrition and vision research team. Additional
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information about the study, detailed directions, a parking pass as well as a health and 
vision history survey (Appendix E) developed for use in a previous study by Cooper et al. 
(183) were also included in the packet. One visit to the nutrition and vision laboratory 
was required. Calls were made 24 to 48 hours prior to scheduled visit to remind subjects 
of their appointments and of the need to fast 10-12 hours prior to the blood test. Food and 
beverage was provided once the blood sample was drawn.
B. Anthropometries and descriptive data
Anthropometric assessments consisted of height, weight, and waist-hip 
measurements. Participants were clothed, but shoes were removed for the weight and 
height assessments. A consumer scale (Thinner Brand ®) was used to record weights. 
Weight was recorded to the nearest pound. To assess height, two yard sticks were affixed 
end to end on the laboratory wall. Participants were asked to stand with the back of their 
heels against the wall and to look straight ahead. A flat ruler was placed gently across the 
top of the participant’s head. Height was recorded to the nearest quarter inch. A flexible 
tape measure was used to assess waist and hip measurements. The waist assessment was 
taken by measuring the narrowest section of the torso, typically using the navel as the 
waist reference point. The hip measurement was taken by measuring the widest part of 
the torso. The waist value was divided by the hip value to determine the waist hip ratio. 
BMI was calculated by using the following formula: BMI = weight in kg / height in m2.
The potential influence of BMI on MPOD was initially evaluated by examining 
the data using two different sets of criteria. In the first set of analyses, participants were 
placed into two categories: those with a BMI of < 27 and those with a BMI of > 27. For 
the second set of analysis, new BMI categories promoted by the NIH were used to
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categorize subjects into three major groups; the healthy weight range (BMI 18.5-24.99), 
the overweight range (BMI 25.00-29.99), and the obese range (BMI>30.00). Descriptive 
data from the health and vision histories were completed by each participant and entered 
into the research database using the Excel 97® (Microsoft) software.
C. Dietary assessments
Fruit and Vegetable Screening Tool (7-FVST)
Subjects were identified as low, US average consumers, above US average 
consumers, and high consumers of fruit and vegetables by the results of a nationally 
available seven item fruit and vegetable screening (7-FVST) tool by Block Dietary Data 
Systems (57)(Appendix F). The low consumer scores reflect intakes of fewer than three 
servings of fruits and vegetables per day, average consumer scores reflect estimated 
intakes close to the American average of less than four servings of fruits and vegetables a 
day and above average consumers scores are indicative of eating close to five servings of 
fruits and vegetables. Those with a score of 16 or more were most likely meeting or 
exceeding the daily goal of the ‘5-A-Day’ fruit and vegetable program guidelines (184) 
(eating 5 servings of fruits and vegetables per day). This survey was completed over the 
phone at the time of recruitment, or during the laboratory visit. The score was calculated 
by adding the assigned points from each of the seven questions presented. All scores 
were double-checked for accuracy.
24 Hour-Carotenoid Guided Food Recall
Total dietary carotenoid intakes were evaluated using instruments designed to 
assess both recent carotenoid intake as measured by a 24-hour carotenoid guided food 
recall (24hr-CGFR) (Appendix G) and long term food and carotenoid intake (as measured
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by multiple FFQ’s). By using the 24hr-CGFR provided by Neuhouser et al. of the Fred 
Hutchinson Cancer Center, intakes of carotenoid during the previous 24-hours prior to 
the laboratory visit were documented (60). Food models and measuring cups were used to 
assist participants in the quantification of food intake. In those instances in which portion 
size was not stated, a medium portion was entered into the analysis. The 24hr-CGFR was 
analyzed using NDS-R nutrient data software version 4.02 developed by the Nutrition 
Coordinating Center (NCC), University of Minnesota, Minneapolis, MN, Food and 
Nutrient Database 30, released November 1999. Only carotenoid values were calculated 
for this recall.
If an analytic value is not available for a nutrient in food, NCC calculates the value 
based on the nutrient content of other nutrients in the same food or on a product 
ingredient list, or estimates the value based on the nutrient content of similar foods. A 
missing value is allowed only if 1) the value is believed to be negligible, 2) the food is 
usually eaten in very small amounts, 3) it is unknown if the nutrient exists in the food 
at all, or 4) there is no way to estimate the value because the food is unlike any other 
(61).
Upon completion of all the data entry from the subjects 24hr-CGFR, the 
arithmetic means and standard deviations for each carotenoid were calculated using the 
SYSTAT 9.0 (© 1999. SPSS Inc. Chicago, IL) program (185). Individual carotenoid 
results that were greater than three standard deviations from the group mean were 
considered outlier data and removed from any additional statistical analysis for that 
individual carotenoid. The number of outliers for each carotenoid assessed included one 
subject for L/Z, two subjects each for AC, BC, BCP, and three subjects for both LY and 
total carotenoid assessment.
Food Frequency Questionnaires
Three FFQ's (the B-FFQ, the FH-FFQ, and the T-FFQ) were given to each 
participant. A list of the names and addresses of each of the FFQ’s are part of
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Appendix G. Detailed instructions were verbally provided, including a review of food 
portion size using food models and measuring cups for most of the naive subjects. Each 
of the FFQ developers provided written directions within their respective booklets. The 
B-FFQ was distributed with additional detailed instructions and a picture of food portions 
provided by Block, which was clipped to each B-FFQ. For participants who had 
familiarity with food portions such as dietitians and nutrition professionals, the use of the 
food models was omitted. Participants were informed that each of the FFQ’s would 
contain similar information, but that the goal of this component of the research was to 
determine if one of these three was better correlated with serum carotenoid 
concentrations or MP. The participants were encouraged to answer as completely as 
possible. Since the other components of the assessment day typically took between three 
to four hours, participants were allowed to take home the FFQ’s and return the completed 
responses in a pre-paid mailer. The FFQ’s were given to the participants in a pseudo 
random order, and subjects were asked to complete the FFQ’s in the order as given. This 
was encouraged to minimize any effect that the order of completing the FFQ’s may have 
on data accuracy or quality. Approximately 25 subjects who started the project in the 
initial stage, (when only one or two FFQ’s were being utilized), were mailed the 
subsequent surveys approximately six months later. Upon completion of the research, all 
subjects had been asked to complete all the surveys.
Each of the FFQ’s was reviewed twice for completeness prior to submission to 
their respective developers for analysis. Individuals were phoned, e-mailed or contacted 
in person to clarify confusing or missing data. At least two attempts were made to reach 
individuals with eight or more missing data entries for any one FFQ. The use of the data
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from the health history or a companion FFQ was also used as a way to resolve incomplete 
data entry.
Some questionnaire data, though completed by the subjects, were deemed 
questionable by the developers based on missing data, improbable total caloric intakes 
and/or failure to answer adjustment questions clearly. For the purpose of our analysis, 
estimated caloric intakes of the FFQ were reviewed as the criteria for inclusion of the 
FFQ into the analysis. Reported caloric intakes were expected to fall within the 2090- 
20,900 kilo-Joules (kJ) per day (500 to 5000 calories per day) as evidence of an 
understanding of the reporting tasks associated with completing a FFQ as well as a 
method to minimize inclusion of outlier data. This cutoff point had also been used in 
previously published study (183).
D. Biochemical assessments 
Blood Sample
Blood was drawn from subjects in a fasted (10-12-hr.) state by trained staff using 
universal precautions. Typically, a 21-gl Precision Glide Vacutainer® needle (# 36-7212 
Becton Dickinson Franklin Lakes, NJ) was used for the blood draw. For some 
individuals, a ‘butterfly needle’ 23 g % Vacutainer®, with 12 in tubing (# 36-7253, 
Becton Dickinson) was used. A latex disposable tourniquet strap (#02002 Hygenic Corp., 
Akron OH, Fischer Scientific, Pittsburgh, PA) was tied along the upper arm. Blood 
samples were drawn from the antecubital vein for both carotenoid and lipid analysis. For 
carotenoid assessment, a 6-mL serum separation Vacutainer® was used 
(# 36-6511 SST® Gel and Clot Activator, gray and red tiger top, Becton Dickinson). The 
tube was wrapped in foil to protect the photosensitive carotenoid pigments from
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excessive exposure to light. An additional 7 mL of blood was drawn into a separate 
Vacutainer® test tube (# 36-6450 K3 EDTA, purple top Becton Dickinson) for total 
cholesterol (TC) and lipoprotein analysis. The samples were inverted 10-15 times by the 
phlebotomist immediately after the draw. The samples were typically processed within 
the next 15 to 45 minutes. If that was not possible, the samples were refrigerated and then 
processed within the same day, but usually no more than two hours after the blood was 
drawn.
Carotenoid Analysis:
The carotenoid samples were centrifuged at 1650 relative centrifugal force (x g) 
for 15 minutes at 4°C (Beckman Model Refrigeration Unit TJ-R and Beckman Model 
Centrifuge TJ-6). Subsequently, 500 pi aliquots of the separated serum were placed into 
six 2mL sterile round bottom cryovials (MS-# 4502 Vangard Cyros™, Neptune, NJ). The 
samples were passed quickly under a stream of nitrogen gas, and then were stored at 
-80°C (# Revco) until immediately prior to assessment of the carotenoids using high 
performance liquid chromatography (HPLC).
Biochemical assessment of carotenoids was conducted using reversed phase 
HPLC. As published in past papers, carotenoid analysis utilized established methods 
from Dr. Joanne Curran Celentano’s laboratory (5, 44). For analysis, 400 pL serum was 
precipitated with ethanol. An internal standard comprised of retinyl acetate and 
tocopherol acetate (Sigma, St. Louis, MO) was added to each sample. After vortexing, 
the sample was extracted into hexane. The hexane layer was removed into a common 
amber vial with a Teflon lined cap (Scientific Specialties # B75582, Randallstown, MD). 
The hexane extraction step was repeated one additional time. The hexane layer was
41
permission of the copyright owner. Further reproduction prohibited without permission.
evaporated under a stream of nitrogen gas until just dried. The sample was either frozen 
at this time for next day analysis, or analysis continued. As the process continued, the 
sample was resuspended in ethanol; then 40 |xL was injected into the HPLC injection 
port, overfilling the sample loop by 20 pL, thus leaving a 20 pL for analysis.
A lab standard was run at the start and the end of each day of carotenoid analysis. 
This standard was comprised of serum that has been pooled from individual volunteers. 
To establish the laboratory standard values, the standard was initially run multiple times 
each day over a 4-day period. The data were then analyzed for inter-day, inter-sample, 
and inter-run variability. The mean and standard deviation was calculated, and used to 
establish the acceptable range for each analyte in the lab standard. At each run of the lab 
standard, the concentrations for each analyte was expected to fall within these ranges.
The HPLC system was a gradient reversed phase system equipped with an HP 
1100 (Agilent Technologies, Burlington, MA) photo diode array detector set at 452 nm, 
for tocopherol, retinol, and carotenoids respectively. The analytical column was a 4.6 x 
250 mm Bakerbond C18 column (Mallinckrodt Baker, Phillibsburg, NJ). The column was 
kept at a constant temperature by using an Eppendorf CH-30 column heater (VWR # 
21506-105 Eppendorf/Brickman, Boston, MA) set at 24.8° C by an Eppendorf TC-50 
temperature controller (VWR # 21506-103 Eppendorf/Brickman). The mobile phase 
consisted of 100% methanol buffered with 0.1% ammonium acetate (solvent B). A flow 
rate of 1.5ml/min transitioned to 80/20% methanol/methylene chloride with 0.1% 
ammonium acetate (solvent A) during the course of the 22.5 run time. The transition 
times from time 0 minutes to 4 minutes, solvent B was running 100% with a flow rate of 
1.5mL/min; by time 10.50 minutes, solvent A was flowing at 100% at a flow rate of
42
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1.5mL/min; this rate reached 2.0mL/min a from time 17 minutes to 20 minutes; at 21 
minutes, solvent B was running at 100% by minute 21 minutes and continued at this rate 
through the remainder of the analysis.
Methods were developed and stored using Agilent Technologies® Hewlett 
Packard (HP) 3365 Series II Chemstation (Agilent Technologies, Burlington, MA). Data 
were also analyzed using the HP 3365 Series II Chemstation and Microsoft ® Excel 97- 
SR-2 (Microsoft Corp., Redmond WA). Quantification was performed using areas under 
the peak to internal standards and the simultaneous running of lab standards and external 
standards. Accuracy was assessed using the National Institute of Standards and 
Technology (NIST) Standard References Material SRM 986 (Gaithersburg, MD).
Each serum carotenoid sample was analyzed in duplicate on the same day; results 
were averaged from these two assessments for the mean serum carotenoid value. If the 
results from the first or second run differed by more than 15% from the mean carotenoid 
value for AC, BC, LY, or L, or 20% for Z, analysis of the carotenoid sample was 
repeated using spare samples obtained during the initial blood draw. The total carotenoid 
calculation was derived by adding the SI conversion results for BC, LY, L and Z 
together.
After results from the serum samples had been obtained, the arithmetic means and 
standard deviations for each carotenoid were calculated using the SYSTAT program. 
Individual carotenoid concentrations that were greater than three standard deviations 
from the group mean were considered outlier data and removed from any additional 
statistical analysis for that individual carotenoid. The number of outliers for each
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carotenoid assessed included one subject each for BC, L, Z, L/Z, and total carotenoids 
results. There were no outliers for LY.
Cholesterol and Lipoprotein Analysis
Total cholesterol and lipoprotein analysis was coordinated with the Jean Meyer 
USDA Human Nutrition Center on Aging at Tufts Nutrition Evaluation Laboratory 
(NFL) in Boston, MA. Lipid samples were drawn at the University of New Hampshire, 
underwent initial processing and storage at UNH, and were eventually shipped under dry 
ice to the NEL. The NEL is a federal and state licensed in-house clinical and analytical 
laboratory that participates in the Clinical Laboratory Improvement Act (CLIA) certified 
proficiency programs. It also participates in the National Institute of Standards (NIST) 
sponsored ‘Round Robin’ programs and in external validation studies in which samples 
are assayed in laboratories possessing similar methodologies. The laboratory has over 15 
years of experience doing lipid analysis and their data have been published from a vast 
number of clinical and epidemiological research studies on aging (186).
For lipid analysis, after the blood was drawn into the one Vacutainer®, it was 
typically kept at room temperature and then centrifuged (with the carotenoid tube sample) 
after balancing at 1650 x g for 15 minutes at 4°C (Beckman Model Refrigeration Unit TJ- 
R and Beckman Model Centrifuge TJ-6).
For the TC sample, 500pl of plasma was removed from the purple top (EDTA) 
Vacutainer® tube and placed directly into a cryovial as identified above. This was 
repeated for a total of three times. The cryovials were stored in the same a -80° C freezer 
identified above. One of the three samples was sent for processing at NEL. The 
remaining two were stored as reserve samples.
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For the HDL-C preparation, one mL aliqouts of serum was from the Vacutainer® 
tube were placed into each of two labeled test tubes (12 X 75 disposable borosilicate 
glass culture tubes, Fisher Scientific, Pitttsburg, PA). Then, 100 pi of reagent (HDL 
Cholesterol #352-3, Dextran Sulfate/Mg2+ Sigma Diagnostics, St. Lewis, MO) was added 
to each tube. The tubes were capped and vortexed for ten seconds. They were allowed to 
set for ten minutes and then centrifuged in the Beckman Centrifuge and spun again for 15 
minutes as previously discussed. Subsequently, 500 pL of the serum (500 pi from each 
tube) was pipetted into the supernatant (SPNT) I and SPNTII labeled cyrovials (2mL 
sterile round bottom cryovial, MS-# 4502 Vangard Cyros™, Neptune, NJ) respectively. 
For the SPNT III cryovial, 250 pi aliquots from each test tube were added to total 500 pL 
for the third cyro vial. The HDL-C samples were stored in a -80°C degree freezer. The 
HDL-C cryovial SPNT I was sent under dry ice to Tufts; the remaining two samples were 
stored at -80°C as reserve samples.
Direct enzymatic reactions and a Cobas Mira Analyzer (Roche Diagnostics,
Basel, Switzerland) were utilized for the TC, HDL, and TRIG analysis at the NEL. For 
TC analysis, an enzymatic endpoint reaction was used. The cholesterol reagent was 
supplied by Roche Diagnostics, (item #44334); the calibrator was Roche Diagnostics 
Cobas Calibrator Serum (item #44157); controls were Chiron Normal and Abnormal 
Assayed Control Serum; the normal range of cholesterol was considered to be between 
3.36-7.19 mmol/L (130-278 mg/dL).
For HDL-C analysis, an enzymatic endpoint reaction was used. The cholesterol 
reagent and calibrator serum was the same as that used for TC identified above. The 
controls included Sigma Assayed Bi-Level HDL Cholesterol Controls (items # H4009
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and #H5009); the normal ranges were considered to be between 0.95-2.12 mmol/L (37-82 
mg/dL).
For TRIG analysis, a coupled enzymatic endpoint reaction was used. The reagent 
was Roche Diagnostics, (item# 44120); the calibrator was Roche Diagnostics Cobas 
Calibrator Serum (item #44157); controls were Chiron Normal and Abnormal Assayed 
Control Serum; normal ranges were between 0.46-2.30mmol/L (41-204 mg/dL).
The VLDL-C and LDL-C were calculated at the NEL using the results from the 
cholesterol and triglyceride analysis and the following formulas based on the work of 
Friedewald (187): VLDL-C=TRIG/5 and LDL-C =TC- (HDL-C) -  (VLDL-C).
E. Ocular assessments 
Vision Screening
Ocular assessment included the following vision screening tests: Early Treatment of 
Diabetic Retinopathy Study (ETDRS, #2111 Precision Vision, Inc., LaSalle IL) for vision 
acuity, the Pelli-Robson© (Chart # 7002250, Metropia Ltd., distributed by Clemente 
Clark Inc., Columbus, Ohio) for contrast sensitivity and the Amsler Grid for central 
vision acuity. Upon completion of these tests, HEP assessment for MP was conducted.
All vision measurements were conducted at the University of New Hampshire Nutrition 
and Vision Screening Laboratory.
For each of the three vision screening tests, subjects were given an eye occluder 
patch (Bemell Vision # U130B, Mishawka, IN). First, the right eye was tested, while the 
left eye was covered. Next, the left eye was tested while the right eye was occluded. 
Finally, binocular vision was assessed. Though both eyes were assessed during the 
screening process, the score on the right eye was used as the criterion of pass or fail since
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only the right eye was being evaluated for MP. Subjects were allowed to use their own 
corrective lenses or magnifying lenses available at the site as necessary.
The ETDRS vision acuity chart was posted 4 meters (13 feet) from the participant 
at eye level. The chart had a luminance of room light levels, approximately 125 cd/m 
(candelas per meters squared). The seated subject was instructed to read a line perceived 
as very readable, typically at the 20/50 Snellen level. From this point, progressively 
smaller lines were read. Subjects were encouraged to give it their best effort. The final 
score was calculated as the last line in which three out of five letters were identified 
correctly. A score of 0.63 LogMAR (logarithm of the minimal angle of resolution) or 
better, which was comparable to 20/32 Snellen score, for the right eye was considered 
passing. A copy of the chart (not scaled to actual size) is presented in Appendix H.
The Pelli-Robson © contrast sensitivity test chart was posted one meter from the 
subject. The chart had a luminance of 63 cd/m2. The subject was instructed to read the 
triplets from left to right. The second line from the top of the chart was approximately 
eye level with the subject. Subjects were encouraged to turn their head from left to right, 
and were allowed to bend down, but not forward, to see subsequent lines. For a small 
group of this sample, a chair was provided to bring the center of the chart at eye level. 
Subjects were encouraged to give it their best effort and to guess when they thought they 
may see a letter. The score was determined from the last triplet in which two out of three 
letters were read correctly. A score of 1.35 or better for the right eye was considered 
passing. A copy of the test record sheet comprises Appendix I.
To conduct the Amsler Grid central vision test, a copy of the grid (Appendix J) 
was held by the subject at reading levels approximately 12-16 inches from the subject's
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eye. The grid’s luminance was approximately 125 cd/m '.  A series of four questions was 
asked in order to determine central vision status (Appendix K) as outlined in the Hamblin 
Instrumentation Handbook (188). Participants passed the test if they were able to 
successfully answer the questions on the grid’s integrity, perimeter and central fixation 
points.
Macular Pigment Assessment
The Macular Metrics Corporation ® (Providence, RI) MP free-view instrument 
was used to assess MPOD and distribution. A detailed discussion of this heterochromatic 
flicker photometry (HFP) system’s design and corresponding validation results are 
available (10). The system was comprised of a Plexiglas-covered optical components 
unit, anterior chin and head rests, a participant’s luminance control unit, a filter wheel 
advancement apparatus and a central digital display/calibration unit. The chin and 
headrests were positioned at the edge of the 36-inch counter top. To minimize stray light 
from the recording area, a plywood frame (8”X15”X8”) was constructed and positioned 
in front of the HFP optical unit, sandwiched between the chin and head rest and the 
optical unit. The effective viewing distance was 16 inches. The luminance control unit 
was positioned within easy reach of the participant. The filter wheel advancement 
apparatus and the central display/calibration units were within reach and in view of the 
test administrator.
The details of the optical system components of this instrument are depicted in 
Figure 2 (10). Within this unit, the light for the background (SI) was provided by three 
light emitting diodes (LED) each with a peak energy of about 470 nm and half-widths of 
about 20 nm (Nichia Corp., Model NSPB300A). This wavelength is used to minimize
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any contribution from the short-wave sensitive cones and rods present in this region of
the retina to be examined. In effect, this biases the test towards the middle-and long-
wavelength sensitive photoreceptors, which are believed to exist in equal ratios in the
fovea and parafovea (5). Sensitivities of the fovea and parafoveal middle-and long-wave
cones are also believed to be similar.
For the SI background light source, the three LED were packed as tightly as possible 
in a triangular configuration. Light from these LED were made parallel with a 
planoconvex lens (LI, at 10cm focal length). A 1.75 inch circular aperture (Al) 
defined the 6 degree background field and was located approximately 2 inches 
beyond the planoconvex lens at a position where light from all three of the S1 LED 
overlapped. The background field was constructed by exposing high-density, 
photographic Mylar film with a computer-generated image of the aperture. The Mylar 
film was then affixed with optical grade glue to the smooth side of a diffuser. The 
polycarbonate diffuser was a high-efficiency, holographic type (Physical Optics 
Corporation) with a circular diffuser angle of 20 degrees. The background as viewed 
by the subject was reflected through a beamsplitter. The background appeared evenly 
filled with the light transmitted through the diffuser.
A second source of light (S2) was made parallel with a planoconvex lens (L2, 10cm 
focal length). The S2 was composed of three LED, two with peaks at near 460 nm, 
(Nichia Corp., Model NSPB 300A) and third one that peaked at 570 nm (UDT 
Technology) with half-bandwidths of 20nm. Construction and composition of the 
aperture-diffuser arrangement for the S2 channel was similar to that described for SI 
(10).
The S2 light sources alternated between 460 nm and 570 nm, the minimum and 
maximum absorption of the MP. When the light falls upon the macula, the 460 nm 
light is absorbed by the yellow MP and is therefore attenuated, while the 570 nm light 
is not changed. This results in a difference in luminance, which in turn causes the 
light impression to flicker (13).
Constant current supplies drove the LED. Radiance was controlled by sending 
brief (1.5 microsecond) square-wave pulses at a rate that could be varied from 
approximately 300 to 300,000 Hz. The frequency of each LED was individually 
adjustable with the radiance levels being measured by a photocell (PC) and the relative 
energy displayed on a digital display (10).
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The luminance of the background was set at 1.5 log Trolands (Td), the highest 
value that would allow for good adjustment range for the test field. The 570nm 
component of the test field was set at 1.7 log Td, the highest value that allowed for a wide 
range of settings for the 460nm component. The 460 nm component was calibrated at 1.7 
log Tds. The pre-determined radiance values of each field were precisely set at the 
beginning of each day (10). Typically the system was operating continuously and was 
recalibrated each day prior to use. In those instances when the instrument had been shut 
off, twenty minutes elapsed from the time of turning the instrument on until calibration.
Prior to the actual assessment, detailed information was provided to the 
participant. A computer simulation was developed by the UNH Nutrition and Vision Lab 
and the UNH Media Services Department (77). Participants used this concise interactive 
program to learn the general concepts and tasks associated with the MPOD assessment.
The actual assessment component consisted of an initial practice time during 
which optimal flicker rates were established for each retinal site assessed, followed by the 
MPOD evaluation. The MPOD evaluation was conducted in a darkened rectangular 
portion of the lab in which the walls were painted black. A black ceiling-to-floor curtain 
separated this area from the remainder of the laboratory. The left eye was covered with 
the same eye patch used during the screening assessment. In addition, the instrument’s 
internal eye occluder minimized any possible contribution by the left eye. A black cloth 
was placed over the back of the participant’s head if additional darkness was requested. 
The instrument’s base was at a counter height of 36 inches from the floor. Appropriate 
chairs were selected to adjust for subject stature and comfort. The participant placed 
his/her chin and forehead on the rests provided. The subject was instructed to peer into
50
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
the system through a one-inch hole centered on the optical axis. The chin support was 
adjusted so that the entire stimulus could be viewed while the right eye was fixated on the 
central 5-minute fixation point used for the four foveal stimuli. The subject dark adjusted 
for three minutes before the practice session began. Initially a flashlight was used as a 
light source for recording data tasks. Due to the length of the assessment and continued 
battery failure a small flexible florescent table lamp was used. In either case, the light 
was directed away from the subject towards the recorder.
During the practice session, the test administrator established the ideal settings for 
each of the sites to be assessed based on the subjects’ feedback. A series of 5 targets was 
used to determine MP density and distribution. The targets were changed using the filter 
wheel advancement apparatus. The foveal sites assessed were at the 0.167°, 0.50°, 1.00°, 
and 2.00° degrees retinal eccentricity. The parafoveal reference field was assessed using a 
1.00° radius disk whose center was 7.00° to the right of the 5-minute fixation light, 
thereby resulting in assessment of the parafoveal site 6 .00° retinal eccentricity.
The participant was instructed to adjust the control dial, (from the luminance 
unit), in order to minimize or eliminate the flickering appearance in the series of targets 
presented. For the fovea sites, the subject viewed the disk or ring shaped targets which 
were composed of a standard light that was fixed in wavelength composition (570nm) 
and intensity but altering in the same position with a 460 nm monochromatic light. The 
central area of each foveal flickering stimulus had a dark central fixation point of 
approximately 5-minutes size. The task for the subject was to set the radiance of the 460 
nm monochromatic light such that the flicker disappeared or was minimal, while fixating 
on the central fixation point. For the parafoveal site, the subject was asked to fixate on a
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small red LED, detectable at the left of the visual field. Then, using peripheral vision, the 
subject was asked to extinguish or minimize the flickering stimulus (10).
To help subjects understand the task at hand, they were asked to adjust the dial 
and to identify in ascending order where the rate of flicker began to slow, where it 
stopped or became minimal, where it increased, and then to manipulate the knob in a 
descending but ultimately a fine-tuning manner to find the most quiet spot for each site 
assessed. It was this last ‘null zone or most quiet position’ that was used to determine the 
consistency of the practice results.
During this practice session frequencies for flicker presentation were determined 
for each subject since optimal frequency rates vary among individuals. According to 
Snodderly and Hammond (131), choice of the best temporal frequency is the most 
challenging part of the procedure for the experimenter. When conditions are properly 
chosen, subjects should perceive distinct changes in the degree of flicker as they vary the 
energy of the 460 nm light. Ideally, there should be a narrow range of settings that 
correspond to minimum flicker, which is referred to as the no-flicker zone or the null 
range (131). Participants were required to identify the null zone with three repeat 
measures that fell within established ranges. For the 20-minute stimulus, the difference 
between the lowest and highest null score was set at 200 units or less; for the 1.0-, 2 .0-, 
and 4.0- degree stimulus, a range of 100 units or less was considered acceptable and for 
the parafoveal site, a range of 75 units or less was set. In some cases, particularly when 
testing the parafoveal site where ranges exceeded the suggested 75 point limit, the 
midpoint was calculated for the MPOD from using the range between where flicker 
stopped initially and where flicker was again perceptible. Frequency settings were
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manipulated at each site to achieve the reproducible results. The acceptable frequency 
levels were identified and later used during the MPOD test. Subjects were given testing 
breaks as needed.
As during the practice setting, during the MPOD test, the 460 nm luminance 
control knob was adjusted by the subject to achieve minimal flicker. The flicker could be 
eliminated or significantly minimized by adjusting the luminance of the attenuated 
460nm light until it matched the luminance of the non-attenuated 570nm light for each 
foveal and parafoveal site measured. Frequency levels were initially based on those used 
during the practice period but were adjusted if the subject could not find a null zone or if 
the null zone was too large. Six measures were taken for each site assessed. However, if 
the results exceeded the acceptable ranges, or if midpoint calculations were used, eight 
measures were taken. As during the practice, participants were asked to adjust the dial 
and identify in ascending order where the rate of flicker began to slow, where it stopped 
or became minimal, where it increased, and then to manipulate the knob in a descending 
but ultimately a fine-tuning manner to find the most quiet spot for each site assessed. It 
was this last “ null zone or most quiet position” that was used to determine the MPOD. 
For some subjects, identification in ascending order where the rate of flicker began to 
slow, where it stopped or became minimal and where it increased seemed 
counterproductive, and therefore as long as the experimenter could see the ascending and 
descending manipulation of the values, verbalizing the intermediary steps was not 
required as long as the final null or most quiet zone was identified. Detailed data from the 
test were recorded. A sample grid for recording data is presented in Appendix L.
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Optical density (OD) was calculated using the formula OD=LogRf/ LogRPi where 
Rf and Rp are the radiances of the 460nm test beam that results in minimum flicker with 
respect to the 570nm reference at the foveal (f) and parafoveal (p) locations, respectively. 
Since the pulse frequency is proportional to the radiance in this free-view system, with a 
slope of 1.0 and an origin of 0.0 the MPOD can be calculated using the formula as 
shown: MPOD=LogFf/ LogFp, where Ff and Fp refer to the frequency of the 460-nm test 
beam at the foveal and parafoveal positions respectively (10). To calculate specific 
MPOD foveal measurements, the average of the values of the parafoveal were subtracted 
from the average of the values for each of the foveal sites assessed.
In addition to the MPOD calculations for the specific sites assessed, a calculation 
for a “composite macular pigment value” (CMPV) was developed to estimate average 
MP over the range of the retinal sites evaluated. Retinal assessment spanned 110 minutes 
as calculated from the most central (0.167 °) to least central foveal site (2.00 degrees). 
Mean MPOD results were averaged yielding mean X, (average of the 0.1670 and 0.50° 
sites), mean Y, (average of the 0.50° and 1.00° sites) and mean Z (average of the 1.00° 
and 2.00° sites). Each of the resultant mean X, Y, and Z values were then multiplied by a 
factor weighted to reflect distance across the macula; 20/110 minutes for distance 
between the 0.167 0 and 0.50° sites (18 %), 30/110 minutes for the distance between 0.50° 
and 1.00° sites (27%) and 60/110 for the distance between the 1.00° and 2.00° sites 
(55%). These values were added together to yield the CMPV. The formula for the 
calculation is summarized where CMPV= (Mean X)(0.18)+ (Mean Y)(0.27)+ (Mean 
Z)(0.55).
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F. Statistical analysis
Microsoft ® Excel (Redmond, WA)(189), SPSS ® SYSTAT 9.0 (Chicago 
IL)(185) SPSS ® SPSS 9.0 (Chicago IL.)(190), and OriginLab® Corp. Origins 6.0 
(Northampton, MA)(191) were used for the data analysis. Carotenoids were analyzed by 
Agilent Technology/ Hewlett Packard Chemstation Version A.06.03-509 ®(192) and 
results initially entered into Microsoft ® Excel, followed by SPSS ® SYSTAT analysis.
A Pearson correlation matrix was constructed to determine correlations between the 
variables studied during an initial review of the data results. A number of statistical tests 
were performed given the number of variables studied and are summarized briefly.
For descriptive statistics, arithmetic means were calculated using the descriptive 
statistics module of the SPSS ® SYSTAT program. For subsequent evaluations, using 
age-quartiles, the BMI grouping of < 27 or > 27, gender, eye-color and the rescaled 7- 
FVST group status as the independent variables, multifactor ANOVA’s were run with 
MPOD at each of the foveal sites, or CMPV, tested as the dependent variable. Where 
ANOVA or analysis of covariance (ANCOVA’s) was used for analysis, the means 
reported in the text, tables, and figures represent the model least square means and the 
standard errors are those derived from the appropriate model error term. If the initial 
ANOVA test for significance p value was < 0.10, a Tukeys pairwise comparison test was 
conducted on descriptive and group and quartile ranked data to determine significance. A 
cutoff of < 0.10 was used to determine if significance between pairs would be lower 
using the Tukeys and to detect relationships that may be nearing statistical significance of 
p < 0.050.
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The 24hr-CGFR was initially calculated using the NDSR 4.02_03 Nutrition 
System dietary analysis software (NDS-R Food and Nutrient Database Version 30© 1999 
Regents of the Univ. of Minnesota, Minneapolis, MN) and results were transferred into 
the SPSS ® SYSTAT program for additional analysis. The developers of the B-FFQ, FH- 
FFQ, and the T-FFQ initially analyzed their respective food frequencies, and then the 
data were entered into SPSS ® SYSTAT.
Carotenoid and nutrient analysis from the 24hr-CGFR was conducted through 
simple linear regression analysis, with the individual nutrients entered singly as the 
independent variable and MPOD at each of the four foveal sites, or CMPV, tested as the 
dependent variable. Simple linear regression was also utilized to assess dietary 
carotenoids from the 24hr-CGFR and serum carotenoid concentrations using dietary 
carotenoids as independent variables and serum carotenoids as dependent variables. A 
multifactor ANOVA was conducted with the 7-FVST (fruit and vegetable group), age 
(quartiles), BMI (< 27 or > 27), eye color, gender, fruit and vegetable group by gender 
considered the independent variables and serum carotenoids as the dependent variable to 
determine if reported fruit and vegetable group status was significantly related to serum 
carotenoid concentrations. To determine if significant differences in estimated dietary 
intakes existed, ANOVA was run using the 24hr -CGFR, the B-FFQ, the FH-FFQ, the T- 
FFQ, and participant as the independent variable, and the dependent variable was the 
individual carotenoid assessed.
Lipoprotein analysis and MPOD status was conducted using multifactor 
ANOVA’s. The independent variables included age (quartiles), eye color, fruit and 
vegetable group from the 7-FVST, the BMI grouping of <27 or >21, gender, one lipid
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factor in quartiles (cholesterol, triglyceride, HDL-C, or LDL-C,) and the lipid factor 
crossed with gender as the independent variables, and the individual foveal sites, or 
CMPV, as the dependent variable.
Serum carotenoids and MPOD were analyzed using simple linear regression. The 
individual serum carotenoid (BC, LY, L, Z, L/Z, or total carotenoids) was the 
independent variable, while MPOD at each foveal site, or CMPV, was the dependent 
variable. Lipoprotein analysis and serum carotenoid status was conducted using 
multifactor ANOVA’s. The independent variables included age (quartiles), eye color, 
fruit and vegetable group from the 7-FVST, the BMI grouping of < 27 or > 27, gender, 
one lipid factor in quartiles (cholesterol, triglyceride, HDL-C, or LDL-C,) and the lipid 
factor crossed with gender as the independent variables, and the individual carotenoids as 
the dependent variable.
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IV. RESULTS
The study results are presented based on the measured MPOD’s, CMPV’s, 
reported dietary practices, and serum carotenoid and lipoprotein concentrations in the 
study population sample. A description of the sample is followed by the results of MP 
status in the group, in women and in men. Data from the dietary assessments, serum 
carotenoids and lipids are considered, with a special emphasis on relationship of these 
results to MPOD. Following these results, data from the analysis of serum carotenoids 
and lipids are presented. In addition, data from the statistical analysis of serum 
carotenoids, lipids, and BMI status are considered. The final component of this section 
examines results from the analysis of dietary carotenoid intakes and serum carotenoid 
concentrations.
Although all subjects were encouraged to complete every component of the study, 
in some cases, such as MPOD testing and FFQ assessment, not all participants 
successfully completed every task. Summaries of the key assessments and their 
completion rates are presented in Tables 5 and 6 .
A. Subject recruitment
A total of 108 subjects (67F, 41M) were recruited primarily from southern New 
Hampshire and Maine. Respondents included University personnel, community 
members, nutrition professionals, friends, and spouses of participants. Subjects reported 
hearing about the study through campus publications, brochures, flyers and 
advertisements distributed through an area optometrist’s office and University locations.
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Professional and community associations, an advertisement in an area newspaper, and 
word of mouth referrals also contributed to subject involvement.
B. Descriptive characteristics and anthropometric data
Characteristics of the subject sample are summarized in Table 7. Two of the 108 
respondents identified themselves with an ethnic background other than of white, non- 
Hispanic origin. The age range for participants was 45-75 years, with a mean age of 
56.10 (SD ± 7.93) years. Approximately two thirds of our participants were under the age 
of sixty; the average age of the women was four years younger than that of the men. 
Quartile age-ranges were calculated based on the ages of the recruited subjects; 45-49 
years comprised the first quartile, 50-55 years comprised the second quartile, 56-61 years 
made up the third quartile, and those between 62-75 years comprised the fourth quartile 
(Table 8).
Over 90% of the subjects had attended and/or graduated from college, including 
55% who reported educational training beyond the bachelor’s degree (Table 7). 
Household income was equal to $50,000 or more for 70% of the participants. Current 
tobacco users were excluded from the study and 62% of the subjects reported they had 
never smoked or smoked less than a total of 100 cigarettes. Of the remaining 38%, close 
to 75% of the subjects had stopped smoking over 15 years ago. The average time since 
quitting was approximately 20 years. Supplement use, including such products as 
multivitamins and minerals, single nutrients, and and/or herbal preparations was reported 
by 70% of the subjects; reported use was slightly higher for women than for men. No 
subjects reported lutein or zeaxanthin use as a single supplement, though some reported
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minimal lutein intake via the use of Centrum® multivitamin/mineral preparation 
containing 250 ug lutein per capsule.
Anthropometric measurements are summarized in Table 9. Mean height and 
weight for women were 163.42 (SD ± 6.54) cm and 70.22 (SD ± 13.29) kg respectively; 
for men, mean height was 176.20 (SD ± 8.62) cm and 89.09 (SD ± 14.55) kg. Body mass 
index results indicated that 58% of the participants had a BMI of < 27, while 42% had a 
BMI > 27.
According to the NIH criteria, the BMI for 33% of the participants were in the 
healthy weight range, while 43% of the participants were classified as overweight and 
24% were classified as obese (193). Women and men were significantly different in their 
distribution pattern of BMI categories in both the assessment using a BMI of 27 as the 
cutoff point (chi-square p= 0.005) as well as NTH categories (chi square p < 0.001). 
Forty-six percent of the female participants were classified as healthy weight, 36% were 
classified as overweight, and the remaining 18% were classified as obese. For males,
10% were classified as healthy weight, 56% were classified as overweight, and 34% were 
considered obese.
Self reported eye color results (Table 6) indicate that blue eyes were the most 
prevalent eye color, followed by hazel eyes, then brown eyes, then green, and one subject 
with gray eyes. Since this individual did not successfully pass the vision-screening test, 
and because there was no replication for the gray eye group, the analysis of the eye color 
data was based on the first four eye color groups.
Over 90% of the subjects successfully completed the vision screenings and 
MPOD assessments (Table 6). The most common reason for MP data to be excluded was
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difficulty or inconsistencies in the parafoveal assessment (4 subjects). Two of the 
subjects did not pass the Amsler Grid screening test, two did not meet vision acuity 
standards, and one declined to participate in the MP assessment during the practice 
component. One additional subject had MPOD that were in the negative scores for three 
out of four foveal sites and was excluded. Of the ten participants whose MP data were 
excluded six were females and four were males. This percent matched the general make­
up of the study sample that was 62% female, and 38% male. There was a mix of eye 
colors for these ten participants including blue (3), brown (2), gray (1), green (1) and 
hazel (3) eye colors.
Macular pigment optical density data was based on the data from the 98 
remaining subjects (6 IF, 37M). These subjects successfully completed at least three out 
of four foveal assessments as well as the one parafoveal assessment. Within this cohort, 
nine subjects (5F, 4M) did not complete the 0.167° site assessment, and one participant 
(1M) did not complete the 2.00° site assessment. The most common reason for not 
completing the 0.167° site was difficulty in seeing the central target, as well as time 
constraints and fatigue. The mix of eye colors recorded for these ten participants included 
blue (5), brown (1), green (2), and hazel (2) eyes. Since ten subjects did not have values 
for all four foveal sites, CMPV calculations were based on the 88 subjects (56F, 32M) 
who had acceptable data for all four foveal sites.
C. Descriptive characteristics and anthropometric data in relation to MPOD and 
MP Distribution
The mean MPOD of the study sample for each of the four foveal sites are 
presented in Table 10. The group mean MPOD of 0.43 (SE ± 0.017),
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0.36 (SE ± 0.013), 0.28 (SE ± 0.012), and 0.13 (SE ± 0.008) (Figure 3) are the 
measurements from the most to least central foveal location respectively. The group 
mean CMPV was 0.26 (SE ± 0.011). Individual subject MPOD calculated for each of the 
four foveal sites, as well as CMPV, are presented in Table 11. Also included within the 
table are data on gender, age, and eye color.
The range and frequency of responses for each of the four foveal sites by the 
participants is summarized in Table 12. At the 0.167° site, MPOD results ranged from 
0.08 to 0.70, for the 0.50° site from 0.07 to 0.73, for the 1.00° site from -0.01 to 0.56 and 
for the 2.00° site from -0.07 to 0.35 (Figure 4). Though “negative MP” does not exist, a 
negative value will mathematically occur if the recorded parafoveal value is greater than 
the value of the site being assessed, since the parafoveal value is subtracted from the 
foveal value for each MPOD calculation. Although calculated as negative MPOD in 
Table 12 and Figure 4, for subsequent statistical analysis, these results were adjusted to 
equal 0.00 to indicate the lack of MP detection, not “negative pigment levels”.
Using one-way ANOVA, no significant differences in MPOD were found 
between females and males at any of the four foveal sites or for CMPV (Table 10)
(Figure 5). (Note: Although the MPOD in Table 10 are presented using the standard two 
decimal places, this text discussion on sex differences presents the data with three 
decimal places since the results were extremely similar for women and men beyond the 
0.167 0 site). Female MPOD were 0.398 (SE ± 0.028) and male were 0.435 (SE ± 0.032) 
at the 0.167° site (p= 0.34); for the 0.50 0 site, MPOD were 0.340 (SE ± 0.020) for 
females and 0.344 (SE ± 0.023) for males (p= 0.89); for the 1.00° site, MPOD were 0.257 
(SE ± 0.016) for females and 0.259 (SE ± 0.019) for males (p= 0.93); for the 2.00° site,
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MPOD were 0.115 (SE ± 0.011) for females and 0.111 (SE ± 0.013) for males (p= 0.82); 
and for CMPV, results were 0.243 (SE ± 0.016) for females and 0.250 (SE ± 0.018) for 
males (p= 0.71).
No linear pattern was found using multifactor ANOVA for MPOD verses age at 
each of the four foveal sites, except that the second age quartile (50-56 years) had the 
lowest MPOD at all sites, and the lowest CMPV, compared to the other age groups 
evaluated (Table 10). Their MPOD results were 0.37 (SE ± 0.039), 0.29 (SE ± 0.029), 
0.19 (SE ± 0.024), and 0.09 (SE ± 0.015) from the most central to least central foveal 
locations. Using a Tukeys multiple comparison test, MPOD was found to be significantly 
lower (p= 0 .02) at the 1.00° site for this age group compared to those in the first age 
group (45-49 years) and fourth age group (62-73 years) (p= 0.01). At the 0.50° site, those 
in the second age group had MPOD of 0.29 (SE ± 0.029) that were nearly significant 
different (p= 0.08) when compared to those in the first age group whose MPOD were 
0.37 (SE ± 0.025).
The pattern of low MPOD for the second age quartile at all foveal sites compared 
to the other age quartiles was evident when female and male MPOD data were examined 
separately (Table 13). A bimodal distribution pattern emerged (Figure 6) when age by 
quartile and MPOD by site were graphed. As depicted, subjects in the first (45-49 years) 
and fourth (62-73 years) age quartile had the highest MPOD, those in the second (50-55 
years) had the lowest MPOD at all sites assessed, while those in the third category (56- 
61 years) had MPOD between those in the second and fourth age range.
Although the parafoveal results are not a focus of this project, it is interesting to 
note that the mean parafoveal measurements were significantly lower (p < 0 .001) for the
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first age quartile when compared to the third and fourth age quartiles; when compared to 
the second age quartile, significance was also demonstrated (p= 0.04) (data not shown).
No significant difference in eye color and MPOD were identified at the 0.167°
(p= 0.27) or the 0.50° (p= 0.13) sites (Table 10). Tukeys multiple comparison tests results 
indicated that subjects with blue eye color had significantly higher MPOD results at the 
1.00° site (p= 0.008), at the 2.00° site (p= 0.01), and for CMPV (p= 0.02) than subjects 
with hazel eyes. Blue eye color was also associated with significantly higher MPOD than 
brown eye color at the 2.00° site (p= 0.05). The frequency of MPOD responses by eye 
color is summarized in Table 14. Histograms depict the frequency of MPOD responses 
by eye color for the 0.167° (Figure 7), 0.50° (Figure 8), 1.00° (Figure 9), and 2.00° 
(Figure 10) foveal sites.
Mean MPOD results were higher at all sites for those with a BMI of less than 27 
compared with those individuals with a BMI equal to or greater than 27 (Table 10). This 
difference was statistically significant at the 1.00° site (p= 0 .02), the 2 .00° site (p= 0 .001), 
and for CMPV (p= 0.02). BMI classification reached near significance (p= 0.06) at the 
0.50° site. No significance was detected at the 0.167° site (p= 0.33). The use of the NIH 
categories for BMI revealed a trend: subjects with the lowest BMI (BMI 18.25-24.99) 
had the highest MPOD results at the 0.50°, 1.00°, and 2.00° sites compared with all other 
subjects, those in the second NIH category (BMI 25.00-29.99) had higher MPOD at all 
sites compared to those in the highest BMI category (BMI >29.99). However there was 
no statistical significance among the groups evaluated at any of the sites evaluated;
0.167° (p= 0.88), 0.50° (p= 0.27), 1.00° (p= 0.69), 2.00° (p= 0.14) or for CMPV 
(p= 0.45).
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D. Dietary assessments and MPOD and MP distribution
Multiple dietary assessments were completed by almost all subjects as 
summarized in Table 5. All subjects completed the 7-FVST and 24hr-CGFR. Only one 
male did not return any of the three FFQs. The 7-FVST (Appendix F) was initially 
evaluated using the Block Dietary Scoring System® as described in the methods section. 
As summarized in Table 8 , there were seven subjects classified as low consumers, nine as 
average US consumers, 28 as above average US consumers, and 64 as high consumers 
who met or exceeded the 5-A-Day fruit and vegetable consumption goals.
To assess the relative impact of fruit and vegetable consumption as it related the 
study sample, the 7-FVST scores were rescaled into four groups based on the range of 
scores (7 through 24) recorded from the results of the study population as indicated in 
Table 8 . The rescaled fruit and vegetable scores consisted of four groups; (one) low 
intake indicated below average intake for our study, (two) moderate intake, (three) high 
intake as amounts met and possibly exceeded 5-A-Day guidelines (the lower value in this 
group range matched the Block equivalent of ‘probably meeting’ the 5-A-Day guidelines) 
and (four) very high intake as amounts recorded reflected exceptionally robust fruit and 
vegetable consumption. This reclassification allowed for a comparative analysis of the 
impact of the range of fruit and vegetable intake reported by this study’s sample, with 
each group having at least ten subjects. The low intake group had the fewest subjects (10) 
while those reporting high intakes had the greatest number of subjects (38).
Overall, highest MPOD at each foveal site were associated with the highest intake 
of fruits and vegetables and low MPOD were found for the lowest fruit and vegetable 
intakes (Table 15). A Tukeys comparison test found statistically significant
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(p= 0.02) lower MPOD at the 0.50° site (and nearly significant differences of 
p= 0.06 at the 1.00° site) between those subjects reporting the lowest fruit and vegetable 
intake compared to those in the fourth group who reported very high consumption of fruit 
and vegetables. At the 2.00° site significant differences (p= 0.02) were also found when 
comparing moderate consumers of fruit and vegetables to those with the highest 
consumption. For CMPV, significantly higher (p= 0.03) MPOD’s were calculated for 
those subjects reporting the highest fruit and vegetable intake compared to those 
reporting the lowest.
The 24hr-CGFR was analyzed to quantify recent carotenoid intake. Results from 
this recall indicated a wide range of carotenoid intakes reported by study participants 
(Table 16). Group estimated total daily carotenoid intake was higher using this screener 
than for total carotenoid intakes estimated from the three FFQ’s. The group average 
reported carotenoid intake from highest to lowest consumption for the 24hr-CGFR was 
LY (8122 ug/day), BC (4233ug/day), L/Z (2647 ug/day), AC (1211 ug/day), and BCX 
(266 ug/day). This group rank order of carotenoid consumption determined by the 24hr~ 
CGFR was also similar to the results from both females and males. Females reported 
higher consumption of L/Z, AC, and BC while males reported higher intakes of BCX and 
LY. The largest difference between female and male carotenoid intake was for LY; 
consumption was estimated to be almost twice as high by males than females using the 
24hr-CGFR.
Mean group MPOD were not significantly associated with the group 24hr-CGFR 
carotenoid results as determined through simple linear regression (Table 17) using the 
specific carotenoid intake as the independent variable and MPOD at each foveal site, or
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CMPV, as the dependent variable. Results for females indicate lycopene did have an 
effect at the 0.50° site (p= 0.04), and a near significant effects at the 1.00° site (p= 0.08) 
and for the CMPV (p= 0.06). For males, lycopene was found to have a near significant 
effect (p= 0.08) at the 2.00° site. No other carotenoids demonstrated any significant or 
near significant effect at any of the other foveal sites for gender using the 24hr-CGFR 
screener.
One hundred seven of the 108 subjects completed and returned at least one of the 
three nationally developed FFQ’s; 105 completed two and 100 subjects completed all 
three. Reported caloric intakes of the FFQ’s were expected to fall within the 2090-20900 
kilojoules (kJ) per day, which is the equivalent of 500 to 5000 calories per day. One 
subject’s caloric intake exceeded this range for one of his questionnaires; no subjects 
reported eating less than 2090 kJ’s per day.
Average daily carotenoid estimates based on the FFQ’s are summarized in Table 
16. Results from the FFQ data reveal total carotenoid intake estimates were between 
10,518 ug/day to 15,482 ug/day. Both the B-FFQ and the FH-FFQ had a similar ranking 
for carotenoid intake which matched that of the 24hr-CGFR for the estimated group 
intake as well as female and male consumption patterns; LY, BC, L/Z AC and BCX were 
estimated from most to least ingestion, respectively. The T-FFG estimated BC as the 
carotenoid of highest consumption, followed by LY for the group and gender analysis. 
The rank order intake for the remaining three carotenoids from T-FFQ was similar to the 
other FFQ’s and therefore the 24hr-CGFR as well.
Although the rankings were similar when comparing results from all the FFQ’s 
and the 24hr-CGFR, the 24hr-CGFR estimated the highest amount of daily carotenoid
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intake (16.5 mg/day), while the T-FFQ estimated the lowest (10.5mg/day) (Table 16). 
Analysis of variance (followed by a Tukeys pairwise comparison test as appropriate) was 
conducted using each of the carotenoid’s estimated intake as the dependent variable, and 
the results from the 24-hr screener and participant number as the dependent variables. 
Results revealed that AC intake as estimated by the T-FFQ was significantly lower than 
all other carotenoid assessment tools used including the 24hr-CGFR(p= 0.002), the B- 
FFQ (p= 0.005) and the FH-FFQ (p= 0.010). The T-FFQ was also significantly lower in 
its estimation of BCX compared to those estimations from the 24hr-CGFR (p < 0.001) 
and estimations from the B-FFQ (p= 0.002). The FH-FFQ also had significantly lower 
estimations for BCX intake than the 24hr-CGFR (p <0.001). Lutein/zeaxanthin 
estimations were significantly higher (p= 0.001) based on results of the 24hr-CGFR when 
compared to the L/Z results of the FH-FFQ. Estimations of LY intake also differed 
significantly by the dietary instruments used; with the T-FFQ results were was 
significantly lower than all other assessment tools, including the 24hr- CGFR (p<0.001), 
the B-FFQ (p= 0.001) and the FH-FFQ (p< 0.001). For BC, there were no significant 
differences among the assessment tools used and the estimations (p= 0.018) generated 
(data not shown).
Simple linear regression was conducted to assess the relationship between of 
reported nutrient intake as reported from each of the FFQ’s and MPOD results at each of 
the four foveal sites and for CMPV (Table 18). Most of the results that reached 
significance (p < 0.05) or near significance (p < 0.10) were for sites beyond the 0.167° 
location. In addition, outcomes did vary depending on the FFQ source. Significant effects 
of diet on MPOD were determined at all four foveal sites by at least one FFQ for dietary
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intakes of L/Z (FH-FFQ), vitamin C (T-FFQ), and iron (T-FFQ). Significant relationships 
for CMPV scores were calculated for intakes of L/Z (FH-FFQ: p= 0.006), iron (T-FFQ: 
p= 0.008), vitamin C (T-FFQ: p= 0.001) and (FH-FFQ: p= 0.008), vitamin E 
(T-FFQ: p= 0.01), BCX (T-FFQ: p= 0.01) and zinc (T-FFQ: p= 0.02). Detailed results for 
carotenoid intake and the additional nutrients are presented below.
The FH-FFQ analyses indicated a significantly positive linear relationship 
between reported group L/Z intake and MPOD at all four foveal sites and for CMPV 
(Tablel8). Results at the 0.167° site indicated p= 0.02, at the 0.50° site (p= 0.02), at the 
0.100° site (p= 0.009) (Figure 11), at the 2.00° site (p= 0.02), and for CMPV (p= 0.006). 
No other FFQ exhibited this linear relationship with respect to L/Z and MPOD.
Results from the T-FFQ indicated BCX exhibited a significant positive linear relationship 
at the 0.50° site (p= 0.008), at the 1.00° site (p= 0.008), at the 2.00° site (p<0.001), and for 
CMPV (p= 0.01). This carotenoid was also shown to have a positive effect at the 2.00° 
site based on the B-FFQ (p= 0.02) and FH-FFQ (p= 0.03) results. In addition, near 
significant effects of BCX on MPOD were found at the 0.50° site based on the B-FFQ 
(p= 0.08) and FH-FFQ (p= 0.10) data. At the 1.00° site, near significance was also 
determined by the B-FFQ (p= 0.08) and FH-FFQ (p= 0.09) as well as for the FH-FFQ 
CMPV (p= 0.08).
According to the FH-FFQ, BC was determined to have a significantly positive 
effect at the 0.50° site (p= 0.04) and near significant effects at the 1.00° and 2.00° sites 
(p= 0.07), as well as for CMPV (p= 0.08). Neither the carotenoid LY nor AC was found 
to be predictive of MPOD at any foveal site or for CMPV.
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All three FFQ’s identified vitamin C intake as having a positive effect on MPOD 
(Table 18). According to the T-FFQ results, vitamin C had a significantly linear effect on 
all foveal sites and the CMPV; at the 0.167° site (p= 0.05), at the 0.50° site (p= 0.001), at 
the 1.00° site (p= 0.003), at the 2.00° site (p=< 0.001), and for CMPV (p= 0.001). For 
vitamin C, the FH-FFQ also indicated significance at the 0.50° site (p= 0.02), at the 1.00° 
site (p= 0.01) and the 2.00° site (p<0.001) and for CMPV (p= 0.008). The B-FFQ 
indicated vitamin C had an effect on MPOD (p= 0.007), but only at the 2.00° site.
Provitamin A was found to have a positive effect on MPOD by the FH-FFQ 
(p= 0.04) at the 0.50° site and by the FH-FFQ (p= 0.03) and T-FFQ (p= 0.01) at the 2.00° 
site (Table 18). Near significance (p= 0.06) was detected for the 0.50° site by the T-FFQ 
as well as by the FH-FFQ at the 1.00° site (p= 0.07). CMPV results were also near 
significance based on the results from the FH-FFQ (p= 0.07) and the T-FFQ (p= 0.08). 
For retinol, the T-FFQ results indicated a positive effect at the 2.00° site (p= 0.008) and 
near significant associations at the 1.00°SIte (p= 0.09) as well as for CMPV (p= 0.06).
Iron intake was also found to have a significant linear relationship to MPOD at all 
sites according to results from the T-FFQ; at the 0.167° site (p= 0.03), at the 0.50° site 
(p 0.01), at the 1.00° site (p= 0.04), at the 2.00° site (p= 0.006), and for CMPV 
(p= 0.008). The FH-FFQ reached near significant levels for iron (p= 0.06) at the 2.00° 
site and for CMPV (p= 0.07). According to the T-FFQ results, zinc was found to have a 
significant effect (p= 0.006) at the 2.00° site and for CMPV (p= 0.02), while reaching 
near significance at the 0.167° (p= 0.06) and 0.50° (p= 0.10) sites.
In general, the energy nutrients did not have a significant effect on MPOD, 
though the T-FFQ indicated a positive effect between carbohydrate intake and MPOD at
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the 0.50° site (p= 0.02) and at the 2.00° site (p= 0.03) as well as near significance for 
CMPV (p= 0.07).
E. Serum carotenoids and MPOD and MP distribution
Mean serum carotenoid concentrations are presented in Table 19. Individual 
subject serum carotenoid results are presented in Table 20. Based on the group results, 
serum L and serum L/Z had a significant positive effect on MPOD at the three most 
central foveal sites as well as for the CMPV results (Table 21). Simple linear regression 
was utilized; the dependent variable was either the MPOD at each foveal site, or the 
CMPV, and the independent factor was a serum carotenoid. There was a significant 
positive linear relationship for serum L and MPOD at the 0.167° site (p= 0.003), at the 
0.50° site (p < 0.001) at the 1.00° site (p < 0.001) (Figure 12) and for CMPV (p= 0.001) 
(Table 21). When serum L and Z concentrations are considered by summing their (L/Z), 
a similar positive linear effect emerges; at the 0.167° site (p= 0.007), at the 0.50° site (p= 
0.001), at the 1.00° site (p < 0.001) and for CMPV (p= 0.003). Serum Z concentrations 
were shown to have a positive effect at the 1.00° site (p= 0.02) while total carotenoids 
were found to be positively related to MPOD for the group at the 1.00° site (p= 0.04) and 
at the 2.00° site (p= 0.04). Serum BC and LY were not shown to have any significant 
effect on MPOD based on the group results.
Serum L and L/Z demonstrated a significant positive effect on MPOD for the 
females in the sample as well (Table 21). Results were similar to those of the group data. 
There was a significant positive linear relationship of L on MPOD at the 0.167° site 
(p= 0.02), at the 0.50° site (p= 0.001), at the 1.00° site (p= 0.001), for the CMPV
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(p= 0.004) and a near significant relationship at the 2.00° site (p= 0.08). When female 
serum L/Z concentrations are reviewed, a similar positive linear effect emerges; at the
0.167° site (p= 0.03), at the 0.50° site (p= 0.002) at the 1.00° site (p= 0.001), for the 
CMPV (p= 0.008) with a near significant relationship at the 2.00° site (p= 0.11). Serum Z 
concentrations were shown to have a near significant effect at the 1.00° site (p= 0.07). 
Total carotenoids were found to be positively related to MPOD for females at the 1.00° 
site
(p= 0.04) and at the 2.00° site to be nearly significant (p= 0.09). For females, LY was also 
found to have a significant effect at the 0.50° site (p= 0.04) and at the 1.00° site (p= 0.05). 
No significant effects were found for serum BC and MPOD in females. Serum carotenoid 
concentrations were not found to have a significant effect on MPOD in males. Near 
significant effects were found for males at the 0.167° site for serum L (p= 0.09).
F. Serum lipids and MPOD and MP distribution
Mean serum lipid results for the group and by gender were calculated using the 
arithmetic module in SPSS ® SYSTAT and are presented in Table 22. The group 
averages for the lipids were 186 mg/dL for cholesterol, 142 mg/dL for triglycerides, 
28mg/dL for VLDL-C, 98 mg/dL for LDL-C, and 66 mg/dL for HDL-C. Individual data 
from the lipid analysis are presented in Table 23.
Lipid results were analyzed using lipid interquartile ranges calculated in SPSS 9.0 
(Table 24). Since the lipid concentrations for this sample had a narrow range, this 
enhanced comparison of results within the sample. After the interquartile ranges had been 
determined, multifactor ANOVA was run, using the independent variables of age 
(quartiles), BMI (< 27 or > 27), eye color, gender, fruit and vegetable group status, a lipid
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factor in quartiles (total cholesterol, triglycerides, HDL-C, or LDL-C) and the respective 
lipid factor crossed with gender. MPOD from each foveal sites, or CMPV, was the 
dependent variable. No significant relationship was found for MPOD at any of the four 
foveal sites, or for CMPV, based on total cholesterol concentrations by quartile ranking 
(Table 25) or by gender. Likewise, there were no significant relationships found between 
LDL-C quartiles (Table 26) or HDL-C quartiles (Table 27) and MPOD at any of the four 
foveal sites or for CMPV results. However, for LDL-C, there was a nearly significant 
lower MPOD at the 2.00 0 site (p= 0.06) between those in the first quartile compared to 
those in the third quartile.
Triglycerides were found to have a significant relationship to MPOD. Overall, those 
in the second quartile (98-124 mg/dL) of triglycerides were found to have the highest 
MPOD at the 0.167° site, at the 0.50° site, at the 1.00° site, and the highest CMPV 
compared to the other triglyceride quartile groups (Table 28). Further analysis with the 
Tukeys multiple comparison tests at the 0.167° and at the 1.00° site revealed significantly 
higher (p= 0.02) MPOD for those in the second quartile compared to those in the fourth 
quartile. CMPV was also significantly higher (p= 0.007) for those in the second quartile 
compared to those in the fourth quartile. Significant differences were not found for 
MPOD at the 0.50° site (p= 0.15) or at the 2.00° site (p= 0.30).
G. Plasma lipoproteins and serum carotenoids
The relationship of plasma lipoprotein concentrations and serum carotenoid 
concentrations was also examined. Multifactor ANOVA was conducted, using age 
(quartiles), gender, BMI (< 27 or > 27), eye color, an individual lipid factor in quartiles
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(total cholesterol, triglycerides, HDL-C, or LDL-C), and the lipid factor crossed with 
gender as the independent variables while the dependent variable was a serum carotenoid.
No significant interaction (p= 0.39) or pattern was observed for total cholesterol and 
serum BC status for any of the cholesterol quartiles examined (Table 29). However, for 
the remaining serum carotenoids, cholesterol did have a significant relationship to serum 
carotenoid concentrations. Generally, as cholesterol concentrations rose by quartile, so 
did serum LY (p= 0.004), L (p < 0.002), Z (p= 0.02), L/Z (p = 0.002) and total 
carotenoids (p= 0.03). The subsequent Tukeys comparison tests indicated significantly 
higher carotenoid concentrations were found for LY, L, Z, and L/Z when comparing 
those results of the fourth quartile compared to those of the first quartile, specifically LY 
(p= 0.007), L (p= 0.001), Z (p= 0.008) L/Z (p= 0.001).
Total serum carotenoids were found to be nearly significant (p= 0.06). Lycopene 
was also found to be significantly higher (p= 0.008) for subjects in the third cholesterol 
quartile compared to those in the first quartile. For L, significantly higher concentrations 
were found for subjects in the fourth quartile when compared to those in the second 
quartile (p= 0.05) and for those in third quartile near significance was found (p= 0.057) 
compared to those in the fourth quartile. This trend continued when the L and Z 
concentrations were examined in the combined form, with serum L/Z being nearly 
significantly higher for those in the fourth quartile when compared to those in the second 
(p= 0.07) or the third quartile (p= 0.052). There was significant interaction between the 
variables of gender and cholesterol for serum Z (p= 0.02), and near significant interaction 
for BC (p= 0.06) and IVZ (p= 0.09).
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Low density lipoprotein quartiles and serum carotenoid concentrations are 
presented in Table 30. Overall, no clear pattern emerges with serum carotenoid 
concentrations and LDL-C status. However, in the three instances where a near 
significant difference was detected for LY, L, and L/Z using ANOVA’s, further analysis 
by the Tukeys pairwise comparison test did not support a near significant relationship. 
There were no significantly different concentrations of any serum carotenoids based on 
HDL-C quartiles as depicted in Table 31. Serum triglycerides and carotenoid 
concentrations are summarized in Table 32. No clear pattern emerges for BC and serum 
triglycerides. For the other carotenoids, as well as total carotenoids, a trend is observed in 
which the lowest triglycerides quartile is associated with the lowest level of serum 
carotenoid; the highest triglyceride quartiles are associated with the highest level of 
carotenoids.
H. Serum carotenoids and body mass index
Results from the multifactor ANOVA assessment of serum carotenoids and BMI 
are summarized in Table 33. The independent variables were age, gender, BMI < or > 27, 
and BMI < 27 or > 27 crossed with gender while the dependent variable was each serum 
carotenoid. Overall, there was a very consistent pattern in the results; lower BMI were 
inversely associated with concentrations of serum carotenoids for every carotenoid 
examined.
Significantly higher concentrations for serum BC (p= 0.03), L (p= 0.05) and total 
carotenoids (p= 0.003) were demonstrated for those with a BMI of < 27 compared to 
those with a BMI of > 27. Near significantly higher serum L/Z and serum LY (p= 0.07) 
were calculated for those with a BMI of < 27 compared to those with a BMI of > 27. No
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significant differences could be attributed to gender. Although it appeared serum BC was 
significantly lower in males than females (p= 0.04), the near significant interaction of 
gender and BMI (p= 0.08) makes it unclear if there really is a gender difference for serum 
BC or is it due to the influence of BMI.
I. Serum carotenoids and estimated dietary carotenoid intake
Results from the multifactor ANOVA analyses in which the 7-FVST group 
rankings, gender, and gender crossed with the 7-FVST were considered the independent 
variables and serum carotenoids the dependent variable did not reveal any significant 
association for the 7-FVST groups and serum carotenoid concentrations (Table 34).
Using linear regression, dietary estimates from the 24hr-CGFR and the FFQ’s 
were compared with serum carotenoids (Table 35). Based on the group results and the 
male results, dietary BC had a significant positive linear relationship with serum BC for 
the 24hr-CGFR (p= 0.003) and for all three FFQ’s (p < 0.001). For females, dietary BC 
exhibited a positive effect on serum concentrations when diet was assessed using the FH- 
FFQ (p= 0.009) and the T-FFQ (p= 0.002) but not the 24hr-CGFR (p= 0.30) or the B-FFQ 
(p= 0.20). The 24hr-CGFR was the only dietary instrument that indicated that LY intake 
appeared to have an effect on serum LY, when analyzing the group data (p < 0.001) as 
well as the female (p= 0.004) and male (p < 0.001) results. Based on the FH-FFQ, dietary 
L/Z was found to have an effect on the group serum L/Z results (p= 0.007) as well as on 
the male serum results (p= 0.02), while near significance (p= 0.08) was found for females. 
The T-FFQ also indicated a significant relationship between the dietary L/Z dietary and 
serum results for the group (p= 0.03) and those for females reached near significance 
(p= 0.052), but not for males (p= 0.59). Both the 24hr-CGFR (p= 0.19) and the B-FFQ
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(p= 0.13) did not show a significant relationships between estimated dietary intake of LZ 
and serum concentrations.
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Y. DISCUSSION
The first section of the discussion considers the composition of the sample 
population recruited for the study. Next, an examination of the results from the present 
investigation is considered in light of the hypotheses developed at the initiation of the 
research. The final component of the discussion includes research results that were not an 
integral part of the hypothesis statements, yet appear to warrant further consideration.
The study reported in this thesis is referred to as the present, current, or UNH study. 
Results are typically presented for the mean of the group, or for women and men, with 
the corresponding standard error (SE). For those studies using standard deviation, the 
‘SD’ notation will be used. The FH-FFQ results will be used to compare the current 
nutrient results to other studies, unless otherwise noted or when comparing results 
between the FFQ’s.
A. Subject Recruitment
The primarily Caucasian population (98%) responding to the request for 
volunteers was a highly educated group of women and men. The limited ethnic diversity 
reflects the New England Region of Vermont, New Hampshire and Maine that has the 
lowest rate of national diversity in the United States. Recent census bureau data indicate 
that less than 4% of the population identifies themselves as other than white, non- 
Hispanic origin. Compared to the national average for educational achievement of 26% 
completing a bachelors degree or more (194), 55% of our respondents reported 
completing a masters degree or greater, while an additional 36% reported attending 
and/or graduating from college. Reported household incomes were higher than the 1997
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national average of $37,005, with 50% of our population reporting a household income 
of over $75,000; this also exceeds the median estimated household income of New 
Hampshire of $42,023 and that of Maine of $33,140 (195), the two states in which the 
majority of the participants resided.
B. Anthropometries and descriptive data
Detailed data from the 1988-1994 NHANES III for women and men aged 45-75 
indicated that approximately 32%, 38% and 28% were classified as healthy weight, 
overweight, and obese, respectively (196). The present study (Table 9) sample had a 
similar percent classified as healthy weight (33%, mostly women), a greater percentage 
(43%) classified as overweight, and a lower percent classified as obese (24%). Compared 
to national trends that indicate a greater percentage of women than men are reported to be 
obese (197), a greater percentage of men than women were obese in our study. This may 
reflect the socioeconomic status of the sample population since the prevalence of obesity 
is found to be inversely related to increasing socioeconomic status, particularly in women 
(198).
For the potential influence of BMI on a number of variables analyzed in the 
present research project, BMI was evaluated using a cutoff category of < 27 or > 27. It 
is typically at a BMI of > 27 where health risks associated with overweight and obesity 
begin to significantly increase (199). Campbell and Gerich found a threshold effect of 
body mass index and insulin sensitivity at or near a BMI of 27 (138). Using the BMI 
cutoff of 27, significant differences were found at the 1.00° site where MP was found to 
be 21% lower (p= 0.02) and at the 2.00° site where MP was 36% lower (p= 0.001) in 
those with a higher BMI compared to those with a lower BMI (Table 10). Though not
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quite reaching significance (p= 0.06), at the 0.50° site, subjects with a higher BMI had 14 
% less MP than those with a lower BMI.
The results from the present study (Table 33) indicate that in all cases, those with 
lower BMI had higher serum carotenoids; and many times the difference in serum 
carotenoid concentrations reached statistical significance. Lower BMI was significantly 
associated with higher serum carotenoids for BC (p = 0.03), L (p= 0.05), and total 
carotenoids (p= 0.003) while near significance was detected for L/Z (p= 0.07) and LY 
(p= 0.07). No significance was demonstrated for Z (p= 0.30).
No significant differences were observed for gender. Although it first appears BC 
is significantly higher in women than men, the near significant interaction of gender and 
BMI (p= 0.08) make the relationship of gender and BC concentrations unclear.
Recent research by Hammond et al. (136) showed there was an inverse 
relationship between MPOD and BMI. This was largely influenced by those subjects with 
a BMI over 29, who had 20% less MP (0.19) than those subjects with a BMI of less than 
29 with a MP of 0.24 at the 0.50° site. In order to compare our results to those of 
Hammond et al., analyses were conducted using the BMI cutoff of 29. Using this cutoff, 
the pattern of lower MP with higher BMI was again evident. A statistically significant 
difference was only detected at the 2.00° site (p= 0.003) where MPOD was 0.13 for those 
with a BMI of less than 29 and was 0.08 for those with a BMI > 29. This translates into 
38% more MP for those with a lower BMI compared to those with a higher BMI (data 
not shown).
Serum carotenoids have been typically found to be higher in those with lower 
BMI compared to those with higher BMI (39, 75, 144). Brady’s research on four hundred
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subjects over the age of 50 who had been randomly selected from the Nutritional Factors 
in Eye Disease Study, (which is a subset of the Beaver Dam Eye Study) revealed that 
reported carotenoid intake did not differ by BMI category. Serum concentrations of 
carotenoids AC, BC, BCX, and L/Z were higher in those subjects with lower BMI 
compared to those with higher BMI. Only LY concentrations did not seem influenced by 
BMI status. The researchers hypothesized that since carotenoids are stored in adipose 
tissue, the inverse association of BMI with serum carotenoids may reflect a greater 
proportional storage of carotenoids in adipose tissue in persons with higher fat stores as 
detected by higher BMI (39). In the present study, reported absolute intakes of 
carotenoids (as well as vitamin C) were not statistically different for those with a BMI of 
< 27 versus those with a BMI > 27 based on the results of the three FFQ’s (data not 
shown).
However, besides an increased capacity to store carotenoids, the metabolic 
environment differs between those with lower BMI compared to those with higher BMI. 
As BMI increases, the incidence of insulin resistance increases. Insulin resistant 
individuals have recently been shown to have lower concentrations of some carotenoids 
(140). In a study by Facchini et al., those subjects in the most-insulin resistant tertile had 
significantly higher plasma lipid hydroperoxide concentrations and significantly lower 
concentrations of AC, BC, L, a-tocopherol and 6-tocopherol.
In addition to the physical characteristic of body weight, eye color and MPOD 
were evaluated. The presence of ocular melanin is correlated to iris pigmentation. 
Melanin has been hypothesized to protect the retina from oxidative damage. In some 
studies, results have indicated that individuals with light iris color tend to have
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significantly lower MP at the 0.50° site compared to those with dark irises (44, 45, 81). 
Light iris color has also been linked to an increased risk for the development of AMD 
(80, 200, 201). Hammond et al. suggested the relationship of MP to iris color might 
reflect a shared tendency to accumulate melanin and carotenoids due to similar 
environmental exposure (81). In addition, lower MP in light iris color may reflect a 
depletion of carotenoids due to increased oxidative stress in light eyes compared to the 
dark eyes that have more melanin. Since there are numerous oxidative reactions in the 
eye due to the photo-oxidative nature of light transmission, the presence of antioxidants 
and light filtering and absorbing substances such as carotenoids and melanin may help to 
reduce tissue damage.
In the present study, at the 0.50° site, (as well as the 0.167° site) there were no 
significant differences in MPOD between any of the eye color groups (Table 10). Since 
most other studies have only examined the 0.50° site, it is not possible to compare results 
of the other foveal sites to other studies. However, at the 1.00° (p= 0.008) and 2.00° sites, 
(p= 0.01), blue iris color showed significantly higher MPOD than hazel iris color. The 
CMPV was also significantly higher (p= 0.02) for those with blue iris color compared to 
hazel. At the 2.00° site those with blue iris color had significantly higher MPOD than 
those with brown iris color (p=0.05). This could potentially be due to a different 
distribution pattern of MP for those with blue irises, with greater pigment deposited 
outside of the central foveal region at the 1.00° and 2.00° sites. Another possible 
explanation may be related to diet. When the diet is as carotenoid rich as those reported 
by the subjects, the relationship of eye color and MP may be attenuated. There were no 
significant differences among the eye color groups and reported dietary intakes of any of
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the carotenoids; AC (p= 0.485), BC (p= 0.645) BCX (p= 0.481), L/Z (p= 0.788), LY (p= 
0.505) (data not shown).
Since subjects self reported their eye color, misclassification may have occurred, 
though it seems unlikely there would be misclassification between brown or blue eye 
color but rather in more subjective categories such as green hazel and gray. However, 
research suggests that eye color can change over time, tending to go from darker to 
lighter eye color due to melanin losses typically associated with aging (202). Since 
subjects were not asked about the history of their eye color, but only their present eye 
color, it is not possible to test the potential effect eye color change had on MPOD results 
in the current study or on results from the previous studies cited. If results are to be 
compared across studies, future research projects may want to incorporate the use of 
standardized color charts or assessment strategies when determining eye color.
At present, published results on eye color and MPOD status are available on 
approximately 600 subjects in the US. Future studies with larger numbers of individuals 
with a mix of verified eye colors, as well as a history of the subjects’ eye color may 
provide additional information on the impact of eye color on MP status.
The results of the study as related to the initial hypotheses are considered next.
C. Hypothesis # la . The New England population will have higher MPOD than 
those reported from other regions in the country.
The mean MPOD of 0.36 (SE ± 0.013) from the 0.50° site based on the current 
research (Table 10) results was 42% higher than that reported for the mean Midwest 
population (0.21 SD± 0.130) (Table 3) (44). In the Midwest sample, about 25% percent 
of the subjects had MPOD between 0.00 and 0.10 indicating minimal MP. In contrast,
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only one subject in the UNH study had MPOD in this range, despite both studies’ using a 
similar Macular Metrics ® MP heterochromatic free view instrument. Greater ranges of 
frequency settings were used in the present study than in the Midwest study. 
Approximately 95% of the four foveal evaluations were tested using a frequency between 
8 -14 Hz, and 98% of the parafoveal assessments were conducted using 5-7 Hz for the 
current study. These frequencies were determined for each individual during his or her 
practice session and reflected ranges at which consistent results were recorded for the 
respective sites being assessed. In the Midwest, subjects were tested at the 0.50° foveal 
site using a frequency of 11-12 Hz and at the parafoveal site using a frequency of 6-7 Hz. 
Individuals vary in their ability to detect flicker, and though the use of a standardized 
range may have set the testing parameters more tightly, it may have also contributed to 
the unexpectedly high rate of individuals categorized as having no MP.
Another factor that may have contributed to lower MPOD in the Midwest 
compared to the present study was that the reference parafoveal measurement was 
obtained at a retinal eccentricity of four degrees in the Midwest, while in the UNH 
research, the parafoveal reference was obtained at a retinal eccentricity of six degrees. 
Some individuals, (though usually older) may have a secondary MP peak at four degrees 
(203), thereby contributing to the overall lower MPOD of the Midwest MP.
Mean L/Z intake in the Midwest was estimated to be 1.1 mg/day using the FH- 
FFQ, while in the present study, mean L/Z intake was estimated to be 1.8 mg/day using 
the same questionnaire. Serum L/Z was lower in the Midwest study (0.372 umol/L) 
compared to the present study (0.427 umol/L SE + 0.015) (Table 19), which may also 
contribute to the differences in the Midwest verses the current study. Both intake and
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serum concentrations have been positively associated with MPOD in many (5, 28, 44,
204) but not all studies (46).
Mean MPOD at the 0.50° for females in the present study (0.34 SE ± 0.020) was 
higher than that reported for females aged 17-19 (0.21 SD ± 0.12) from the Southwest 
(45). The mean MPOD (0.34 SE± 0.023) for males was higher than male MPOD (0.24 
SD ± 0.15) from the Southwest population. The trend for lower MPOD in the Southwest 
sample was also evident at the 1.00° site. Mean MPOD for this site for the 
South westerners was 0.13 (SD ± 0.10), while in the present study, the mean MPOD was 
0.28 (SE ± 0.012). As noted by the researchers of the Southwest population, one of the 
factors that may have contributed to lower MPOD in their sample was that the reference 
parafoveal measurement was measured at four degrees retinal eccentricity (similar to the 
Midwest study) compared to the six degree retinal eccentricity site used at UNH (45). 
Since there were no comparable dietary assessments or serum measurements, it is not 
possible to compare the UNH study to the Southwest results based on those parameters.
A comparison of results from a 1996 study with subjects from the New England 
(NE) area (5) suggests that the MPOD results from the present study at the 0.50° site 
were higher for female results from NE (0.24 SD ± 0.159) but lower for male results from 
NE (0.38 SD ± 0.216). Dietary L/Z intake are compared using the current results from the 
B-FFQ since the Block HHQ Diet System software was used for the 1996 analysis. 
Estimated dietary L/Z intake for females (2.5 mg SE ± 0.194) and males (1.8 mg SE ± 
0.256) in present study (Table 16) were estimated to be lower than intakes for females 
(3.7mg SD ± 1.81) and males (3.5 mg SD ± 1.74) reported previously in NE. Part of these 
differences in estimated intake may indeed be true differences in intake, but may also
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reflect the differences in carotenoid databases used in the present research versus those 
available in 1996. Serum L/Z concentrations (umol/L) were found to be higher for both 
females (0.439 SE ± 0.021) and males (0.407 SE ± 0.020) in the present study (Table 19) 
compared to those reported in the NE area for females (0.376 SE ± 0.181) and males 
(0.356 SE ± 0.174). Though the elevated serum concentrations in the present study may 
help to explain the higher MPOD in women, these levels do not explain the slightly lower 
MPOD for males.
Mean MP was also higher than that reported on a study of 32 subjects investigated 
by Hammond in 1997 (15) (0.29) but lower than those reported by Werner (0.39)
(no SD reported) on fifty subjects (Table 2). Since there was no serum or dietary 
information, it is difficult to hypothesize some of the reasons for the differences in 
MPOD. Differences in the ages of the subjects evaluated in any of the studies tested may 
well be contributing to some of the differences reported in mean MPOD, although no 
statistical differences were noted by (27). Although mean MPOD results were higher in a 
study by Beatty et al. (1), the method used to estimate MPOD was different that that used 
in the other research and therefore it remains unclear what the differences, if any, exist 
between the subjects studied.
D. Hypothesis # lb . Men in NE will have higher MPOD than women.
Unlike previous results from the NE region (5), men did not have statistically 
higher MPOD than women at any of the foveal sites evaluated in the present sample 
(Table 10) (Figure 5). Total dietary L/Z intake using the current B-FFQ estimated dietary 
L/Z intake for females (2.5 mg SE ± 0.194) and males (1.8 mg SE ± 0.236) was lower in 
the current study when compared to the 1996 estimates for females (3.7mg SD± 1.81)
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and males (3.5mg SD ± 1.74). In both studies, females reported higher intakes of L/Z 
compared to males. Serum L/Z concentrations (umol/L) were found to be higher for both 
females (0.439 SE ± 0.021) and males (0.407 SE ± 0.020) in the present study (Table 19) 
compared to those reported in the NE for females (0.376 SE ± 0.181) and males (0.356 
SE ± 0.174). Dietary carotenoid intake and serum carotenoid concentrations followed the 
same pattern in the current study as in the 1996 study; females had higher estimated 
dietary and serum carotenoid concentrations than males. However, in the 1996 study, 
men had significantly higher MPOD than women did where as results from the present 
study detected no statistical difference in MPOD based on gender. It remains to be 
determined why women, despite higher serum carotenoid concentrations, did not have 
higher MPOD than men in this study or the 1996 study.
One of the factors that may be contributing to the difference in female and male 
results is BMI status. Though these values are not available for the 1996 study, in the 
present study, of those whose MPOD were included, approximately 45% of the women 
had a BMI of < 27, while only about 15% of the men were in this category. Lower BMI 
were found to be associated with almost significantly higher (p= 0.06) MPOD at the 
0.50° site (Table 10). At the 1.00° site (p= 0.02), 2.00° site (p= 0.001) and for CMPV 
(p=0.02) lower BMI were statistically associated with higher MPOD.
E. Hypothesis #lc. Increasing age would be associated with lower MPOD.
Increasing age was not associated with decreasing MPOD at the four foveal sites. 
For the sample studied, MPOD exhibited a somewhat bimodal pattern, with the highest 
mean results measured for the most central 0.167° site by subjects comprising the first 
age quartile (45-49 years) (0.47 SE ± 0.033), and the highest measurements for the least
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central 2.00° site recorded for subjects in the fourth age quartile (62-73 years) (0.14 SE ± 
0.017) (Table 10) (Figure 6). At the 0.50° site, mean MPOD were similar for both the 
first and fourth age quartile subjects who had higher MPOD than those in the second or 
third age quartile. Subjects in the fourth age-quartile had the highest MPOD at the 1.00° 
site. However, at all sites evaluated, and for CMPV, those in the second age quartile (50- 
55 years) had the lowest MPOD (Table 10). These were significantly lower compared to 
those in the first age quartile (p= 0.02) and the fourth age quartile (p= 0.01) at the 1.00° 
site. Those in the third age quartile (56-61 years) had measurements in between those in 
the second and fourth age quartile.
Aging has not been shown to have a consistent relationship to MP status 
(Table 2). Werner did not demonstrate a decline with aging (subjects 10-90 years old) 
(27), nor did Ciulla et al (subjects 18-50 years) (44) or Hammond (subjects 21-63 years) 
(15). However, some research has indicated a decline in MPOD associated with age, such 
as in the 60-84 year sub-group studied by Hammond.
According to Eisner et al (78) small alterations in the foveal cone photopigment, 
or the MP were found in a small group (n=l 1) of healthy subjects aged 31-59 years. 
These changes seemed to be associated with age. Using reflectometry with a scanning 
laser ophthalmoscope, subjects were classified into three groups according to the type of 
alterations in the regularity of their pigment distribution. The first group was noted to 
have a central foveal peak of photopigment with a mean age of 43, the second group had 
small foveal alterations with a mean age of 46, while the third group had a broad 
distribution of pigment with a central missing peak of photopigment or MP in the fovea 
with a mean age of 59 years. The groups differed significantly by age (p= 0.05). Eisner
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et al proposed three hypotheses for the changes observed, and all are related to change in 
the foveal architecture, particularly at the central 1.00° site. With age or increased ocular 
insult, foveal cone cells may die and not be replaced as tightly or uniformly as in younger 
subjects. Secondly, they propose that the structure of the fovea and the positions of the 
photoreceptors may not be static in adults. Cone packing, outward migration, and the 
adhesiveness of the interphotoreceptor matrix could change in the fovea. These changes 
could vary by the location in the retina as well as be associated with disease, age and 
gender differences. The third hypothesis suggests that rather than photoreceptor death, or 
the outward migration of photoreceptor cells, there is a broadening of the foveal 
curvature associated with aging. This concept supports the changes in the difference 
between the cone photopigment and MP distributions demonstrated between the youngest 
and oldest group of subjects (78).
This study did not include subjects beyond the age of 60; it would be interesting 
to see if this pattern of a decreased peak MP would continue, or if there would be a shift 
towards higher MP for individuals in their sixties and early seventies as seen in the 
present study. As mentioned in the results section, a significant difference was detected 
for the parafoveal measurements for those in the first age quartile when compared to 
those in all the other age quartiles, with the youngest subjects demonstrating the lowest 
parafoveal measurements. This finding may support Eisner’s work that there are changes 
in the architecture of the fovea between younger and older subjects. Sharpe et al. 
suggested that there may be regional differences in the cone photopigments in the central 
verses peripheral regions of the macula, and that such receptor variation needs to be 
verified and further investigated in light of the assumptions made when calculating MP
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(205). Since the values derived from the 6.00° parafoveal site are subtracted from all 
other sites to calculate MPOD, the existence of this difference associated with age needs 
to be further explored.
F. Hypothesis #2. Mean serum carotenoid and MPOD of consumers of fruits and 
vegetables would increase as reported intakes of fruit and vegetables increased.
A pattern of increasing mean serum concentrations of carotenoids as reported 
intake of fruits and vegetables increased (Table 34) using the rescaled 7-FVST was 
evident when comparing intakes as reported by the first three groups of consumers (low, 
modererate, and high). However, this pattern was not sustained for those reporting the 
very highest levels of fruit and vegetable consumption. Their serum carotenoid 
concentrations were closer to those in the low to moderate range. Campbell et al. had 
demonstrated that plasma carotenoids were useful biomarkers of fruit and vegetable 
intake (128) when comparing low and high consumers of fruit and vegetables. However, 
for the UNH study, there were only ten subjects who were classified as low consumers, 
(defined as probably eating less than 3-4 servings of fruit and vegetables per day); nearly 
60 % of the UNH participants met or exceeded the 5-A-Day fruit and vegetable intake 
goals compared to the estimated national average of 23% of the US adults meeting the 
fruit and vegetable intake goals (206). In the Campbell study, fifty low consumers 
(defined as probably eating less than two servings of fruit and vegetables per day) were 
matched with an almost equal number of high consumers.
Despite the lack of a significant association between reported intake and the 
serum results, there was a definite positive pattern associated with increased fruit and 
vegetable intake and increasing MPOD (Table 15). Significance levels were determined
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at the 0.50° (p= 0.20), and 2.00° sites (p= 0.02) and for CMPV (p=0.03), when comparing 
those with the highest levels of consumption to those reporting lower amounts. What 
appear to be contradictory between the serum and the tissue response become less 
contradictory if one considers MPOD status not only related to L/Z or other carotenoid 
intake, but also as a tissue that reflects carotenoid exposure over a long period of time, 
while serum concentrations reflect more recent intakes (207). Hammond has shown that 
the MP of individuals remains relatively constant over long periods of time in subjects 
who report their diet or supplement use has remained fairly constant as well (15). 
Research also indicates that MP can be increased with diet or supplement use (204) for 
some individuals, and the MP measurements remain elevated long after the supplement 
use stopped (87).
G. Hypothesis #3. Mean calculated dietary estimates of carotenoid intake from the 
FFQ’s for both males and females would be higher using the newly expanded 
carotenoid databases than those generated from previous analyses.
Results from the current research indicated mean daily calculated estimates of 
dietary carotenoids were lower than estimates for the same two carotenoids (BC, L/Z) 
assessed in the 1996 study on MP and nutrition (5). However, as mentioned earlier in the 
discussion section, the estimated dietary L/Z intake for females (2.5 mg SE ± 0.194) and 
males (1.8 mg SE ± 0.236) (Table 16) in the present study were estimated to be lower 
than the intakes for females (3.7mg SD ± 1.81) and males (3.5 mg SD ± 1.74) reported 
previously in NE and calculated by using the B-FFQ (5). Part of these differences in 
estimated intake may indeed be true differences in intake, but may also reflect periodic 
updates in the carotenoid databases used in the present research. Most of the research
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linking diet and vision has been conducted since 1993 when the expanded carotenoid 
databases were developed, thereby making an extensive comparison of comparably sized 
vision research projects using significantly older databases not possible. Earlier estimates 
were designed to primarily estimate the potential BC that could be derived from the 
carotenoid under investigation. Enhanced analytical capabilities and increased awareness 
of the potential unique biological actions of each of the six major carotenoids have 
contributed to the realization that updated and expansive carotenoid databases were 
needed in order to conduct comprehensive carotenoid research.
In a study designed to compare the influence of using different sources of 
carotenoid data in epidemiological studies, 2152 dietary FFQ’s were analyzed from 
participants in the Nutritional Factors in Eye Disease Study by VandenLangenberg et al.
(67). In this study, the Block Health Habits History Questionnaire (HHHQ) had been 
initially administered during in-home interviews conducted between May 1988 and 
December 1990. Both health history and food frequency data were collected using this 
instrument. Usual daily nutrient intake was calculated using DIETSYS software (HHHQ- 
DIATSYS Analysis Software, version 3.4 1995) and an accompanying nutrient database 
developed for the National Cancer Institute (NCI). Later, the same food consumption data 
was linked to the USDA-NCI carotenoid database and the results were reanalyzed. The 
results from this comparison indicated there were significantly different estimates of 
carotenoid intake, but there were only minor differences in carotenoid rankings and diet- 
serum relationships between the two analyses. These results are similar to those of the 
present study.
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Total carotenoid intake using the Block HHQ mean results (3.4 mg ± SD 1.9) and 
those of the USDA-NCI mean results (4.6 mg ± SD 2.4) were lower than those estimated 
in the present study for the group mean based on the B-FFQ (15.2 mg) (Table 16). When 
the mean results from the current study are compared to those consumers in the 75th 
percentile of intake in the VandenLangenberg study, the UNH results indicate an intake 
that is over three times that estimated by the B-HHQ (4.2 mg/day) and over 2.5 times by 
the NCI-USDA (5.7mg/day). (Note: the B-HHQ is similar to the current B-FFQ used in 
the present study, however the health habits questions were not used in the present study 
since a vision and health history was used instead). There are a couple of factors that may 
indeed be contributing to these differences. The sample recruited may indeed have had a 
more nutrient dense diet than those in the other studies. In addition, as the carotenoid 
database information expands, researchers may be capturing more carotenoid sources 
which ultimately contribute to higher estimates of carotenoid intake. It may well be that 
the older studies underestimated intake.
Mean carotenoid intake assessed through the current FH- FFQ’s (Table 16) was 
for 15 mg/day (sum of 1.13 mg AC; 4.00mg BC; 0.10 mg BCX; 8.40 mg LY; and 1.70 
mg L/Z). This was also higher than carotenoid intake estimated by Chug-Ahuja et al.
(68). Data on women (n=l,102) aged 19-50 years old surveyed through the USDA 
Continuing Survey of Food Intake by Individuals in 1986 was assessed using the 
expanded 1993 carotenoid databases. Total carotenoid intake was estimated to be 
approximately 6 mg per day (the sum of 0.40 mg AC; 1.80 mg BC; 0.30 BCX; 2.60 mg 
LY; and 1.30 mg L/Z).
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Comparisons to the VandenLangenberg and Chug-Ahuja studies are based on the 
initial carotenoid database information available in the early 1990’s. In 1998, the USDA 
updated their carotenoid database to include the concentrations of AC, BC, BCX, LY and 
L/Z found in common fruits and vegetables, making individual carotenoid content 
information more available. In the summer of 2000, the NDSR released its nutrient data 
software that included carotenoid intake for fruits and vegetables as well as mixed food 
items containing carotenoid rich foods such as pizza, spaghetti with sauce, etc. Since the 
1993 release of the original carotenoid analyses (69), there has been a continuous and 
extensive expansion of information on the carotenoid content of foods. This increase in 
data breadth and access enhances the ability to conduct comprehensive research on 
carotenoids.
When comparing all three FFQ’s, the daily total carotenoid intake for women 
ranged from between 11.6 mg/day to 16.0 mg/day and for men daily carotenoid intake 
was estimated to be between 8.8 mg/day to 15.9 mg/day (Table 16). Although there are 
wide variations in the total intakes, the relative rankings of carotenoid intake are very 
similar (Table 16). Except for the difference in the Tuft’s calculations which ranked BC 
as the carotenoid of highest intake, while the FH-FFQ and the B-FFQ rank LY as the 
highest, the FFQ’s indicate a remarkable consistency in the relative rankings of mean 
carotenoid intake. Comparison by gender indicated that all three FFQ’s estimated higher 
consumption of AC, BC, L/Z, by women then men. For BCX, similar intakes for women 
and men were reported by the B-FFQ, with slightly higher intakes for women than men 
reported by the FH-FFQ and the T-FFQ. Lycopene estimates were estimated to be higher 
for men by the B-FFQ and by the FH-FFQ, but higher in women by the T-FFQ. Estimates
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for LY intake had the greatest difference in terms of the absolute range and in terms of 
the percent difference.
EL Hypothesis #4. Mean calculated dietary estimates of carotenoid ingestion 
would enhance prediction of serum carotenoid concentrations, compared to earlier 
studies that used vitamin A activity to estimate carotenoid concentrations, with the 
FH-FFQ best able to predict MP status.
Results from the 24hr-FVST and the three FFQ’s indicate differences in the 
ability of the results of the dietary instrument to serve a predictor of serum carotenoid 
concentrations (Table 35). Although it was anticipated that the 24hr-CGFR would be best 
able to predict serum carotenoid concentrations, since both measure recent carotenoid 
intake, results linking dietary estimates and serum concentrations appeared to be a 
function of the carotenoid evaluated as well as the instrument used. For instance, 
significant positive associations were found for BC based on the group results and the 
male results, and, for females, only the 24hr-GCFR (p= 0.30) and the B-FFQ (p=0.20) 
did not show a significant linear relationship between dietary BC and serum BC 
concentrations. Dietary LY was found to have significant positive association with serum 
BC based on the results from the 24hr-CGFR for the group (p < 0.001), for females (p=
0.004) and for males (p < 0.001). No other assessment tool detected a significant 
association between reported dietary LY and serum LY concentrations. Dietary L/Z were 
found be significantly and positively associated using the group results for serum L/Z by 
the FH-FFQ (p= 0.007) and by the T-FFQ (p= 0.03). For females, nearly significant 
effects were detected by the T-FFQ (p= 0.052) and by the FH-FFQ (p= 0.08). For males,
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a significant positive association was found between reported intake and serum 
concentrations using the FH-FFQ (p= 0.02) but not by any other instrument.
The 24hr-FVST did not demonstrate an effect between carotenoid intake and 
MPOD (Table 17) based on the group results or those of the male subjects. For females, a 
significantly (p= 0.04) positive effect of LY was noted at the 0.50° site, and a nearly 
significant (p= 0.08) effect for LY at the 1.00° site and for the CMPV (p=0.06). For 
males, near significance was also demonstrated between LY intake and MPOD at the 
2.00° site (p= 0.08). These results may indicate that LY is a marker for overall carotenoid 
intake, though foods rich in lycopene are not rich sources of L or Z. Though LY is not 
found to any great extent in the MP, Bernstein et al. report that LY, as well as AC, has 
been detected in the pooled tissue samples of the retinal pigment epithelium and the 
choroid (208). However, the UNH results could also reflect the chance of finding 
significance when multiple statistical tests are conducted.
Results from the FFQ’s indicate that reported intake of L/Z and to a lesser degree 
of BCX were significantly and positively associated with MPOD (Table 18). The FH- 
FFQ- estimated intakes for L/Z was the only FFQ instrument in the UNH study that 
showed a significant association of L/Z intake with MPOD at all four foveal sites; 0.167° 
site (p= 0.02), 0.50° site (p= 0.02), 1.00° site (p= 0.009), 2.00° site (p= 0.02) and for 
CMPV (p= 0.006). This same questionnaire and its expanded database were used in the 
Midwest study on diet and MPOD (44). Results from that research indicated that the 
dietary L/Z results were predictive of MPOD, explaining approximately 2.01% of the 
variance in MPOD results and significant at the p= 0.02 level.
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In the present study, other carotenoids including BC and BCX were also shown 
to have a significant association with MPOD at some foveal sites based on the FFQ 
results from the three national distributors. Beta-carotene was found to be significantly 
associated (p= 0.04) with MPOD at the 0.50° site and nearly significant (p= 0.07) at both 
the 1.00° and 2.00° site by the FH-FFQ. All three FFQ’s found a significant positive 
association between BCX and MPOD at one or more foveal sites (Table 18).
The BCX CMPV results from the T-FFQ were found to be significant (p= 0.01), while 
those from the FH-FFQ were nearly significant (0.08). Though foods rich in BC may also 
be good sources of L/Z (spinach, broccoli, mustard and collard greens) foods rich in BCX 
are not particularly robust sources of L/Z. For instance, orange juice, oranges, and 
peaches provide close to 92% of the BCX in the diet, while orange juice and blends 
contribute only about 2% of the L in the diet (68). Except for L and Z, the other dietary 
carotenoids including AC, BC, BCX, and LY have not been detected in the retina or the 
lens in more than trace amounts (34, 208, 209). However, according to Yemelyanov et al. 
(210), the macula and retina may have xanthophyll-binding protein(s) (XBP) that have 
been shown to bind with BCX as well as with L and Z. Since BCX has not been found in 
appreciable amounts in the retina, the researchers were surprised of its binding affinity to 
XBP; they postulated that the human retina might have the enzymatic capacity to convert 
the cryptoxanthins into either L, Z, or vitamin A. Other possible explanations for the 
association between the dietary intake of BC and BCX overall carotenoid consumption 
are these foods may enhances antioxidant activity and/or foods rich in BC and BCX 
could be sources of other yet identified components of carotenoid rich foods that enhance 
MP deposition.
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Vitamin C was also shown to be positively associated with MPOD by all three 
FFQ’s at one or more foveal sites (Table 18). Since vitamin C acts as an antioxidant, 
higher concentrations of circulating vitamin C may help to reduce oxidative stress in the 
foveal region, thereby enhancing the health and MP status of this region. Higher intakes 
of vitamin C have been linked to lower rates of AMD risk in a study conducted in 1988 
based on results from the NHANES research (30). Like BC and BCX, vitamin C intake 
may also be serving as a biomarker for fruit and vegetable consumption. In addition, iron 
and retinol, and provitamin A were also were found to be significantly associated with 
MPOD.
As noted in the results section, significant effects of diet on MPOD were 
determined at all four foveal sites by at least one FFQ for dietary intakes of L/Z (FH- 
FFQ), vitamin C (T-FFQ), and iron (T-FFQ). Significant relationships for CMPV scores 
were calculated for intakes of L/Z (FH-FFQ: p= 0.006), iron (T-FFQ: p= 0.008), vitamin 
C (T-FFQ: p= 0.001) and (FH-FFQ: p= 0.008), vitamin E. All of these have been linked 
to eye health in a number of studies (5) (44)(51) Surely multiple positive associations as 
seen with vitamin C, L/Z, BCX, and iron lend support for future research into these 
nutrients as well as continued research into the design of nutrient assessment tools and 
their respective databases. The role of antioxidant reactions surely seems to hold research 
promise, since many of the nutrients identified are antioxidants.
I. Hypothesis #5. Higher concentrations of serum carotenoids would be associated 
with higher MPOD.
The mean serum carotenoids for the group in umol/L were for BC 0.621 
(SE ± 0.042), for LY 0.432 (SE ± 0.018), for L 0.358 (SE ± 0.013), for Z 0.069
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(SE ± 0,003) and for L/Z 0.427 (SE ± 0.015). (Table 19) The UNH results are similar to 
those individuals at the 50th percentile to close to the 75th percentile of intake when 
compared to results from the National Health and Nutrition Examination Study (Table 
19).
The mean serum L/Z value based on the group result in the present study was 
0.427 umol/L SE ± 0.015. These serum concentrations are higher than the serum 
concentrations reported for the Midwestern mean group result of 0.372 umol/L SD± 
0.169 as well as higher than the mean group serum results reported in 1996 of 0.366 SD± 
0.178 (calculated from the female and male results in the publication)(5). The mean 
group MPOD value at the 0.50° site (the one site measured in all three studies) was also 
higher in the present study (0.36 SE ± 0.013) than the mean MPOD measured in the 
Midwest (0.21 SD ± 0.13)(44) or the mean MPOD reported from the NE study (0.31 SD 
±0.188)(5).
At first glance, these results seem to indicate higher concentrations of serum 
carotenoids are associated with higher MPOD. However, group serum carotenoid results 
from NE were lower than the serum carotenoid concentrations of the Midwest, yet group 
mean MPOD from the NE study were higher than those reported from the Midwest. One 
of the differences between the Midwest study and the NE study was the parafoveal 
assessment. As mentioned previously, the parafoveal assessment in the Midwest was 
assessed at four degrees retinal eccentricity; in the NE study, the parafoveal was 
measured by placing a fixation point at 5.5 degrees eccentricity. Given the number of 
variables that may influence MPOD results, standardization of the parafoveal test site 
location may help to make comparisons among studies more meaningful.
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When the results from the present study, the Midwest study and the NE study are 
evaluated by gender, differences appear between the female and male responses to serum 
L/Z concentrations. The mean serum L/Z value for females in the present study was 
0.439 umol/L (SE ± 0.021) and that of males was 0.407 umol/L (SE ± 0.020) (Table 19) 
These serum concentrations are higher than the serum concentrations reported for the 
Midwestern females (0.349 umol/L SD± 0.307) or males (0.211 SD ± 0.248) (44) as well 
as higher than the serum results from those reported in 1996 of NE females (0.376 SD± 
0.181) and males (0.356 SD± 0.174) (5). In all three studies females had higher 
concentrations of serum L/Z than males, yet this did not translate into significantly higher 
MPOD for females in the present study or for females in the Midwest. In the NE study, 
women had significantly lower MPOD than men. Differences in the response to 
circulating carotenoids appear to be associated with sex, but a number of factors appear 
to ultimately influence MPOD concentrations.
Research results by Hammond et al showed some, but not all, individuals respond 
to an increased intake of dietary L/Z with increased serum concentrations of L/Z and 
increased MPOD (28). In the study, 10 of the 13 subjects consumed additional spinach 
and com, (rich sources of L and Z, respectively) in their diet for up to 15 weeks. Based 
on these ten subjects, increasing the intake of L/Z increased serum concentrations of 
these carotenoids by 33% SD ± 22% and MPOD by 19 % SD ± 11% in seven “retinal 
responders”. Two “retinal non-responders” showed a 31% increase in serum L/Z but an 
11% decline in MP. For one subject, the “blood and retinal nonresponder,” serum L/Z 
did not change, and MP increased by 6%. A number of studies have shown that 
individuals vary greatly in their serum response based on dietary manipulation of the
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carotenoid content of the diet (37, 49, 51, 110, 211, 212). The Hammond study represents 
one of the first studies to show individual differences in the response to dietary 
carotenoid intake, serum carotenoid concentrations, and subsequent MP deposition (28).
Rather than using dietary manipulation, Landrum and Bone designed a 
supplement intervention study (87). Two subjects were provided a lutein ester 
supplement equivalent to 30 mg of free lutein per day during a 140-day period. Serum 
carotenoid concentrations and MPOD were assessed before, during and after the 
intervention period. Twenty to forty days after the supplementation began, the MPOD 
began to increase in each subject. During this same period, serum L increased 
approximately 10 fold. The MPOD increases were fairly similar for both individuals, 
although one subject maintained different MPOD in the left and right eye throughout the 
study. Even though L supplementation ended on day 140, there was a continued increase 
in MPOD for approximately 40-50 more days, while serum L concentrations remained 
elevated, but were decreasing. By the end of the study, mean MPOD had increased by 
39% in one subject, and by 21% in the other. The study also revealed that MPOD 
remained elevated, even after serum L returned to pre-supplementation levels. According 
to the authors, the results indicate the turnover of carotenoids in the retina is very slow. 
These results are from a very small sample but demonstrate differences in individual 
responses to carotenoid exposure. Since both subjects were working in the research 
laboratory in which the MP investigation was conducted, differences in compliance with 
the supplement ingestion regime was addressed and ruled out as a contributing factor for 
the variation in the responses by the subjects.
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Although increasing concentrations of circulating nutrients often translates into 
increasing tissue deposition (102), this is not always the case with MP (5, 28). The 
deposition of MP may not only be influenced by serum carotenoid availability, but also 
by the ability of the carotenoids to bind to the retinal tissue (210). Lutein and Z are 
selectively deposited in the retina, and according to Yemelyanov et al. concentrations of 
L/Z in the fovea are approximately 1000-fold higher than L/Z concentrations in the serum 
and other tissues such as the liver, kidneys, or lung.
Selective deposition of a compound (such as L or Z) often indicates the presence 
of specific binding proteins involved in the accumulation of the compound. In 1997, 
Bernstein et al. reported that experiments on bovine retinal tissue indicated that tubulin 
could function as a major soluble carotenoid-binding protein (159). When soluble 
extracts of human MP were examined, the carotenoids L and Z were found in concert 
with the protein tubulin as well. Expanded research published from Bernstein and 
associates suggests that possibly a xanthophyll-binding protein (XBP) family may be 
present in the retina and macula. This specific protein or group of proteins could help to 
regulate the uptake, stabilization, and function of L and Z (210). The XBP(s) could also 
act as enzymes mediating the interconversion of L, Z, BCX, and their various metabolites 
within the retina as well as facilitate the antioxidant action of carotenoids. Two proteins 
were identified as possible members of XBP family. The carotenoids that showed a 
substantial ability to bind with XPB, starting with the most highly bound were L, 3’- 
epilutein, BCX, Z, meso- zeaxanthin and isozeaxanthin. The carotenoids astaxanthin, 
canthaxanthin, BC, and basal consistently showed much lower levels of binding affinity 
to XBP than L.
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The results from the group analysis reveal those higher concentrations of the 
serum L and/or serum L/Z carotenoids were significantly associated with higher MP at 
the three most central foveal sites and for CMPV (Table 21). For serum L, the group 
results show a strong positive effect of serum L on MPOD at the 0.167° site (p= 0.003), 
at the 0.50° site (p < 0.001) at the 1.00° site (p < 0.001) and for CMPV (p= 0.001). For 
serum L/Z, the group results show a strong positive effect of serum L/Z on MPOD at the 
0.167° site (p= 0.007), at the 0.50° site (p= 0.001) at the 1.00° site (p < 0.001) and for 
CMPV (p= 0.003). For women, similar positive effects were demonstrated for serum L 
on MPOD at the 0.167° site (p= 0.02), at the 0.50° site (p= 0.001), at the 1.00° site (p= 
0.001), and for CMPV (p= 0.004). A near significant effect at the 2.00° site (p= 0.08) was 
calculated. Likewise, for women, similar positive effects were demonstrated for serum 
L/Z on MPOD at the 0.167° site (p= 0.03), at the 0.50° site (p= 0.002), at the 1.00° site 
(p= 0.001), and for CMPV (p= 0.008). These effects of serum L on MPOD were not 
demonstrated in men, where at the 0.167° site near significance was reached (p= 0.09), 
but no significance was detected at the remaining sites; 0.50° site (p= 0.35) at the 1.00° 
site (p= 0.16) and at the 2.00° site (p= 0.46).
J. Hypothesis #6. Elevated LDL-C would enhance MPOD, while higher HDL-C 
concentrations would be associated with lower MPOD.
The results from our study do not indicate a significant, predictive relationship 
between total cholesterol (Table 25), LDL-C (Table 26), or HDL-C (Table 27) 
concentrations and MPOD measurements in men or women. Triglyceride concentrations 
however were associated with MPOD at both the 0.167° site (p= 0.02), at the 1.00° site 
(p= 0.02), and for CMPV (p= 0.007) (Table 28). In these cases, those in the second
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triyglyceride quartile had higher MPOD than those in the fourth quartile. Though not 
significant at all sites, a trend was observed that (except for one value from the first 
quartile participants at the 0.50° site, indicated those in the fourth quartile had the lowest 
MPOD when compared to the any of the other results at each of the foveal sites assessed. 
The HDL and LDL are considered to be the principle carriers of the carotenoids (54, 213). 
The association of MPOD with circulating triglycerides was somewhat unexpected since 
plasma L/Z concentrations were not significantly associated with triglycerides based on 
results from the Framingham Heart Study
The fat-soluble carotenoids are dependent on the presence of lipids for absorption 
and transport (74, 132). Lipoprotein carriers demonstrate selectivity for specific 
carotenoids. For instance, Forman et al determined that the hydrocarbon carotenoids (a~ 
and P-carotene, and Iycopene) were highly concentrated in LDL, while the xanthophyll 
carotenoids (lutein, zeaxanthin,) were more evenly distributed between the LDL and HDL 
(55). Within the lipoprotein categories, subclasses have been identified. In the HDL 
subclasses, lutein/zeaxanthin were more concentrated in the HDL 3 than in the HDL2 
fractions (135). Investigation of lipoprotein subclass carotenoid composition in future 
research projects may help to shed some light on the role of lipoproteins in carotenoid 
metabolism.
Presently there is little research data available that examines lipoprotein and/or 
serum carotenoid concentrations andMP status. Though numerous studies have 
examined the role of lipoproteins and carotenoids, (39, 54, 214, 215), and other studies 
have examined the role of carotenoids and MP status (28, 216) little research is available 
that specifically examines the role of lipoproteins on MP deposition.
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Some research is available that has examined the role of diet, including fats on 
MPOD. Research results by Hammond et al. indicated that dietary intake of carotenoids, 
fat, iron, and plasma concentrations of lutein and zeaxanthin were positively related to 
MPOD in males. Only plasma lutein and zeaxanthin were positively related in females, 
but dietary fat was negatively related to MP density (5). No lipoprotein analysis was 
conducted in that study.
Additional information is available on the role of diet and disease based on results 
from the Beaver Dam Eye Study that indicated that a high intake of saturated fat and 
cholesterol was associated with an increased risk of early AMD in their sample. Persons 
with intakes of saturated fat and cholesterol in the highest quintile had 80% and 60% 
higher odds for early age-related maculopathy (ARM) than those in the in the lowest 
quintile (8). Researchers offered the possible mechanisms influencing the association of 
saturated fat and cholesterol with macular disease. First, these dietary factors increase the 
risk for systemic vascular disease. Secondly, higher concentrations of saturated fat or 
cholesterol may enhance direct deposition of fat in Bruch’s membrane that may interfere 
with the flow of metabolites in and out of the retinal pigment epithelium. Thirdly, high 
intakes of dietary saturated fat or correlates (high butter intake) may reflect other 
unmeasured behaviors that increase risk for AMD (8). In contrast to this research,
Sanders et al. did not show a relationship between cholesterol and AMD (179). Recent 
results by Cho et al indicated that total fat intake as assessed through FFQ were positively 
associated with the risk of AMD (123). The researchers speculated it might have been 
due to intakes of specific fatty acids such as linolenic acid, instead of total fat per se. The 
same study indicated a high intake of fish might reduce the risk of AMD. Since there was
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a modest inverse association with docosahexaenoic acid (top verses bottom quintile of 
RR 0.70; 95% Cl 0.52,0.93 p for trend =0.05) there appears to be a potentially protective 
role from this particular fatty acid. It is well known that the rod outer segments of the 
retina are rich in this fatty acid.
Based on the results already presented from this research project (Table 33), it has 
been demonstrated that increasing body weight as measured by increasing BMI has been 
associated with lower MPOD. Increasing body weight has also associated with increasing 
triglyceride concentrations and increasing insulin resistance (138). As mentioned in the 
discussion of BMI, Facchini et al have shown that the more insulin resistant healthy 
volunteers are, the lower their concentrations of circulating carotenoids (140).
In addition to the potential impact of lipoprotein concentrations on MPOD, the 
influence of lipids on serum carotenoid concentrations were also evaluated (Table 29). 
Except for BC (p= 0.39), increasing cholesterol concentrations were associated with 
increasing concentrations of LY (p= 0.004), L (p= 0.002), Z (p= 0.02), L/Z (p= 0.002) 
and total carotenoids (p= 0.03) (Table 29). Additional pair wise comparisons showed 
significantly higher concentrations of carotenoids for those in the fourth quartile for LY 
(p= 0.007), L (p= 0.001), Z (p= 0.008) and L/Z (p= 0.001) when compared to those in the 
first quartile; near significance was found for total carotenoids (p= 0.06) when comparing 
the same quaitiles. Significance was also demonstrated for LY since those in the fourth 
quartile had significantly higher (p= 0.008) serum concentrations than those in the first 
quartile. Lutein concentrations were significantly higher (p= 0.05) for those in the fourth 
quartile compared to those in the second quartile; near significance (p= 0.07) was 
detected when comparing these same two groups and L/Z concentrations. No significant
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differences were detected for serum carotenoids based on LDL-C (Table 30), HDL-C 
(Table 31) or triglycerides (Table 32) comparisons.
Part of the limited ability to detect results by the different lipoprotein carriers on 
serum carotenoids may have been due in part to the overall low lipid concentrations for 
the sample population. The lipid results from the study sample indicate the mean group 
concentrations for cholesterol were 186 mg/dL (SE ± 3.218), for VLDL-C 28 mg/dL 
(SE ± 1.231), for LDL-C 98 mg/dL (SE ± 2.892), for HDL-C 66 mg/dL (SE ± 2.288) 
and for TRIG 142 mg/dL (SE ± 6.145) (Table 22). The reference values for cholesterol 
concentrations in the population are listed for adults in five-year increments in Table 36. 
As indicated in the table, the variance in this population was extremely low, making it 
much more difficult to detect significant differences. Results from our subjects in the 5% 
to-95% fall within those of the reference 5 % to 95%. for cholesterol, but our upper range 
for cholesterol was approximately 230mg/dL while the reference data is close to 300 
mg/dL depending on the age evaluated. For LDL-C our ranges are lower than those of the 
reference text by age are, while for HDL-C the concentrations are higher. For 
triglycerides, the lower limits were higher in the UNH study, but the 95% concentrations 
were lower than the reference standards. The lipids were evaluated at the nationally 
certified NEL at Tufts, Boston. On request, selected samples were reprocessed by Tufts 
and in the UNH laboratory yielding similar results.
K. Limits of the study
One of the major limits of this study is that the sample that responded to the 
request for study participants was not representative of the population of the region, but 
had higher incomes and more education than the general population. Both factors have
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been shown to influence dietary selections. The recruitment of a healthy cohort is not 
unusual when nutrition and health studies are conducted, since those interested in 
participating in the research often have an interest in nutrition. Based on the design of the 
research, participants were asked to come to UNH for one comprehensive visit. Although 
this helped in recruitment efforts, serum carotenoid concentrations and MPOD results 
represent one assessment, when multiples are preferred. Though attempts were made to 
recruit an equal number of females than males, the study had more females than males, 
which again is typical of many health and nutrition studies.
108
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
VI. CONCLUSION
Numerous factors are believed to influence MPOD and MP distribution. In the 
present study dietary L/Z intake and serum L/Z were shown to be positively associated 
with MPOD, while there was an inverse relationship between BMI and MPOD status.
Sex did not significantly predict MPOD .
The relationship of age and MP status showed that in the study sample, age was 
not related linearly to MPOD; rather a pattern was observed with those in the youngest 
and oldest age quartiles had higher MPOD than those in their fifties and early sixties.
This trend was evident at all foveal sites. Future research should explore whether this was 
unique to our sample, or represents a typical pattern for MP status. Age also was related 
to the parafoveal values, with subjects under the age of fifty having significantly lower 
parafoveal values than all other subjects. This may indicate difference in factors such as 
photopigment distribution, retinal structure or melanin concentrations. Since the 
parafoveal values are subtracted from the foveal values, this difference should be further 
evaluated.
Our results for eye color, at first glance, appear to be different from those 
previously reported, in which light iris color was significantly associated with lower MP 
at the 0.50° degree site. There were no significant differences detected at this site for 
results from the present study, while higher MP were detected in blue eyes than hazel 
eyes at the 1.00° and 2.00° foveal sites. Although additional information on the 
distribution of MP has been generated by the results of the study, new questions emerge
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as to why some sites, but not all sites, appear be affected by factors such as eye color, 
serum carotenoid concentrations or reported nutrient intake.
The evaluation of different dietary tools indicated there are many ways to capture 
dietary information. For vision research in which L and Z are being evaluated, the FH- 
FFQ appeared preferable to the Tufts and Block instrument as evaluated in this study. 
The results from the FH-FFQ assessment tools were most closely associated with both 
MPOD results and serum L/Z carotenoid concentrations. It was surprising to detect 
significance for reported BOX intake and MPOD but given BOX xanthophyll structure, 
this may warrant additional investigation.
The relationship of BMI status, triglycerides, and MPOD status is especially 
intriguing as research continues to try to determine the biochemical parameters and 
environments that influence carotenoid deposition in general, and MP status in particular. 
Because the range of the variance in our lipid results was very narrow, the ability to detect 
potentially significant differences between the lipid variables and MPOD status was 
diminished. Perhaps the role and the impact of triglycerides on carotenoid status will be 
enhanced as understanding of both lipid metabolism and carotenoid transport is enhanced 
through increasingly sophisticated ways to trace these substances such as the in the use of 
labeled isotopes (102)
Like many studies in nutrition and health, it appears our subjects were a healthy 
cohort. More research, with more diverse cohorts, needs to be carried out in order to lead 
us to a more complete understanding of the intricate relationships between dietary 
practices, carotenoid absorption, and macular pigment deposition.
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VII. Tables
Table 1. Summary of Assessment Procedures for Study Participants
SUBJECT
QUESTIONNAIRE




































• Carotenoid intake 
guided food recall
• Food frequency 
questionnaires 




























Table 2. Summary of Studies: Macular Pigment Optical Density and Heterochromatic Flicker Photometry
S tu d y #  * 
G roups "






# 7 # 8  A # 9
Age range 21-39 10-90 19-22 19-83 21-63 22-36 60-84 22-84 17-19 21-81 18-51



























Foveal Stimulus Size 1.00° 1.00 ° 1.00° 20
minutes
1.00° 1.00° 1.00° 1.00° 0.95° 1.00°
Assessment: Degrees 
Retinal Eccentricity
0.67 0.50 0.50 0.50 1.00 0.50 0.50 0.50 0.50 0.475 0.50
Mean MPOD 0.77 0.39 0.28 0.38: m 
0.24: f
0.29 0.40 0.46 0.24: m 
0 .21 :f
0.29 0.21: m 
0 .21 :f
Age — ns . . . — ns ------ p<0.01AA ns p<0.02AA p<0.0001AA ns
Sex . . . — — p<0.001 ------ ------ --- p<0.05 ns ns
* #1 (166)#2 (27) # 3 (46) #4 (5) #5 (15) # 6 (14) #7 (45) # 8 (1) #9 (44)
** Subgroups within studies:
A = Young group of subjects 
B = Old group of subjects 
C = Combination of A and B
A Method used to determine MPOD by HFP differed from all other investigators, thereby making comparison difficult. Results based on a subset of subjects identified a s  not at risk 
of AMD in England. All other studies are from subjects assessed  in the United States.
M  Macular pigment declined with age.
f = females; m = males; ns = not significant MPOD = macular pigment optical density
Table 3. Summary of Research Results on the Influence of Dietary Substances
on Macular Density and Macular Disease Risk: 
_____________________Nutrients, Supplements, and Dietary Selections___________
Nutrient Potential influence on MPOD and Macular Disease Risk Ref#
Vitamin C 
(intake)
Not statistically linked to reduced risk of AMD but intake from food sources 




Not statistically linked to reduced risk of AMD #4
Vitamin E 
(intake)
Not statistically linked to reduced risk of AMD






Not statistically linked to reduced risk of AMD #4, #9
Zinc (intake) As a supplement, oral zinc administration appeared beneficial for prevention of 
macular degeneration, but authors do not support routine supplementation 
due to small study size and risk of toxicity
#7
Higher intake associated with decrease in pigment abnormalities in AMD # 8
No significant protection between antioxidant intake and early ARM # 8
Data are weakly supportive of zinc protecting against the development of 








No significant protection between antioxidant intake and early ARM 






Antioxidant index that combined vitamins C and E, selenium, and carotenoids 
indicated higher the index, the lower the risk of AMD
#4
Lipids Dietary fat intake positively correlated to MPOD in males # 1
Dietary fat intake negatively associated to MPOD in females # 1
Higher intake of vegetable fat increased risk for neovascular AMD #4
Non-significant trend of higher linoleic acid intake and early AMD in women # 10
High sat. fat and cholesterol intake increases risk for ARM # 10
Low total cholesterol intake and elevated HDL-C conc. are associated with 
increased risk for females for early ARM
#11
Fatty acids in the serum were not related to early ARM # 12
Iron Intake positively correlated to MPOD density in males only # l
Food
Consumption
Vegetable intake appears to positively influence MPOD





Ingestion of a 14 component antioxidant tablet taken twice daily stabilized but 
did not improve dry AMD
# 14
Study Reference Number: #1 (5) #2(28) #3(9) #4(29) #5 (44) #6(30) #7 (217) #8 (218) #9(219) 
#10 Macular Degeneration Study Group (8) #11(73) # 12 (179) #13 (181) #14(220)
AMD = age related macular degeneration 
ARM = age related maculopathy 
MPOD = macular pigment optical density 
CONC = concentration
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T a b le  4. Summary of Research Results on the Influence of
Dietary Substances on Macular Density and Macular Disease Risk: 
Vitamin A and the Carotenoids
Nutrient Potential influence on MPOD and Macular Disease Risk Ref#
Vitamin A Preformed A not linked to decreased risk of AMD




Total carotenoids (intake) Higher intake associated with decreased risk of AMD
Higher intake not associated with decreased risk of AMD





Total carotenoids (blood) Subjects with medium and high circulating carotenoids conc. had a 
decreased risk for the development of the wet type of AMD
#4
Beta-carotene (intake) Intake positively correlated to MPOD density in males only 
Not associated with increase in MPOD in males or females
# 1 
# 5
Beta-carotene (blood) Intake positively correlated to MPOD density in males only 
Not associated with increase in MPOD in males or females 






Among dietary factors lutein most strongly linked to increased 
MPOD
Among carotenoids, L/Z most strongly linked with decreased AMD
#5 
# 3
Lutein/zeaxanthin (blood) Positively correlated to MPOD density in males and females # 1
Lutein (intake) Diet enriched with lutein increased serum conc. and MPOD in 8/13 
subjects;
1 subject had no change in serum lutein
2 subjects had elevated serum conc. but no change in MPOD
Lutein supplement increased serum lutein and MPOD in 8 male 
subjects





Lutein (blood) Increases in serum conc. may lead to increases in MPOD (see 
above)
Positively correlated to MPOD density
#2  
# 5
Zeaxanthin (intake) In one subject, increased Z intake, serum increased 70%: MPOD 
by 25%
#2
Zeaxanthin (blood) Blood conc. were not correlated to increase in MPOD density, 
although blood conc. increased as diet intake increased
# 5
Study Reference Number: #1 (5) #2(28) #3(9) #4(29) #5(44) #6(30) #7(217) #8(218) #9(219) #10 
(204) # 11 (87)
AMD = age related macular degeneration 
ARM = age related maculopathy 
MPOD = macular pigment optical density 
CONC= concentration
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Table 5. Subject Assessment Completion Rates
Number 
Plan to 




W omen Men Group Women Men Group
Health Assessments
Health and vision survey 108 67 41 108 67 41 108 100%
Weight 108 67 41 108 67 41 108 100%
Height 108 67 41 108 67 41 108 100%
Waist .108 64 40 104 64 40 104 96%
Hips 108 64 40 104 64 40 104 96%
Food and Nutrition Surveys
7-FVST 108 67 41 108 67 41 108 100%
24hr-CGFR 108 67 41 108 67 41 108 100%
B-FFQ 108 65 38 103 65 38 102 94%
FH-FFQ 108 67 39 106 67 39 106 98%
T-FFQ 108 63 40 103 63 40 103 95%
Serum Analysis
Carotenoids 108 66 41 107 66 41 107 99%
Lipids 108 67 41 108 67 41 108 100%
Vision Assessment
ETDRS 108 67 41 108 65 41 106 98%
Contrast Sensitivity 108 67 41 108 67 41 108 100%
Amsler Grid 108 67 41 108 67 39 106 98%
MPOD A ssessm ent *** 108 66 41 107 61 37 98 91%
Eye color**** 108 67 41 108 61 37 98 91%
* Includes subjects who attempted to complete the task.
** Includes subject results that were used for som e or all of the analysis.
*** Subjects had to successfully pass vision screening tes ts  and complete at least three retinal site evaluations and the parafoveal
site assessm en t for MPOD data inclusion. Of these  98 subjects, nine could not complete the 0.167 degree site, and one did not
complete the 2.00 degree site.
**** Analyses of eye color data and MPOD levels were based on the 98 subjects meeting the vision testing criteria.
7-FVST = Seven item fruit and vegetable screening tool 
24hr-CGFR = Twenty-four hour carotenoid guided food recall
B-FFQ, FH-FFQ, T-FFQ= Block, Fred Hutchinson, and Tufts food frequency questionnaires respectively 
ETDRS = Early Treatment Diabetic Retinopathy Study 
MPOD = macular pigment optical density
Table 6. Subject Assessment Details: Macular Pigment Optical Density and Eye Color
Number 
Plan to 




Women Men Group Women Men Group
Macular Pigment Optical Density
MPOD Assessment ** 108 66 41 107 61 37 98 91%
0.167 degrees 108 61 37 98 56 33 89 82%
0.50 degrees 108 66 41 107 61 37 98 91%
1.00 degrees 108 66 41 107 61 37 98 91%
2.00 degrees 108 66 40 106 61 36 97 90%
6.00 degrees (parafovea) 108 66 41 107 61 37 98 91%
CMPV calculation*** 108 56 32 88 56 32 88 81%
Eye Color
Eye Color Total**** 108 66 41 107 61 37 98 91%
Blue 41 21 20 41 19 19 38 93%
Brown 27 16 10 26 16 9 25 93%
Gray 1 1 0 1 0 0 0 0%
Green 9 8 1 9 7 1 8 89%
Hazel 30 20 10 30 19 8 27 90%
* Includes subject results that were used for some or all of the analysis.
** Subjects had to successfully complete at least three retinal sites evaluations and the parafoveal site for MPOD data inclusion.
Of these 98 subjects, nine could not complete the 0.167 degree site, and one did not complete the 2.00 degree site.
*** CMPV = composite macular pigment value was based on 88 subjects who successfully completed assessment at all four foveal sites.
**** Analyses of eye color data and MPOD levels were based on the 98 subjects meeting the testing criteria.











Table 7. Subject Descriptive Characteristics
Women Men Group Total
Number
% of 
Women % of Total Number % of Men % of Total Number % of Total
I Number of Subjects 67 100% 62% 41 100% 38% 108 100%
Age*
Mean Age 54.62 (SD + 7.56) 58.51 (SD + 8.03) 56.10 (SD + 7.93)
Age Range 45-71 47-75 45-75
45-49 24 36% 22% 7 17% 6% 31 ' 29%
50-59 24 36% 22% 16 39% 15% 40 37%
60-69 17 25% 16% 13 32% 12% 30 28%
70-75 2 3% 2% 5 12% 5% 7 6%
Race
White or Caucasian 66 99% 61% 40 98% 37% 106 98%
Other 1 1% 1% 1 2% 1% 2 2%
Education
Hiqh School Graduate 8 12% 7% 2 5% 2% 10 9%
Colleqe attendance and/or qraduate 27 40% 25% 12 29% 11% 39 36%
Graduate School and/or advanced 32 48% 30% 27 66% 25% 59 55%
Household income
No response 5 7% 5% 2 5% 2% 7 6%
Less than 15,000 1 1% 1% 1 2% 1% 2 2%
Between 15-24,999 2 3% 2% 1 2% 1% 3 3%
Between 25-34,999 6 9% 6% 3 7% 3% 9 8%
Between 35-49,999 7 10% 6%. 4 10% 4% 11 10%
Between 50-74,999 14 21% 13% 7 17% 6% 21 19%
Greater than 75,000 32 48% 30% 23 56% 21% 55 51%
Smoking History
Never or less than 100 cigarettes 46 69% 43% 21 51% 19% 67 62%
More than 100 cigarettes 21 31% 19% 20 49% 19% 41 38%
Supplement Practice
Non-supplement user 18 27% 17% 14 34% 13% 32 30%
Supplement user 49 73% 45% 27 66% 25% 76 70%
* Totals may not exactly equal 100% due to rounding.
Table 8. Interquartile and Group Ranges for Statistical Analysis: Age Ranges and 7-FVST
Age Group by Quartiles Quartile Range in years # of Women # of Men Total
One 45-49 24 7 31
Two 50-55 13 9 22
Three 56-61 16 13 29
Four 62-75 14 12 26
7-FVST: Block Fruit and Vegetable Groups* Group Score Range # of Women # of Men Total
Seven Item Fruit and Vegetable Screening Tool , One 0-10 2 5 7
Two 11-12 4 5 9
Three 13-15 19 9 28
Four 16 plus 42 22 64
7-FVST: New Fruit and Vegetable Groups (rescaled)** Group Score Range # of Women # of Men Total
Seven Item Fruit and Vegetable Screening Tool One (low) 7-11 4 6 10
Two (moderate) 12-15 21 13 34
Three (high) 16-19 24 14 38
Four (very high) 20-24 18 8 26
*Block Categories
One: Low, eating probably fewer than 3 servings of fruit and vegetables per day.
Two: U.S. average, eating probably fewer than 4 servings of fruit and vegetables per day.
Three: Eating above U.S. average, but not quite 5 servings of fruits and vegetables per day.
Four: With a score of 16, probably m eets 5-A-Day goals, eating approximately the five servings of fruits and vegetables per day.
"R esca led  7-FVST Categories
One (low): Low consumption for the study population, eating probably fewer than 3 to 4 servings of fruit and vegetables per day.
Two (moderate): At, or a  bit above the U.S. average, eating probably between 4- 5 servings of fruit and vegetables per day.
Three (high): Eating above U.S. average, probably many eating 5 or more servings of fruits and vegetables per day.
Four (very high): With a score of 20 or more, this group contains the highest consum ers in the population studied; intake exceeds 5-A-Day goals, 
eating well above the five servings of fruits and vegetables per day.
Table 9. Anthropometric Measurements
Height
Number Mean Height (inches) Mean Height (cm)
Women 67 64.34(SD */- 2.57) 163.42(SD 7-6.54)
Men 41 69.37(SD */-3.39) 176.20(SD 7- 8.62)
Group__________________________________108____________66.25(SD 7- 3.80) 168.28(SD */- 9.64)
Weight
Number Mean Weight (pounds) Mean Weight (kg)
Women 67 154.47(SD7- 29.24) 70.22(SD */- 13.29)
Men 41 195.99(SD */- 32.02) 89.09(SD */- 14.55)
Group 108 170.23(SD */- 36.34) 77.38(SD */- 16.52)
BMI < 27.00 >27.00
Number Number % Group
Women 46 21 62%
Men 17 24 38%
Group Total 63 45 100%
Healthy Weight (BMI=18.5-24.99)
Number % of Gender % Group
Women 31 46% 29%
Men 4 10% 4%
Group Total 35 33%
Overweight (BMI=25.00-29.99)
Number % of Gender % Group
Women 24 36% 22%
Men 23 56% 21%
Group Total 47 43%
Obese (BM1>30.00)
Number % of Gender % Group
Women 12 18% 11%
Men 14 34% 13%
Group Total 26 24%
Waist Hip Ratios: Healthy (<  0.80 Women, < 0.95 Men)







Group Total 67 62% *
Waist Hip Ratios Less Healthy (>  0.80 Women, _> 0.95 Men)







Group Total 37 32% *
* Waist-hip ratios do not add up to 100% since values for 4 subjects (3f, 1 m) were not available. 
BMI = body mass index
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Table 10. Subject Descriptive Characteristics and Mean Macular Pigment Optical Density
Foveal Site & Composite Value 0.167° 0.50° 1.00° 2.00 CMPV1 II II 1 is iWSJ+vxjxXxXij.mvXxXw:;:;-xxjxCixiCxKxsrsxiXvfWx
Group*
MPOD 0.43 (SE + 0.017) 0.36 (S E + 0.013) 0.28 (SE + 0.012) 0.13 (SE + 0.008) 0.26 (S E + 0.011)
Gender**
ANOVA P Value * 0.34 0.89 0.93 0.82 0.71
MPOD
Female 0.40 (SE + 0.028) 0,34 (SE + 0.020) 0.26 (SE + 0.016) 0.12 (SE + 0.011) 0.24 (SE + 0.016)
Mate 0.44 (SE-t-0.032) 0.34 (SE + 0.023) 0.26 (SE + 0.019) 0.11 (SE + 0.013) 0.25 (SE ±0.018)
m m w m m m m m m m m x m m
.
.....................................
I I I I I I I I I I I I
Age by Quartile
ANOVA P Value 0.22 0,09 0.007" 0.12 0.06
MPOD
First Quartile (45-49 years) 0.47 (SE + 0.033) 0.37 (SE + 0.025) 0.28 (SE + 0.021) 0.12 (SE + 0.013) 0.27 (SE + 0.019)
Second Quartile (50-55 years) 0.37 (SE + 0.039) 0.29 (SE + 0.029) 0.19 (SE + 0.024) 0.09  (SE + 0.015) 0.20 (SE + 0.022)
Third Quartile (56-61 years) 0.41 (SE + 0.035) 0.34 (SE + 0.026) 0.26 (S E '+ 0.021) 0.11 (SE + 0.014) 0.25 (SE + 0.020)
Fourth Quartile (62-73 years***) 0.43 (SE + 0.047) 0.37 (SE + 0.031) 0.30 (SE + 0.026) 0.14 (SE + 0.017) 0.26 (SE + 0.027)
Tukeys P Value
First Quartile : Second Quartile 0.08 0.02* 0.05*
First Quartile : Third Quartile 0.70 0.86 0.76
First Quartile : Fourth Quartile 1.00 0.96 0.99
Second Quartile : Third Quartile 0.51 0.11 0.33
Second Quartile : Fourth Quartile 0.19 0,01* 0.22
Third Quartile : Fourth Quartile 0.85 0.63 0.96
Eye Color
ANOVA P Value 0.27 0.13 0.01* 0.01* 0.03*
MPOD
Blue 0.43 (SE + 0.029) 0.36 (SE + 0.022) 0.30 (SE + 0.018) 0.15 (SE + 0.012) 0.28 (SE + 0,017)
Brown 0.44 (SE + 0.035) 0.38 (SE + 0.026) 0.28 (SE + 0.022) 0.10 (SE + 0.014) 0.26 (SE + 0.020)
Green 0.43 (SE + 0.068) 0.34 (SE + 0.045) 0.25 (SE + 0.038) 0.11 (SE + 0.024) 0.24 (SE + 0,039)
Hazel 0.36 (SE + 0.032) 0.30 (SE + 0.024) 0.21 (SE + 0.020) 0.09 (SE + 0.013) 0.21 (SE + 0,020)
Tukeys P Value
Blue: Brown 0.90 : 0.05* 0.84
Blue.Green 0.66 0.46 0.79
Blue:Hazel 0 .008" 0.01* 0.02*
Brown: Green 0.91 1.00 0.97
Brown:Hazel 0.09 0.97 0.18
Green:Hazel 0.79 0.95 0.84
BMI (Health Risk Cut-Off Value)
ANOVA P Value 0.33 0.06 0.02* 0.001* 0.02*
MPOD
<27.00 0.43 (SE + 0.028) 0.37 (SE + 0.020) 0.29 (SE + 0.017) 0.14 (SE + 0.011) 0.27 (SE + 0.016)
> 27.00 0.40 (SE + 0.031) 0.32 (SE + 0.022) 0.23 (SE + 0.018) 0.09 (SE + 0.012) 0.22 (S E +0.018)
BMI (NIH Categories)
ANOVA P Value 0.88 0.27 0.69 0.19 0.45
MPOD
18.25-24.99 0.42 (SE + 0.040) 0.37 (SE + 0.028) 0.28 (SE + 0.024) 0.13 (SE + 0.016) 0.26 (SE + 0.023)
25.00-29,99 0.43 (SE + 0.030) 0.35 (SE + 0.021) 0.26 (SE + 0.018) 0.12 (SE-+0.012) 0.26 (SE + 0.018)
>30100 0.40 (SE + 0.039) 0.31 (SE + 0.029) 0.25 (SE + 0.025) 0.09 (SE + 0.016) 0.23 (SE + 0.023)
* The arithmetic mean and standard error (SE) w ere calculated using SYSTAT.
Multifactor ANOVA was utilized tor initial test of significance; results < 0.10 were further a ssessed  with a  Tukeys multiple comparison 
test. Significance w as established at *p < 0.050 -0.011; **p < 0.010.
** Subsequent analysis of the variables presented were conducted using ANOVA (and Tukeys): age (quartiles), eye color, gender,
BMI status (either using < 27 />  27 cutoffs, or the NIH standards) and fruit and vegetable intake were the independent variables;
MPOD at each foveal site, or CMPV, was the dependent variable.
AAA Although the 4th quartile includes subjects aged 52-75, no subjects over the age ot 73 successfully completed the MP assessm ents.
BMI = body m ass index; NIH = National Institutes of Health; MPOD = macular pigment optical density; CMPV = composite macular pigment value
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Table 11. Individual Subject Data by Gender, Eye Color, Age, and
- -  i f f  N ■ ■ ■ ■ I ,  I I  Mi l . — I l l . —  M ' T  . . . . . . . . . .
Sub. # Gender Eye Color** Age 0.167° site*** 0.50u site 1.00“ site 2.00 site**** CMPV-
(n=89) (n=98) (n=98) (n=97) (n=88)
101 female hazel S3 0.38 0.36 0.16 0.20 0.234
102 male brown 58 0.58 0.50 0.35 0.12 0.341
103 male green 49 0.47 0.42 0.30 0,14 0.300
104 female hazel 71 0.43 0.35 0.24 0.09 0.238
105 female hazel 57 0.08 0.12 0.12 0.05 0.098
106 female hazel 63 0.21 0.16 0.15 0.06 0.135
107 male blue 64 0.61 0.38 0.34 0.17 0.328
108 female brown 57 0.50 0.45 0.40 0.12 0.344
109 male blue 57 0.40 0.34 0.29 0.09 0.256
110 male blue 68 0.32 0.27 0.21 0.05 0.189
111 male blue 55 0.33 0.27 0.19 0.00 0.169
112 female hazel 65 0.52 0.37 0.27 0.05 0.255
113 male brown 70 0.36 0.38 0.24 0.10 0.245
114 female blue 61 0.48 0.34 0.13 0.01 0.174
115 female hazel 56 0.49 0.36 0.41 0.16 0.340
116 female blue 63 0.61 0.35 0.43 0.16 0.354
117 female brown 52 0.15 0.07 0.04 -0.06 0.045
118 male brown 57 0.35 0.23 0.21 0.09 0.192
119 female green 47 0.58 0.46 0.29 0.11 0.305
120 female hazel 47 0.33 0.34 0.19 0.05 0.199
121 female blue 46 0.08 0.11 0.12 0.08 0.104
122 female blue 45 0.38 0.30 0.30 0.18 0,273
123 male blue 47 0.64 0.57 0.42 0.21 0.414
124 female green 52 0.16 0.27 0.24 0.10 0.202
125 female blue 57 0.21 0.20 0.19 0.10 0.168
*126 female blue 49
127 female blue 47 0.64 0.59 0.44 0.17 0.417
128 female blue 60 0.53 0.33 0.43 0.17 0.345
129 female blue 59 0.51 0.43 0.35 0.28 0.363
130 female brown 51 0.50 0.31 0.30 0.12 0.267
131 female brown 48 0.39 0.41 0.35 0.12 0.304
132 female brown 45 0.19 0.16 0.07 0.00 0.081
133 female hazel 48 0.30 0.36 0.14 0.10 0.194
134 male blue 48 0.45 0.44 0.36 0.24 0.352
*135 female brown 45
136 male brown 55 0.31 0.34 0.31 0.13 0.269
137 female blue 53 0.25 0.27 0.20 0.08 0.185
138 male hazel 65 0.51 0.39 0.32 0.12 0.299
139 female hazel 60 0.37 0.30 0.15 -0.03 0.163
140 female hazel 47 0.24 0.12 -0.01 -0.03 0.048
141 male blue 73 0.39 0.39 0.34 0.27 0.338
142 female brown 69 0.73 0.38 0.31
143 female hazel 50 0.14 0.21 0.16 0.06 0,141
144 female blue 57 0.50 0.37 0.14
145 female brown 53 0.56 0.64 0.46 0.17 0.427
*146 female hazel 63
147 female hazel 51 0.27 0.37 0.17 0.02 0.183
*148 male hazel 71
*148 male hazel 71
*149 female green 58
*150 male hazel 75
*151 female gray 68
152 female blue 53 0.65 0.41 0.36 0.18 0.349
153 female brown 49 0.59 0.52 0.34 0.12 0.344
154 female hazel 50 0.26 0.17 0.10 0.07 0.119
Mean MPOD
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Table 11. (Coninued)
S u b .# Gender Eye Color** Age 0.167° site*** 0.50° site 1.00° site 2.006 site**** CMPV-
(n=89) (n=98) (n=98) (n=97) (n=88)
155 female blue 57 0.21 0.29 0.26 0.21 0.248
156 female green 46 0.38 0.39 0.15
157 female green 47 0.66 0.45 0.24 0.14 0.296
158 female hazel 49 0.14 0.14 0.23 0.15 0.183
159 female blue 62 0.35 0.27 0.30 0.22 0.277
160 female brown 50 0.42 0.29 0.16 0.10 0.195
161 male blue 59 0.22 0.16 0.06
*162 female blue 67
163 female brown 54 0.62 0.48 0.33 0.06 0.318
164 male blue 72 0.46 0.35 0.12
165 female blue 68 0.57 0.52 0.56 0.24 0.463
166 female brown 47 0.54 0.51 0.37 0.09 0.340
167 female brown 48 0.66 0.53 0.41 0.23 0.413
168 male brown 49 0.38 0.27 0.23 0.07 0.211
169 female blue 59 0.61 0.45 0.36 0.14 0.341
170 male brown 61 0.51 0.36 0.31 0.09 0.279
171 female brown 62 0.65 0.72 0.55 0.26 0.517
172 male blue 67 0.51 0.40 0.32 0.15 0.310
173 female hazel 46 0.60 0.50 0.37 0.09 0.342
174 female brown 54 0.37 0.25 0.18 0.05 0.178
175 male hazel 47 0.32 0.20 0.26 0.07 0.199
176 male blue 63 0.39 0.42 0.21
177 female blue 59 0.54 0.55 0.55 0.35 0.493
178 male blue 45 0.68 0.54 0.40 0.08 0.370
179 female hazel 48 0.67 0.49 0.28 0.13 0.323
*180 male brown 51
181 female brown 61 0.44 0.27 0.14 -0.07 0.158
182 male hazel 50 0.62 0.40 0.26 0.14 0.290
183 female green 71 0.35 0.31 0.18
184 male hazel 48 0.58 0.36 0.41 0.19 0.354
185 female blue 45 0.70 0.54 0.51 0.31 0.477
186 female hazel 67 0.52 0.42 0.26
187 female hazel 45 0.37 0.26 0.20 0.16 0.218
188 male blue 60 0.64 0.47 0.29 0.07 0.303
189 male brown 61 0.21 0.13 0.10 -0.01 0.090
190 female blue 61 0.53 0.43 0.29 0.18 0.314
191 female hazel 63 0.36 0.35 0.27 0.18 0.272
*192 male blue 69
193 male blue 55 0.34 0.25 0.15 0.12 0.180
194 male blue' 63 0.37 0.30 0.22 0.08 0.213
195 male blue 54 0.55 0.36 0.32 0.18 0.314
196 male hazel 61 0.65 0.43 0.25 0.08 0.280
197 female blue 49 0.38 0.45 0.40 0.17 0.345
198 male brown 56 0.43 0.31 0.37 0.09 0.285
199 female green 47 0.64 0.42 0.29 0.09 0.296
200 male hazel 57 0.35 0.40 0.10
201 male blue 53 0.28 0.22 0.18
202 female green 57 0.29 0.31 0.23 0.16 0.235
203 male hazel 58 0.17 0.18 0.19 0.06 0.147
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Table 11. (Coninued)
Sub. # Gender Eye Color** Age 0 .1 6 / site*** O.SO6 site 1.006 site 2.00° site**** CMPV-
(n=89) (n=98) (n=98) (n=97) (n=88)
204 male brown 55 0.42 0.28 0.17 0.06 0.187
205 male hazel 61 0.36 0.34 0.30 0.21 0.289
206 male blue 53 0.28 0.31 0.18 0.08 0.188
207 female brown 46 0.59 0.39 0.30 0.08 0.286
208 male blue 52 0.23 0.16 0.11 0.08 0.122
* Ten subjects' data were excluded from analysis for one or more of the following reason: 
difficulty in providing consistent foveal or parafoveal values (5), 
refusal to do the task (1), failure to pass vision screening tests (4).
** Eye color data is presented for all subjects; comparisons of MP and eye color were 
based on those subjects for whom MP values were accepted for analysis.
*** Nine subjects were unable to see  or successfully complete the 0.167 site.
**** One subject was unable to complete the 2.00 degree site due to time constraints.
CMPV = composite macular pigment value was based on the 88 subjects with acceptable data 
for all four foveal sites.
MPOD = macular pigment optical density
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Tabte 12. Frequency of MPOD Results by Participants at Four Foveal S ites
Absorbance Units
Below 0* Oto. 09 .10 to 19 .20 to .29 .30 to .39 .40 to .49 .50 to .59 .60 to .69 .70-.79 Total
Retinal Site
0.167 degrees 0 2 6 11 23 10 19 17 1 89
0.50 degrees 0 1 10 19 32 20 13 1 2 98
1.00 degrees 1 2 23 26 29 13 4 0 0 98
2.00 degrees 5 35 41 13 3 0 0 0 0 97
* The one negative value at the 1.00 degree site and the five negative values at the 2.00 degree site were adjusted to 0.00 for 
subsequent statistical analysis since pigment was non-detectable (but mathematically negative) at these sites.
MPOD = macular pigment optical density
to
Table 13. Mean MPOD Measurements by Gender and Age Quartiles
Foveal Site 0.167° 0.50° 1.00° 2.00° CMPV
Female Results (SE + ) by Age Quartile
First Quartile (45-49 years) 0.46 (SE + 0.042) 0.37 (SE + 0.034) 0.28 (SE + 0.028) 0.12 (SE + 0.017) 0.27 (SE± 0.025)
Second Quartile (50-55 years) 0.34 (SE + 0.053) 0.28 (SE + 0.042) 0.21 (SE + 0.035) 0.09 (SE + 0.021) 0.21 (SE + 0.032)
Third Quartile (56-61 years) 0.40 (SE ±  0.052) 0.34 (SE + 0.042) 0.26 (SE + 0.035) 0.11 (SE + 0.021) 0.24 (SE + 0.031)
Fourth Quartile (62-73 yearsA) 0.47 (SE + 0.070) 0.39 (SE + 0.050) 0.33 (SE + 0.042) 0.16 (SE + 0.025) 0.30 (SE + 0.042)
Male Results (SE + ) by Age Quartile
First Quartile (45-49 years) 0.48 (SE + 0.056) 0.39 (SE + 0.039) 0.33 (SE + 0.029) 0.13 (SE + 0.024) 0.30 (SE + 0.026)
Second Quartile (50-55 years) 0.39 (SE + 0.069) 0.28 (SE + 0.046) 0.19 (SE + 0.034) 0.10 (SE + 0.029) 0.20 (SE + 0.032)
Third Quartile (56-61 years) 0.45 (SE + 0.062) 0.35 (SE + 0.042) 0.26 (SE ±  0.031) 0.11 (SE + 0.027) 0.27 (SE + 0.030)
Fourth Quartile (62-73 yearsA) 0.41 (SE + 0.073) 0.35 (SE + 0.049) 0.28 (SE + 0.036) 0.14 (SE + 0.031) 0.25 (SE + 0.034)
Statistical analysis: ANOVA
Independent variables: age(quartiles), BMI (< 27 or > 27), eye color, fruit and vegetable group by female or male subjects 
Dependent variable: MPOD at each foveal site or CMPV by female or male subjects
A Although subjects were recruited through age 75, only those through age 73 had data that were included in the results. 
MPOD = macular pigment optical density 
CMPV = composite macular pigment value
Table 14. Frequency of MPOD Responses by Participant Eye Color at Four Foveal Sites
Eye Color Absorbance Units
Below 0* | 0.00-.09 0.10-0.19 0.20-0.29| 0.30-0.39 0.40-0.49 | 0.50-0.59 | 0.60-0.69 0.70-0,79 Total
Site: 0.167 Degrees retinal eccentricity
Blue 0 1 0 5 8 3 7 8 1 33
Brown 0 0 2 1 6 4 8 3 0 24
Green 0 1 0 1 0 1 1 2 0 6
Hazel 0 1 3 4 9 2 3 4 0 26
89
Site: 0.50 Degrees retinal eccentricity
Blue 0 0 2 9 11 9 7 0 0 38
Brown 0 1 2 6 6 3 4 1 2 25
Green 0 0 0 1 3 4 0 0 0 8
Hazel 0 0 6 3 12 4 2 0 0 27
98
Site: 1.00 Degrees retinal eccentricity
Blue 0 0 8 8 12 7 3 0 0 38
Brown 0 2 5 3 11 3 1 0 0 25
Green 0 0 0 5 3 0 0 0 0 8
Hazel 1 0 11 9 3 3 0 0 0 27
98
Site: 2.00 Degrees retinal eccentricity
Blue 0 12 16 8 2 0 0 0 0 38
Brown 3 10 9 2 1 0 0 0 0 25
Green 0 1 7 0 0 0 0 0 0 8
Hazel 2 12 9 3 0 0 0 0 0 26
97
* The one negative value at the 1.00 degree site and the five negative values at the 2.00 site were adjusted to 0.00 for 
subsequent statistical analysis since pigment was "non-detectable" (but mathematically negative) at these sites. 
MPOD = macualr pigment optical density
Table 15. Fruit and Vegetable Consumption and Mean MPOD at Four Foveal Sites
Foveal Site 0.167° 0.50° 1.00° 2.00° CMPV
ANOVA P Value* 0.14 0.03* 0.10 0.02* 0.04*
Fruit and Vegetable Consumption
MPOD
First Quartile (7-11) 0.32 (S E +0.053) 0.27 (S E +0.040) 0.20 (SE + 0.033) 0.09 (SE + 0.024) 0.19 (SE +0.031)
Second Quartile (12-15) 0.44 (SE + 0.035) 0.34 (SE± 0.025) 0.26 (SE + 0.020) 0.09 (SE + 0.014) 0.25 (SE+ 0.020)
Third Quartile (16-19) 0.43 (S E + 0.033) 0.35 (SE + 0.024) 0.27 (SE+0.020) 0.12 (SE+0.013) 0.26 (SE +0.019)
Fourth Quartile (20-24) 0.47 (SE+0.038) 0.41 (SE± 0.028) 0.30 (SE + 0.023) 0.15 (SE +0.016) 0,29 (S E +0.022)
Tukeys P Value
First to Second 0.38 0.38 1.00 0.32
First to Third 0.21 0.25 0.59 0.14
First to Fourth 0.02* 0.06 0.10 0.03*
Second to Third 0.95 0.98 0.40 0.90
Second to Fourth 0.17 0.48 0.02* 0.32
Third to Fourth 0.35 0.66 0.31 0.64
* Multifactor ANOVA was utilized for the initial test of significance; results <0.10 were further assessed with a 
Tukeys multiple comparison test.
Significance was established at *p < 0.050 -0.011; **p < 0.010.
Independent variables: age (quartiles), BMI (< 27 or > 27), eye color, gender, and fruit and vegetable group 
Dependent variable: MPOD at each foveal site or CMPV 
MPOD = macular pigment optical density 
CMPV = composite macular pigment value
Table 16. Average Carotenoid Intake Based on the 24 Hour Recall and Food Frequency Questionnaires
Dietary Assessment Tool 24hr-CGFR B-FFQ FH-FFQ T-FFQ
Group Results ug/day (SE +) ug/day (SE +) ug/day (SE +) ug/day (SE +)
Alpha-carotene 1211 (154) 1123(102) 1136 (82) 674(50)
Beta-carotene 4233 (374) 4680(306) 4010 (244) 4119(231)
Beta-cryptoxanthin 266 (36) 176(14) 128(8) 73(6)
Lycopene 8122 (1059) 7032 (718) 8423 (424) 3398 (208)
Lutein/Zeaxanthin 2647(195) 2199(153) 1785(103) 2254 (159)
Total Carotenoids* 16479 15210 15482 10518
Dietary Assessment Tool 24hr-CGFR B-FFQ FH-FFQ T-FFQ
Female Results ug/day (SE +) ug/day (SE +) ug/day (SE +) ug/day (SE +)
Alpha-carotene 1528 (212) 1250 (135) 1318 (114) 764 (69)
Beta-carotene 4907 (501) 5142 (415) 4550 (329) 4606 (304)
Beta-cryptoxanthin 258 (49) 176 (18) 131 (11) 79 (9)
Lycopene 6221 (1024) 5760 (640) 8124 (514) 3613 (276)
Lutein/Zeaxanthin 2758 (245) 2465 (194) 1915 (144) 2522 (210)
Total Carotenoids* 15672 14793 16038 11584
Dietary Assessment Tool 24hr-CGFR B-FFQ FH-FFQ T-FFQ
Male Results ug/day (SE +) ug/day (SE +) ug/day (SE +) ug/day (SE +)
Alpha-carotene 690 (184) 908 (144) 825 (87) 532 (63)
Beta-carotene 3122 (505) 3902 (410) 3082 (297) 3339 (318)
Beta-cryptoxanthin 280 (52) 175 (22) 121 (11) 62 (9)
Lycopene 11474 (2225) 9174 (1554) 8938 (738) 3055 (309)
Lutein/Zeaxanthin 2469 (321) 1750 (236) 1561 (129) 1825 (227)
Total Carotenoids* 18035 15909 14527 8813
* Calculated from five preceding carotenoids 
Calculations based on SYSTAT module for arithmetic mean calculations.
B-FFQ = Block food frequency questionnaire
FH-FFQ = Fred Hutchinson Cancer Research Center food frequency questionnaire 
T-FFQ = Tufts food frequency questionnaire
Table 17. 24hr-Carotenoid Guided Food Recall Intake and MPOD Results:
Regression Analysis P Values
Group Results
Foveal S ite 0.167° 0.50° 1.00° 2.00° CMPV
Alpha-carotene 0.75 0.56 0.48 0.33 0.51
Beta-carotene 0.48 0.61 0.32 0.28 0.48
Beta-cryptoxanthin 0.64 0.61 0.97 0.10 0.91
Lycopene 0.49 0.29 0.18 0.15 0.10
Lutein/Zeaxanthin 0.87 0.95 0.53 0.48 0.76
Female Results
Foveal Site 0.167° 0.50°
O©
2.00° CMPV
Alpha-carotene 0.97 0.95 0.88 0.48 0.80
Beta-carotene 0.88 0.94 0.67 0.28 0.74
Beta-cryptoxanthin 0.20 0.33 0.81 0.10 0.83
Lycopene 0.24 0.04* 0.08 0.41 0.06
LuteirVZeaxanthin 0.77 0.95 0.41 0.35 0.74
Male Results
Foveal Site 0.167° 0.50° 1.00° 2.00° CMPV
Alpha-carotene 0.36 0.30 0.29 0.91 0.43
Beta-carotene 0.21 0.39 0.28 0.73 0.46
Beta-cryptoxanthin 0.12 0.33 0.62 0.73 0.41
Lycopene 0.77 0.83 0.67 0.08 0.59
Lutein/Zeaxanthin 0.42 0.92 0.80 0.80 1.00
Statistical analysis: Simple linear regression
* Significance was established at *p < 0.050 -0.011; **p < 0.010.
Independent variable: Carotenoid intake
Dependent variable: MPOD at each foveal site or CMPV
MPOD = macular pigment optical density
CMPV = composite macular pigment value
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Table 18. FFQ Estimated Nutrient Intake and MPOD Results: Regression Analysis P Values
Foveal Site 0.167° 0.50° 1.00” 2.00“ CMPV
Calories B-FFQ 0.83 .0.63 0.37 0.90 0.93
FH-FFQ 0.37 0.77 0.96 0.97 0.42
T-FFQ 0.17 0.17 0.35 0.14 0.11
Protein B-FFQ 0.89 0.40 0.51 0.70 0.75
FH-FFQ 0.62 0.89 0.81 0.80 0.63
T-FFQ 0.53 0.42 0.43 0.06 0.25
Fat B-FFQ 0.69 0.44 0.40 0.37 0.91
FH-FFQ 0.63 0.62 0.44 0.20 0.97
T-FFQ 0.38 0.89 0.88 0.62 0.43
Carbohydrate B-FFQ 0.75 0.89 0.54 0.28 0.84
FH-FFQ 0.50 0.28 0.49 0.16 0.22
T-FFQ 0.30 0.02* 0.11 0.03* 0.07
Zinc B-FFQ 0.66 0.99 0.81 0.84 0.74
FH-FFQ 0.17 0.49 0.69 0.30 0.23
T-FFQ 0.06 0.10 0.14 0.006** 0.02*
Iron B-FFQ 0.72 0.95 0.74 0.73 0.96
FH-FFQ 0.10 0.10 0.18 0.06 0.07
T-FFQ 0.03* 0.01* 0.04* 0.006** 0.008*
Selenium B-FFQ
FH-FFQ 0.69 0.86 0.97 0.89 0.68
T-FFQ 0.87 0.54 0.54 0.11 0.48
Pro-vitamin A B-FFQ 0.84 0.91 0.66 0.46 0.76
FH-FFQ 0.12 0.04* 0.07 0.03 0.07
T-FFQ 0.14 0.06 0.12 .01* 0.08
Retinol B-FFQ 0.92 0.95 0.68 0.51 0.78
FH-FFQ 0.52 0.64 0.51 0.24 0.37
T-FFQ 0.20 0.18 0.09 .008" 0.06
Vitamin C B-FFQ 0.55 0.19 0.16 0.007“ 0.20
FH-FFQ 0.11 0.02* 0.01* <0.001** 0.008**
T-FFQ 0.05* 0.001" 0.003** <0.001** 0.001"
Vitamin E (a-tocopherol) B-FFQ , 0.61 0.84 0,96 0.28 0.36
FH-FFQ 0.15 0.40 0.25 0.12 0.06
T-FFQ 0.08 0.17 0.12 0.005" 0.01*
Alpha-Carotene B-FFQ 0.91 0.66 0.76 0.69 0.87
FH-FFQ 0.32 0.09 0.23 0.12 0.23
T-FFQ 0.69 0.50 0.97 0.47 0.77
Beta-Carotene B-FFQ 0.74 0.95 0.65 0.45 0.71
FH-FFQ 0.13 0.04* 0.07 0.07 0.08
T-FFQ 0.41 0.14 0.47 0.09 0.38
Beta-Cryptoxanthin B-FFQ 0.33 0.08 0.08 0.02* 0.11
FH-FFQ 0.27 0.10 0.09 0.03* 0.08
T-FFQ 0.24 0.008" 0.008" 0.<001** 0.01*
Lycopene B-FFQ 0.82 0.25 0.44 0.89 0.54
FH-FFQ 0.97 0.28 0.52 0.54 0.75
T-FFQ 0.16 0.35 0.53 0.27 0.35
Lutein/Zeaxanthin B-FFQ 0.50 0.79 0.43 0.14 0.33
FH-FFQ 0.02* 0.02* 0.009” 0.02* 0.006**
T-FFQ 0.25 0.35 0.33 0.11 0.19
Statistical analysis: Simple linear regression
* Significance was established at *p < 0.050 -0.011; **p < 0.010
Independent variable: Individual estimated nutrient intake from each FFQ
Dependent variable: MPOD at each foveal site or CMPV
MPOD = macular pigment optical density
CMPV = composite macular pigment value
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Table 19. Mean Serum Carotenoids, UNH Study (umol/L and ug/dL) and National Data (umol/L)
Carotenoid ug/dl. B-Catotene Lycopene Lutein Zeaxanthin m
UNH Study Data
Group 33.313 (SE+ 2.235) 23.173 (SE + 0.993) 20.371 (SE + 0.745) 3.909 (SE + 0.152) 24.262 (SE + 0.870)
Females 38.040 (SE + 3.060) 23.030 (SE + 1.222) 21.058 (S E +1.030) 3,855 (SE + 0.200) 24.946 (SE+ 1.206)
Males 25.818 (SE + 2.800) 23.399 (SE+ 1.703) 19.237 (SE + 0.996) 3.993 (SE + 0.234) 23.132 (SE + 1.161)
Carotenoid umoi/L' B-Carotene Lycopene Lutein Zeaxantnia L/Z
UNH Study Data
Group 0.621 (SE + 0.042) 0.432 (SE + 0.018) 0.358 (SE + 0.013) 0.069 (SE + 0.003) 0.427 (SE + 0.015)
Females 0.709 (SE + 0.057) 0.429 (SE + 0.023) 0.370 (SE + 0.018) 0.068 (SE + 0.004) 0.439 (SE + 0.021)
Males 0.481 (SE + 0.052) 0.436 (SE + 0.032) 0.338 (SE + 0.018) 0.070 (SE + 0.004) 0.407 (SE + 0.020)
National Data (European Americans)**
Group 0.27 0.41 0.32
Females 0.32 0.39 0.32
Males 0.23 0.44 0.32
* SI conversion factor used for BC and LY was 0.018663 x ug/dL = umol/L.
SI conversion factor used for L, Z, and L/Z was 0.01758 x ug/dL = umol/L. 
** Mean data from Ford, E.S. (# 221)
Table 20. ndividual Subject Data by Gender and Ag e for Serum Carotenoids










101 female 53 0.224 0.178 0.177 0.039 0.215
102 male 58 0.281 0.241 0.459 0.079 0.538
103 male 49 0.903 0.646 0.379 0.078 0.456
104 female 71 0.864 0.131 0.246 0.038 0.284
105 female 57 0.413 0.288 0.157 0.038 0.195
106 female 63 0.925 0.128 0.224 0.067 0.292
107 male 64 0.219 0.208 0.203 0.054 0.257
108 female 57 0.406 0.532 0.110 0.642
109 male 57 1.771 0.120 0.486 0.116 0.602
110 male 68 0.579 0.353 0.393 0.068 0.461
111 male 55 0.235 0.256 0.461 0.105 0.566
112 female 65 1.116 0.415 0.730 0.154 0.884
113 male 70 0.420 0.276 0.309 0.078 0.388
114 female 61 0.916 0.209 0.305 0.078 0.384
115 female 56 0.457 0.496 0.473 0.133 0.605
116 female 63
117 female 52 0.536 0.396 0.193 0.042 0.235
118 male 57 0.352 0.434 0.421 0.115 0.536
119 female 47 0.654 0.324 0.387 0.076 0.462
120 female 47 0.971 0.825 0.545 0.104 0.648
121 female 46 0.729 0.350 0.438 0.146 0.584
122 female 45 0.651 0.433 0.508 0.058 0.565
123 male 47 0.304 0.302 0.291 0.057 0.348
124 female 52 0.480 0.521 0.302 0.059 0.360
125 female 57 0.517 0.424 0.368 0.055 0.423
126 female 49 0.381 0.424 0.175 0.030 0.204
127 female 47 0.540 0.425 0.533 0.077 0.610
128 female 60 0.340 0.466 0.183 0.031 0.213
129 female 59 0.573 0.613 0.321 0.064 0.385
130 female 51 1.275 0.423 0.400 0.175 0.575
131 female 48 0.398 0.665 0.275 0.066 0.342
132 female 45 0.339 0.744 0.150 0.028 0.178
133 female 48 0.553 0.764 0.272 0.056 0.329
134 male 48 0.596 1.012 0.840 0.139 0.979
135 female 45 1.010 0.648 0.367 0.068 0.435
136 male 66 0.198 0.273 0.255 0.067 0.322
137 female 53 1.700 0.236 0.484 0.079 0.563
138 male 65 0.271 0.362 0.509 0.115 0.624
139 female 60 0.255 0.388 0.416 0.066 0.482
140 female 47 0.390 0.274 0.164 0.051 0.215
141 male 73 0.680 0.376 0.269 0.043 0.312
142 female 69 0.884 0.715 0.512 0.093 0.605
143 female 50 0.822 0.562 0.311 0.068 0.379
144 female 57 3.656 0.636 0.467 0.056 0.523
145 female 53 1.180 0.714 0.511 0.092 0.602
146 female 63 0.054 0.079 0.065 0.065
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 20. Continued )










147 female 51 0.173 0.433 0.348 0.070 0.418
148 male 70 1.028 0.361 0.416 0.061 0.478
149 female 58 0.387 0.209 0.170 0.032 0.202
150 male 75 1.063 0.473 0.318 0.048 0.366
151 female 68 1.256 0.384 0.392 0.059 0.451
152 female 53 0.276 0.426 0.164 0.033 0.197
153 female 49 0.399 0.568 0.435 0.064 0.499
154 female 50 1.398 0.403 0.438 0.070 0.508
155 female 57 0.280 0.307 0.303 0.053 0.356
156 female 46 0.911 0.926 0.548 0.080 0.627
157 female 47 0.155 0.460 0.226 0.031 0.256
158 female 49 0.850 0.602 0.185 0.032 0.216
159 female 62 1.100 0.520 0.506 0.075 0.581
160 female 50 0.632 0.408 0.345 0.043 0.388
161 male 59 0.343 0.465 0.190 0.040 0.230
162 female 67 0.092 0.124 0.169 0.034 0.204
163 female 54 2.080 0.267 0.440 0.089 0.529
164 male 72 0.333 0.325 0.256 0.048 0.304
165 female 68 0.654 0.448 0.654 0.132 0.785
166 female 47 0.639 0.385 0.493 0.065 0.558
167 female 48 0.583 0.364 0.450 0.053 0.503
168 male 49 0.436 0.502 0.435 0.090 0.525
169 female 59 1.033 0.440 0.604 0.082 0.685
170 • male 61 0.423 0.661 0.364 0.062 0.426
171 female 62 0.640 0.667 0.457 0.066 0.522
172 male 67 0.652 0.458 0.233 0.052 0.285
173 female 46 0.418 0.644 0.197 0.042 0.239
174 female 54 0.333 0.532 0.509 0.095 0.604
175 male 47 0.402 0.506 0.295 0.090 0.385
176 male 63 0.149 0.222 0.198 0.055 0.253
177 female 59 0.439 0.538 0.470 0.102 0.572
178 male 45 0-194 0.398 0.352 0.077 0.430
179 female 48 0.248 0.381 0.520 0.079 0.598
180 male 51 0.082 0.225 0.643 0.060 0.703
181 female 61 0.540 0.294 0.292 0.058 0.349
182 male 50 0.141 0.322 0.338 0.065 0.403
183 female 71 0.999 0.168 0.458 0.083 0.541
184 male 48 0.289 0.496 0.625 0.137 0.762
185 female 45 1.952 0.201 0.274 0.049 0.323
186 female 67 1.295 0.433 0.565 0.078 0.643
187 female 45 2.163 0.141 0.466 0.087 0.553
188 male 60 0.273 0.213 0.309 0.068 0.377
189 male 61 0.401 0.466 0.246 0.044 0.290
190 female 61 0.620 0.469 0.236 0.041 0.277
191 female 63 1.091 0.272 0.250 0.068 0.318
192 male 69 0.295 0.147 0.225 0.044 0.269
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Table 20. Continued )












193 male 55 0.209 0.269 0.240 0.051 0.291
194 male 63 0.382 0.683 0.287 0.061 0.348
195 male 54 0.419 0.713 0.280 0.059 0.340
196 male 61 0.697 0.735 0.491 0.092 0.583
197 female 49 0.371 0.504 0.441 0.069 0.510
198 male 56 0.591 0.551 0.365 0.069 0.435
199 female 47 0.504 0.314 0.558 0.095 0.652
200 male 57 0.130 0.220 0.211 0.037 0.247
201 male 53 1.156 0.860 0.333 0.027 0.359
202 female 57 0.655 0.384 0.426 0.076 0.503
203 male 58 0.414 0.645 0.268 0.054 0.322
204 male 52 0.665 0.376 0.325 0.087 0.412
205 male 61 0.853 0.512 0.303 0.051 0.354
206 male 53 0.453 0:746 0.335 0.070 0.405
207 female 46 0.346 0.378 0.255 0.035 0.290
208 male 52 0.438 0.463 0.213 0.065 0.277
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Table 21. Serum Carotenoids and MPOD: Linear Regression Significance Values
Foveal Site
Group Results 0.167° 0.50° o o o 2.00° CMPV
Serum Carotenoidsfumol/L)
Beta-carotene 0.94 0.82 0.45 0.16 0.72
Lycopene 0.85 0.26 0.15 0.22 0.30
Lutein 0.003** <0.001** <0.001** 0.12 0.001**
Zeaxanthin 0.30 0.17 0.02* 0.77 0.15
Lutein/Zeaxanthin 0.007** 0.001** <0.001** 0.19 0.003**
Total Carotenoids 0.53 0.14 0.04* 0.04* 0.12
Foveal Site
Females 0.167° 0.50° 1.00° 2.00° CMPV
Serum Carotenoids(umol/L)
Beta-carotene 0.78 0.85 0.49 0.32 0.75
Lycopene 0.94 0.04* 0.05* 0.32 0.18
Lutein 0.02* 0.001** 0.001** 0.08 0.004**
Zeaxanthin 0.54 0.19 0.07 0.54 0.21
Lutein/Zeaxanthin 0.03* 0.002** 0.001** 0.11 0.008**
Total Carotenoids 0.37 0.10 0.04* 0.09 0.15
Males 0.167° 0.50° 1.00° 2.00° CMPV
Serum Carotenoids(umol/L)
Beta-carotene 0.51 0.58 0.96 0.57 0.96
Lycopene 0.65 0.32 0.77 0.42 0.17
Lutein 0.09 0.35 0.16 0.46 0.27
Zeaxanthin 0.36 0.63 0.17 0.70 0.47
Lutein/Zeaxanthin 0.11 0.43 0.17 0.37 0.34
Total Carotenoids 0.85 0.69 0.71 0.37 0.66
Statistical analysis: Simple linear regression.
* Significance was established at *p < 0.050- 0.011; **p < 0.010 
Independent variable: serum carotenoid level 
Dependent variable: MPOD value at each foveal site or CMPV 
MPOD = macular pigment optical density 
CMPV = composite macular pigment value
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Table 22. Mean Plasma Lipid Results in mmol/L and mg/dL Units
Lipid
Total Cholesterol 









Group 4.82 (SE + 0.083) 1.59 (SE + 0.070) 0.73 (SE + 0.032) 2.53 (SE ±  0.075) 1.54 (S E ±  0.046)
Females 4.92 (SE + 0.113) 1.46 (SE + 0.089) 0.67 (SE ±0.041) 2.52 (SE + 0.100) 1.71 (SE + 0.059)










HD1 -C mg/d! 
(SE)
Group 186 (SE + 3.218) 142 (S E ±  6.145) 28 (SE + 1.231) 98 (SE + 2.892) 66 (SE + 2.288)
Female 190 (SE + 4.373) 132 (SE ±7.773) 26 (SE + 1.558) 97 (SE + 3.861) 70 (SE + 2.288)
Males 180 (SE + 4.451) 160 (SE + 9.516) 32 (SE + 1.908) 99 (SE + 4.325) 49 (SE + 1.919)
* To convert cholesterol, VLDL-C, LDL-C, and HDL-C from mg/dL to mmol/L, the mg/dL values were multiplied by 0.02586
* * To convert triglycerides from mg/dL to mmol/L, the mg/dL values were multiplied by 0.01129 
mmol/L = millimoles per liter 
mg/dL = milligrams per deciliter
Table 23. Individual Subject Data Results from Lipid Analysis
Sub # Gender Age CHOL mg/dL* TRIG mg/dL** VLDL mg/dL LDLmg/dL HDL mg/dL TOTC/HDL
101 female 53 144 119 24 58 62 2.32
102 male 58 130 81 16 69 45 2.89
103 male 49 211 261 52 121 38 5.55
104 female 71 188 70 14 46 128 1.47
105 female 57 171 91 18 96 57 3.00
106 female 63 179 90 18 89 72 2.49
107 male 64 152 147 29 89 34 4,47
108 female 57 191 122 24 65 102 1.87
109 male 57 204 202 40 131 33 6.18
110 male 68 185 230 46 9.8 41 4.51
111 male 55 174 238 48 79 47 3.70
11 2 female 65 205 154 31 84 90 2.28
113 male 70 201 159 32 102 67 3.00
114 female 61 181 300 60 71 50 3.62
115 female 56 239 155 31 119 89 2.69
116 female 63 222 163 31 7.16
117 female 52 204 268 54 99 51 4.00
118 male 57 173 159 32 97 44 3.93
119 female 47 153 88 18 66 69 2.22
120 female 47 173 78 16 49 108 1.60
121 female 46 221 344 69 116 36 6.14
122 female 45 177 61 12 92 73 2.42
123 male 47 171 125 25 102 44 3.89
124 female 52 191 60 12 96 83 2.30
125 female 57 223 135 27 123 73 . 3.05
126 female 49 260 130 26 164 70 3.71
127 female 47 179 119 24 84 71 2.52
128 female 60 179 146 29 101 49 3.65
129 female 59 167 122 24 91 52 3.21
130 female 51 181 106 21 95 65 2.78
131 female 48 141 159 32 65 44 3.20
132 female 45 184 107 21 121 42 4.38
133 female 48 163 159 32 75 56 2.91
134 male 48 200 296 59 110 31 6.45
135 female 45 144 73 15 77 52 2.77
136 male 66 140 109 22 68 50 2.80
137 female 53 211 82 16 133 62 3.40
138 male 65 168 112 22 88 58 2.90
139 female 60 169 154 31 79 59 2.86
140 female 47 153 63 13 70 70 2.19
141 male 73 170 204 41 94 35 4.86
142 female 69 313 256 51 195 67 4.67
143 female 50 187 138 28 109 50 3.74
144 female 57 185 107 21 117 47 3.94
145 female 53 202 100 20 104 78 2.59
146 female 63 147 97 19 58 70 2.10
147 female 51 176 310 62 72 42 4.19
148 male 70 174 166 33 93 48 3.63
137
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Table 23. (Continued)
Sub # Gender Age CHOL mg/dL* TRIG mg/dL** VLDL mg/dL LDLmg/dL HDL mg/dL TOTC/HDL
149 female 58 188 103 21 92 75 2.51
150 male 75 147 156 31 68 48 3.06
151 female 68 144 152 30 61 53 2.72
152 female 53 194 163 33 114 47 4.13
153 female 49 199 107 21 100 78 2.55
154 female 50 176 80 16 80 80 2.20
155 female 57 182 122 24 109 49 3.71
156 female 46 204 141 28 106 70 2.91
157 female 47 183 126 25 94 64 2.86
158 female 49 190 127 25 102 63 3.02
159 female 62 218 95 19 114 85 2.56
160 female 50 154 225 45 58 51 3.02
161 male 59 237 157 31 165 41 5.78
162 female 67 127 117 23 78 26 4.88
163 female 54 149 98 20 58 71 2.10
164 male 72 149 122 24 60 65 2.29
165 female 68 227 123 25 119 83 2.73
166 female 47 178 181 36 92 50 3.56
167 female 48 147 61 12 74 61 2.41
168 male 49 206 268 54 100 52 3.96
169 female 59 186 88 18 95 73 2.55
170 male 61 215 174 35 139 41 5.24
171 female 62 195 141 28 96 71 2.75
172 male 67 180 151 30 105 45 4.00
173 female 46 197 114 23 117 57 3.46
174 female 54 250 99 20 163 67 3.73
175 male 47 165 62 12 71 82 2.01
176 male 63 164 79 16 107 41 4.00
177 female 59 199 108 22 128 49 4.06
178 male 45 238 163 33 159 46 5.17
179 female 48 270 158 32 191 47 5.74
180 male 51 174 228 46 83 45 3.87
181 female 61 193 84 17 109 67 2.88
182 male 50 209 110 22 111 76 2.75
183 female 71 225 139 28 129 68 3.31
184 male 48 164 122 24 82 58 2.83
185 female 45 158 70 14 76 68 2.32
186 female 67 216 185 37 98 81 2.67
187 female 45 136 51 10 76 50 2.72
188 male 60 203 210 42 115 46 4.41
189 male 61 164 124 25 72 67 2.45
190 female 61 224 119 24 109 91 2.46
191 female 63 202 79 16 82 104 1.94
192 male 69 141 187 37 63 41 3.44
193 male 55 125 151 30 55 40 3.13
194 male 63 242 166 33 149 60 4.03
195 male 54 167 111 22 87 58 2.88
196 male 61 207 82 16 149 42 4.93
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Table 23. (Continued)
Sub# Gender Age CHOL mg/dL* TRIG mg/dL** VLDL mg/dL LDLmg/dL HDL mg/dL TOTC/HDL
197 female 49 186 88 18 75 93 2.00
198 male 56 197 110 22 130 45 4.38
199 female 47 264 273 55 122 87 3.03
200 male 57 148 102 20 77 51 2.90
201 male 53 186 85 17 92 77 2.42
202 female 57 243 218 44 142 57 4.26
203 male 58 171 306 61 70 40 4.28
204 male 52 202 89 18 121 63 3.21
205 male 61 156 159 32 76 48 3.25
206 male 53 182 195 39 101 42 4.33
207 female 46 126 84 17 38 71 1.77
208 male 52 184 207 41 105 38 4.84
* To convert cholesterol, VLDL-C, LDL-C, and HDL-C from mg/dL to mmol/L, 
multiply the mg/dL unit by 0.02586
* * To convert triglycerides from mg/dL to mmol/L, multiply the mg/dL unit by 0.01129
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Table 24. Interquartile Lipid Ranges for Statistical Analysis
Cholesterol Group
Quartile Range in mg/dL # of Women # of Men Total Total
One 125-164 15 12 27
Two 165-183 15 12 27
Three 184-204 20 9 29
Four 205-313 17 8 25 108
VLDL-C* Group
Quartile Range in mg/dL # of Women # of Men Total Total
One 10-19 21 6 27
Two 20-25 18 9 27
Three 26-32 17 10 27
Four 33-69 10 16 26
Missing 1 1 108
LDL-C Group
Quartile Range in mg/dL # of Women # of Men Total Total
One 38-75 17 9 26
Two 76-95 17 11 28
Three 96-114 16 11 27
Four 115-191 17 10 27 108
HDL-C Group
Quartile Range in mg/dL # of Women # of Men Total Total
One 26-45 6 21 27
Two 46-57 19 9 28
Three 58-71 21 8 29
Four 72-128 21 3 24
. 108
HDL-C to  Total Cholestrol Ratio Group
Quartile Range in mg/dL # of Women # of Men Total Total
One 1.47-2.55 23 4 27
Two 2.56-3.04 19 8 27
Three 3.05-4.00 15 13 28
Four 4.01-7.16 10 16 26 108
Triglcerides Group
Quartile Range in mg/dL # of Women # of Men Total Total
One 51-97 21 6 27
Two 98-124 18 9 27
Three 125-163 17 10 27
Four 164-313 10 16 26
Missing 1 108
* Based on triglyceride calcuations of interquartile ranges.











Table 25. Total Cholesterol and Mean MPOD A ssessm ents at Four Foveal S ites
Foveal Site 0.167“ 0.50“ 1.00° 2.00“ CMPV
Group Totals
ANOVA P Value * 0.50 0.81 0.84 0.49 0.77
Total Cholesterol (mg/dL) MPOD MPOD MPOD MPOD CMPV
First Quartile (125-164) 0.43 (S E + 0.044) 0.34 (S E + 0.031) 0.24 (S E + 0.025) 0.12 (SE + 0.017) 0.24 (SE + 0.026)
Second Quartile (165-183) 0.39 (SE+ 0.039) 0.32 (S E + 0.029) 0.24 (S E +0.023) 0.09 (S E +0.015) 0.23 (S E + 0.022)
Third Quartile (184-204) 0.40 (S E + 0.039) 0.34 (SE + 0.028) 0.26 (S E ± 0.023) 0.11 (S E +0.015) 0.24 (SE + 0.022)
Fourth Quartile (205-313) 0.46 (SE+ 0.042) 0.36 (SE+ 0.029) 0.27 (S E + 0.024) 0.12 (S E +0.016) 0.26, (S E +0.023)
Gender
ANOVA P Value 0.37 0.74 0.62 0.92 0.61
MPOD MPOD MPOD MPOD CMPV
Female 0.40 (S E + 0.030) 0.33 (S E + 0.022) 0.25 (SE + 0.017) 0.11 1SE+0.011) 0.24 (S E +0.017)
Male 0.44 (S E + 0.033) 0.34 (SE + 0.024) 0.26 (S E +0.019) 0.11 (SE+ 0.013) 0.25 (SE +0.019)
Gender X Total Cholesterol (Quartiles)
ANOVA P Value 0.74 0.58 0.14 0.44 0.39
* Multifactor ANOVA was utilized for the initial test of significance.
Significance was established at *p < 0.050-0.011; **p<0.010.
Independent variables: age (quartiles), BMI (< 27 or > 27), eye color, gender, fruit and vegetable group,
total cholesterol (quartiles) and total cholesterol (quartiles) x gender
Dependent variable: MPOD at each foveal site or CMPV
MPOD = macular pigment optical density
CMPV = composite macular pigment value
Table 26. LDL-C and Mean MPOD at Four Foveal Sites
Foveal Site 0.167 0.50° © o c 2.00° CMPV
Group Totals
ANOVA P Value 0.28 0.86 0.58 0.053 0.65
LDL-C (mg/dL) MPOD MPOD MPOD MPOD CMPV
First Quartile (38-75) 0.37 (SE + 0.044) 0.32 (SE + 0.032) 0.23 (SE + 0.026) 0.09 (SE + 0.016) 0.22 (SE + 0.026)
Second Quartile (76-95) 0.47 (SE + 0.042) 0.34 (S E + 0.032) 0.25 (SE + 0.026) 0.12 (SE + 0.017) 0.26 (SE + 0.026)
Third Quartile (96-114) 0.39 (SE + 0.038) 0.35- (SE+ 0.027) 0.27 (SE + 0.022) 0.14 (SE + 0.014) 0.25 (SE + 0.022)
Fourth Quartile (115-191) 0.44 (SE + 0.038) 0.35 (SE + 0.028) 0.26 (SE + 0.023) 0.10 (SE + 0.014) 0.25 (SE + 0.022)
Tukeys P Value
First Quartile : Second Quartile 0.46
First Quartile ; Third Quartile 0.06
First Quartile : Fourth Quartile 0.94
Second Quartile : Third Quartile 0.75
Second Quartile : Fourth Quartile 0.76
Third Quartile : Fourth Quartile 0.14
Gender
ANOVA P Value * 0.57 0.93 0.69 0.88 0.69
MPOD MPOD MPOD MPOD CMPV
Female 0.40 (SE + 0.028) 0.34 (SE + 0.021) 0.25 (SE + 0.017) 0.11 (SE + 0.011) 0.24 (SE + 0.017)
Male 0.43 (SE + 0.033) 0.34 (SE + 0.024) 0.26 (SE + 0.020) 0.11 (SE + 0.012) 0.25 (SE + 0.019)
Gender x LDL-C (quartiles)
ANOVA P Value 0.61 0.71 0.46 0.16 0.74
* Multifactor ANOVA w as utilized for the initial test of significance; results < 0.10 were further assesed  with a Tukeys multiple comparison test.
Significance was established at *p < 0.050-0.011; **p< 0.010
Independent variables: age (quartiles), BMI (< 27 or > 27), eye color, gender, fruit and vegetable group,
LDL-C (quartiles) and LDL-C (quartiles) x gender 
Dependent variable: MPOD at each foveal site or CMPV 
MPOD = macular pigment optical density 











Table 27. HDL-C and Mean MPOD at Four Foveal Sites
Foveal Site 0.167° 0.50° 1.00° 2.00° CMPV
Group Totals
ANOVA P Value * 0.13 0.16 0.31 0.20 0.17
HDL-C (mg/dL) MPOD MPOD MPOD MPOD CMPV
First Quartile (26-45) 0.33 (S E ± 0.046) 0.28 (S E ± 0.035) 0.22 (SE+ 0.029)- 0.08 (SE + 0.018) 0.20 (SE + 0.027)
Second Quartile (46-57) 0.42 (SE + 0.044) 0.38 (SE + 0.033) 0.27 (SE + 0.027) 0.12 (SE + 0.018) 0.26 (SE + 0.026)
Third Quartile (58-71) 0.44 (SE + 0.040) 0.33 (S E ± 0.028) 0.25 (SE ±  0.024) 0.10 (SE + 0.015) 0.24 (SE ±  0.023)
Fourth Quartile (72-128) 0.49 (S E ± 0.063) 0.36 (SE + 0.041) 0.30 (SE + 0.035) 0.14 (SE + 0.022) 0.30 (SE + 0.036)
Gender
ANOVA P Value 0.06 0.35 0.35 0.49 0.15
MPOD MPOD MPOD MPOD CMPV
Female 0.38 (S E ± 0.031) 0.32 (SE + 0.022) 0.25 (S E + .0.019) 0.10 (SE + 0.013) 0.23 (SE + 0.018)
Male 0.46 (S E ± 0.041) 0.35 (SE + 0.028) 0.27 (SE + 0.023) 0.11 (SE + 0.016) 0.27 (SE ±  0.023)
Gender x HDL-C
ANOVA P Value 0.41 0.45 0.87 0.15 0.56
* Multifactor ANOVA was utilized for the initial test of significance.
Significance was established at *p < 0.050 -0.011; **p < 0.010
Independent variables: age (quartiles), BMI (< 27 or > 27), eye color, gender, fruit and vegetable group,
HDL-C (quartiles) and HDL-C (quartiles) x gender
Dependent variable: MPOD at each foveal site or CMPV
MPOD = macular pigment optical density











Table 28. Triglycerides and Mean MPOD at Four Foveal S ites
Foveal Site 0.167° 0.50° 1.00° 2.00° CMPV
Group Totals
ANOVA P Value * 0.03* 0.14 0.02* 0.30 0.02*
Triglycerldes (mg/dL) MPOD MPOD MPOD MPOD CMPV
First Quartile (51 -97) 0.45 (SE + 0.051) 0.31 (SE + 0.033) 0.24 (SE + 0.026) 0.10 (SE + 0.018) 0.24 (SE + 0.028)
Second Quartile (98-124) 0.49 (SE _+ 0.039) 0.39 (SE + 0.028) 0.31 (SE +0.023) 0.13 (S E + 0.016) 0.30 (SE + 0.022)
Third Quartile (125-163) 0.45 (SE _+ 0.038) 0.36 (SE + 0.027) 0.27 (SE + 0.022) 0.13 (SE + 0.015) 0.28 (SE + 0.021)
Fourth Quartile (164-313) 0.34 (SE + 0.039) 0.33 (SE ±  0.027) 0.22 (SE + 0.022) 0.10 (SE + 0.015) 0.20 (SE + 0.021)
Tukeys P Value
First Quartile : Second Quartile 0.85 0.12 0.17
First Quartile : Third Quartile 1.00 0.71 0.63
First Quartile ; Fourth Quartile 0.33 0.95 0.77
Second Quartile ; Third Quartile 0.86 0.63 0.81
Second Quartile : Fourth Quartile 0.02* 0.02* 0.007**
Third Quartile : Fourth Quartile 0.10 0.26 0.04*
Gender
ANOVA P Value 0.07 0.76 0.53 0.99 0.27
MPOD MPOD MPOD MPOD CMPV
Female 0.40 (S E + 0.027) 0.34 (S E + 0.020) 0.25 (SE + 0.016) 0.12 (SE + 0.011) 0.24 (SE + 0.015)
Male 0.47 (SE + 0.033) 0.35 (SE+ 0.023) 0.27 (SE + 0.019) 0.12 (SE + 0.013) 0.27 (SE + 0.018)
Gender X Triglycerides (Quartiles)
ANOVA P Value 0.52 0.51 0.47 0.71 0.72
* Multifactor ANOVA was utilized for the initial test of significanc; results < 0.10 were further assessed with a Tukeys multiple comparison test. 
Significance was established at *p < 0.050-0.011; **p< 0.010
Independent variables: age (quartiles), BMI (< 27 or > 27), eye color, gender, fruit and vegetable group,
triglycerides (quartiles) and triglycerides (quartiles) x gender
Dependent variable: MPOD at each foveal site or CMPV
MPOD = macular pigment optical density
CMPV = composite macular pigment value
Table 29. Serum Carotenoids and Cholesterol (quartiles)
Carotenoid (umo|/L)(SE + ) B-Carotene Lycopene I utein Zeaxanthin UZ TotalCarotenoids
Cholesterol (quartiles) mg/dL
ANOVA P Value * 0.39 0.004** 0.002** 0.02* 0.002** 0.03*
First Quartile (125-164) 0.617 (0.095) 0.307 (0.042) 0.290 (0.028) 0.056 (0.006) 0.347 (0.033) 1.267 (0.116)
Second Quartile (165-183) 0.473 (0.092) 0.430 (0.040) 0.340 (0.027) 0.067 (0.006) 0.413 (0.032) 1.313 (0.112)
Third Quartile (184-204) 0.653 (0.089) 0.484 (0.039) 0.342 (0.027) 0.070 (0.006) 0.408 (0.031) 1.552 (0.108)
Fourth Quartile (205-313) 0.647 (0.089) 0.496 (0.040) 0.436 (0.026) 0.083 (0.006) 0.521 (0.031) 1.664 (0.109)
Tukeys P Value
First Quartile : Second Quartile 0.11 0.51 0.48 0.41 0.99
First Quartile : Third Quartile 0.008** 0.50 0.27 0.49 0.23
First Quartile : Fourth Quartile 0.007** 0.001 *A 0.008** 0.001** 0.06
Second Quartile : Third Quartile 0.73 1.00 0.98 1.00 0.34
Second Quartile : Fourth Quartile 0.63 0.05* 0.22 0.07 0.10
Third Quartile : Fourth Quartile 1.00 0.057 0.38 0.052 0.88
Gender
ANOVA P Value 0.02* 0.07 0.75 0.16 0.91 0.32
Female 0.707 (0.063) 0.391 (0.028) 0.356 (0.019) 0.065 (0.004) 0.424 (0.022) 1.506 (0.077)
Male 0.488 ( 0.075) 0.467 (0.033) 0.348 (0.022) 0.073 (0.005) 0.420 (0.026) 1.393 (0.092)
Gender x cholesterol (quartiles)
ANOVA P Value 0.06 0.54 0.12 0.02* 0.09 0.17
* Multifactor ANOVA was utilized for initial data analysis; results <0.10 were further assessed with a Tukeys multiple comparison test. 
Significance was established at *p < 0.05 -0.011; **p <0.010.
Independent variables: age (quartiles), BMI (<27 or > 27), eye color, gender, cholesterol (quartiles) and cholesterol (quartiles) x gender 
Dependent variable: serum carotenoid
Table 30. Serum Carotenoids and LDL-C (quartiles)
Carotenoid (umol/i.) (SE + ) B-Carotene Lycopene Lutein Zeaxanthin U Z TotalCarotenoids
LDL-C (quartiles) mg/dL
ANOVA P Value * 0.42 0.08 0.09 0.14 0.07 0.12
First Quartile (38-75) 0.504 (0.099) 0.371 (0.046) 0.317 (0.032) 0.062 (0.007) 0.380 (0.037) 1.241 (0.124)
Second Quartile (76-95) 0.653 (0.098) 0.377 (0.045) 0.385 (0.031) 0.069 (0.007) 0.460 (0.037) 1.479 (0.123)
Third Quartile (96-114) 0.529 (0.084) 0.488 (0.039) 0.334 (0.028) 0.068 (0.006) 0.398 (0.032) 1.440 (0.105)
Fourth Quartile (115-191) 0.670 (0.087) 0.473 (0.040) 0.405 (0.028) 0.082 (0.006) 0.489 (0.032) 1.627 (0.109)
Tukeys P Value
First Quartile : Second Quartile 1.00 0.38 0.38
First Quartile : Third Quartile 0.18 0.98 0.98
First Quartile : Fourth Quartile 0.31 0.14 0.11
Second Quartile ; Third Quartile 0.21 0.58 0.56
Second Quartile : Fourth Quartile 0.36 0.96 0.93
Third Quartile : Fourth Quartile 0.99 0.24 0.19
Gender
ANOVA P Value 0.02* 0.16 0.23 0.49 0.30 0.16
Female 0.698 (0.061) 0.397 (0.028) 0.378 (0.020) 0.068 (0.004) 0.450 (0.023) 1.528 (0.077)
Male 0.480 (0.076) 0.457 (0.035) 0.342 (0.024) 0.073 (0.005) 0.414 (0.029) 1.366 (0.095)
Gender x LDL-C (quartiles)
ANOVA P Value 0.09 0.62 0.80 0.23 0.70 0.36
* Multifactor ANOVA was utilized for initial data analysis; results <0.10 were further assessed with a Tukeys multiple comparison test. 
Significance was established at *p < 0.05 -0.011; **p < 0.010.
Independent variables: age (quartiles), BMI (< 27 or > 27), eye color, gender, LDL-C (quartiles) and LDL-C (quartiles) x gender 











Table 31. Serum Carotenoids and HDL-C (quartiles)




ANOVA P Value * 0.97 0.34 0.62 0.85 0.75 0.83
First Quartile (26-45) 0.500 (0.124) 0.497 (0.056) 0.319 (0.038) 0.076 (0.009) 0.394 (0.045) 1.399 (0.155)
Second Quartile (46-57) 0.527 (0.108) 0.390 (0.049) 0.344 (0.033) 0.067 (0.007) 0.411 (0.039) 1.322 (0.135)
Third Quartile (58-71) 0.558 (0.092) 0.429 (0.042) 0.360 (0.028) 0.071 (0.006) 0.433 (0.034) 1.416 (0.115)
Fourth Quartile (72-128) 0.588 (0.138) 0.494 (0.063) 0.393 (0.043) 0.070 (0.010) 0.464 (0.051) 1.519 (0.173)
Gender
ANOVA P Value 0.08 0.52 0.67 0.78 ' 0.70 0.27
Female 0.640 (0.075) 0.436 (0.034) 0.362 (0.023) 0.070 (0.005) 0.434 (0.028) 1.491 (0.094)
Male 0.447 (0.093) 0.469 (0.042) 0.347 (0.029) 0.072 (0.006) 0.418 (0.034) 1.338 (0.116)
Gender x HDL-C (quartiles)
ANOVA P Value 0.43 0.34 0.57 0.29 0.54 0.75
* Multifactor ANOVA was utilized for initial data analysis; results <0.10 were further assessed with a Tukeys multiple comparison test. 
Significance was established at *p < 0.05 -0.011; **p < 0.010.
Independent variables: age (quartiles), BMI (< 27 or > 27), eye color, gender, HDL-C (quartiles) and HDL-C (quartiles) x gender 











Table 32. Serum Carotenoids and Triglycerides (quartiles)
Carotenoid (urrtol/f-XSE + ) B-Carotene Lycopene i  utein Zeaxanthin Uf. TotalC a .ro M li i i l |
Triglycerides (quartiles) mg/dL
ANOVA P Value * 0.25 0.26 0.30 0.22 0.29 0.22
First Quartile (51-97) 0.666 (0.110) 0.355 (0.047) 0.331 (0.036) 0.062 (0.008) 0.394 (0.042) 1.407 (0.138)
Second Quartile (98-124) 0.468 (0.095) 0.442 (0.041) 0.372 (0.030) 0.072 (0.007) 0.447 (0.036) 1,335 (0.119)
Third Quartile (125-163) 0.513 (0.090) 0.457 (0,039) 0.336 (0.029) 0.067 (0.006) 0.404 (0.034) 1.370 (0.113)
Fourth Quartile (164-313) 0.667 (0.089) 0.470 (0.038) 0.401 (0.029) 0.081 (0.006) 0.481 (0.034) 1.634 (0.111)
Gender
ANOVA P Value 0.02* 0.21 028 0,53 0.38 0.13
Female 0.689 (0.062) 0.406 (0.027) 0.377 (0.020) 0.068 (0,004) 0.448 (0.024) 1.525 (0.078)
Male 0.468 (0.079) 0.456 (0.034) 0.343 (0.025) 0.073 (0.006) 0.416 (0,030) 1.348 (0.099)
Gender x Triglycerides (quartiles)
ANOVA P Value 0.59 0.03* 0.88 0.89 0.87 0.49
* Multifactor ANOVA was utilized for initial data analysis; results < 0.10 were further assessed with a Tukeys multiple comparison test. 
Significance was established at *p < 0.05 -0.011; ** p <0.010.
Independent variables: gender, age, BMI (< 27 or > 27), eye color, triglycerides (quartiles) and triglycerides (quartiles) x gender 











Table 33. Serum Carotenoids and Body Mass Index




ANOVA P Value * 0.03* 0.07 0.05* 0.30 0.07 0.003**
Body Mass Index
<27 0.652 (0.069) 0.487 (0.032) 0.392 (0.023) 0.076 (0.005) 0.467 (0.027) 1.613 (0.087)
>27 0.454 (0.073) 0.410 (0.034) 0.333 (0.024) 0.069 (0.005) 0.402 (0.028) 1.269 (0.092)
Gender
ANOVA P Value 0.04* 0.28 0.31 0.45 0.41 0.21
female 0.651 (0.064) 0.425 (0.030) 0.378 (0.021) 0.070 (0.005) 0.450 (0.025) 1.514 (0.082)
male 0.455 (0.078) 0.472 (0.036) 0.347 (0.025) 0.075 (0.006) 0.420 (0.030) 1.367 (0.099)
Gender x BMI
ANOVA P Value 0.08 0.27 0.89 0.33 0.85 0.46
BMI < 27 female 0.832 (0.065) 0.440 (0.031) 0.405 (0.021) 0.070 (0.005) 0.478 (0.025) 1.730 (0.083)
BMI < 27 male 0.472 (0.115) 0.534 (0.054) 0.379 (0.038) 0.081 (0.008) 0.455 (0.045) 1.496 (0.145)
BMI > 27 female 0.471 (0.105) 0.411 (0.049) 0.350 (0.034) 0.070 (0.007) 0.421 (0.040) 1.299 (0.133)
BMI > 27 male 0.438 (0.092) 0.410 (0.043) 0.316 (0.030) 0.068 (0.007) 0.384 (0.035) 1.239 (0.116)
* Multifactor ANOVA was utilized for data analysis.
Significance was established at *p < 0.05 -0.011; **p < 0.010.
Independent variables: age, eye color, gender, BMI (< 27 or > 27), and BMI (< 27 or > 27) x gender 











Table 34. Serum Carotenoids and Estimated Dietary Carotenoid Intake: 7-FVST Results
Serum Carotenoids umol/L (SE + ) Beta-Carotene Lycopene Lutein/zeaxanthin Total Carotenoids
Group Results
ANOVA P Value * 0.31 0.10 0.25 0.07
7-FVST
Low Consumers 0.380 (0.135) 0.454 (0.062) 0.346 (0.051) 1.183 (0.164)
Moderate Consumers 0.590 (0.082) 0.390 (0.038) 0.436 (0.031) 1.414 (0.100)
High Consumers 0.665 (0.079) 0.503 (0.037) 0.463 (0.031) 1.635 (0.097)
Very High Consumers 0.569 (0.101) 0.403 (0.047) 0.432 (0.038) 1.398 (0.123)
Tukeys P Value
Low: Moderate Consumers 0.80 0.63
Low: High Consumers 0.90 0.08
Low: Very High Consumers 0.91 0.73
Moderate: High Consumers 0.09 0.30
Moderate: Very High Consumers 1.00 1.00
High: Very High Consumers 0.31 0.40
Gender
ANOVA P Value 0.13 0.40 0.82 0.40
7-FVST
Females 0.632 (0.073) 0.417 (0.034) 0.424 (0.028) 1.462 (0.089)
Males 0.470 (0.080) 0.458 (0.037) 0.414 (0.031) 1.353 (0.097)
Gender x 7-FVST
ANOVA P Value 0.22 0.93 0.65 0.11
 ^ .............
* Multifactor ANOVA was utilized for the initial test of significance; results < 0. f 0 were further assessed 
with a Tukeys multiple comparison test.
Significance was established at the *p < 0.050-0.011; **p < 0.010.
Independent variable: age (quartiles), BMI (< 27 or > 27), eye color, gender, fruit and vegetable group,and gender x fruit and vegetable group 











Table 35. Serum Carotenoids and Estimated Dietary Carotenoid Intake: 24hr-CGFR and FFQ Results
__________ Dietary Assessment Tool________
Group Results 24hr-CGFR B-FFQ FH-FFQ
Linear Regression Signifigance Values
Serum Carotenoids
Beta Carotene 0.003** 0.001** <0.001** <0.001**
Lycopene <0.001** 0.11 0.13 0.54
Lutein/Zeaxanthin . 0.14 0.15 0.007** 0.03*
T-FFQ
Females 24hr-CGFR Block Hutch Tufts
Serum Carotenoids
Beta Carotene 0.30 0.20 0.009** 0.002**
Lycopene 0.004** 0.95 0.63 0.98
Lutein/Zeaxanthin 0.39 0.49 0.08 0.052
Males 24hr-CGFR Block Hutch Tufts
Serum Carotenoids (umole/L)
Beta Carotene <0.001** <0.001** <0.001** 0.001**
Lycopene < 0.001 ** 0.09 0.10 0.29
Lutein/Zeaxanthin 0.19 0.13 0.02* 0.59
Statistical analysis: simple linear regression 
Significance was established at *p < 0.050 through 0.011; 
Independant variable: dietary carotenoid intake 












Table 36. Lipid Results by Age Ranges: UNH Results and Text Reference Data
Cholesterol(mg/dL) LDL(mg/dL) HDL(mg/dL) TG(mg/dL)A
5-95%TILE 5-95%TILE 5-95%TILE 5-95%TILE
UNH Age quartiles
45-49 male 168-219 80-133 35-65 102-268
female 166-199 79-108 57-71 94-152
50-55 male 160-197 77-107 42-66 110-204
female 169-203 77-114 54-70 95-189
56-61 male 161-200 83-126 41-50 114-190
female 182-208 92-114 56-74 107-165
62-73 male 155-190 78-108 41-56 131-182
female 174-226 77-123 58-88 100-161
Text Reference Data
45-49 male 158-276 97-202 30-64 55-327
female 152-265 79-186 34-87 45-214
50-54 male 158-277 89-197 28-63 58-286
female 163-285 88-201 37-92 52-262
55-59 male 155-276 88-203 28-71 58-286
female 172-300 89-210 37-91 52-262
60-64 male 159-276 83-210 30-74 Values decrease
female 172-297 100-224 38-92 slightly after age 60
65-69 male 158-274 98-210 30-75
female 171-303 92-221 35-96
>70 male 144-265 88-186 31-75
female 173-280 96-206 33-92













Figure 1. Structure of Provitamin A and Nonprovitamin A Carotenoids









Taken from Dietary Reference Intakes for Vitamin C. Vitamin E. Selenium, and Carotenoids, Food and Nutrition Board, Institute o f Medicine, National 
Academy Press, Washington, D.C., 2000.
Figure 2. Optical System Components of the Macular Metrics Corporation® 






; . . . f p
ficuas 3 . A schematic.Of the optical system used so measure MP 
optical density in fiec view. Ai and A2, Apertures 1 and 2; BS. beam 
splitter, i l  and 12. planoconvex achromatic lenses; PC, photocell; H, 
hot minor used to  reduce heat transmission; SI and S2. tight sources; 
D1 and D2, optical diffusers.
Taken with permission from Dr. Billy Wooten, from “A Practical Method for Measuring Macular Pigment 
Optical Density”, IVOS, 1999; 40:2481-2489.
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Figure 11. Dietary Lutein/Zeaxanthin Intake as Estimated by the Fred Hutchinson 
Food Frequency Questionnaire and MPOD at the 1.00 Degree Foveal Site
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IX. APPENDICES
Appendix A.
Institutional Review Board Documentation
U n iv er sity  o f  N e w  H a m psh ir e
Office of Sponsored Research 
Service Building 
51 College Road
Durham, New Hampshire 03824-3585 
(603) 862-3564 FAX
LAST NAME B-irke FIRST NAME Joanne
DEPT Animal andNutritional Sciences - Kendall Hall APP'L PATE 1 0 /2 8 /2 0 0 0
The Institutional Review Board for the Protection of Human Subjects in Research has reviewed and approved your 
request for time extension for this protocol. Approval is  granted  for o n e  year  from  th e  approval date  
above. At the end of the approval period you will be asked to submit a project report with regard to the involvement 
of hum an  subjects, if your project Is still active, you may appiy for extension of iRB approval through this office.
The protection of human subjects in your study is an ongoing process for which you hold primary responsibility. 
Changes in your protocol must be submitted to the IRB for review and approval prior to their implementation. If you 
have questions or concerns about your project or this approval, p lease feel free to contact this office at 862-2003.
PSease refer to the IRB # above in all correspondence related to this project. The IRB w ishes you su ccess with your 
research.
IRB # 208 4
OFF-CAMPUS 4  Berkeley Street 
ADDRESS Nashua, NH 03060  
(if a p p licab le )
REVIEW LEVEL EXP':
DATE OF NOTICE 12 /8 /2 0 0 0





Office of Sponsored Research
cc: File OFSIG APP'L 12/4/1998
Joanne Curran-Celentano, Anim. Sci - Kendall
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Appendix B. 
Recruitment Flyer
YOU CAN HELP US UNDERSTAND THE 
ROLE OF NUTRITION AND VISION HEALTH
Age-related macular degeneration is the leading cause of eye disease in the United 
States. We are investigating the relationship of food intake with eye health. Your 
participation in our study will give us important information that will be used to 
improve nutrition and eye health advice.
You may be eligible to participate if you are
■ Between the ages of 45-70
■ Have no known macular disease
■ Have no diagnosis of diabetes
Participants will receive
■ Information about their diet, blood cholesterol levels and vision test results.
■ $35.00 compensation
For more information, please contact us at the University of New Hampshire:
(603) 862-2573 or (603) 862-3182 
Joanne Burke, Ph.D. Candidate -  iburke @ cisunix.unh.edu 
Crystal Lariviere, Graduate Student— cal5@cisunix.unh.edu 
Laboratory of Dr. Joanne CurranCelentano
Dept, of Animal & Nutritional Sciences (7/20/2000)
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Appendix C. 
Participant Information and Inclusion Data
Nutrition ami Vision Study • Date_____
A d d ress      ' Phone-? liome_
Sli^SSSIiiilSFBsllSSSIiWSfti^SillSSlSiSSilSSlBlS
I .Study about Nutrition and the Retina. We will be : '
A- Asking (fucstions about the food you'eat '
’ j i n v  m , . ,  ' . i n ; . .  . . . u iii .. .‘ i n  • ■> - . *  t ■. .p t. ■ . o  11. ,>'•
C . Will be conducting vision tests, so bring yoin reading glasses.
D Plan ie r  a morning visit d.5 to 4  hours
E. Two additional hours at home for survey completion • - '
Review Criteria v C ircle Response
i i i m p
4  Axe you presently a  smoker ? , No
1 '1. . 0.. , u ,  li.il.' 1 'l-i 1 u"> .J, J i .
7. Do you have diabetes No
, h a . ,  m it .ii,.•’ e l s  'i " |i  L. ’ No
<3. Have you been diagnosed with color;bimdness ? l i f t ® ! ! !
10. Are you post-menopausal 1 - i f g j f g i
11. I f  yes, for about how  long have vou heea Post VI ? ® ^ ® S S s i S s S
’ D. i ho1. >. . > ’ lillil
> u’kIik! : ; "> y v . . , . .  ei tSMSfSSIItliift
14. Determine subject group - Group
15 Set assessment date D ate
’Number
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Appendix D.
Informed Consent
Consent Form for Subjects enrolled in the Nutrition and Vision Study
INFORMED CONSENT
Purpose: The purpose o f this research is to measure the macular pigment of the eye. The macular pigment of the 
eye contains the carotenoids, lutein and zeaxsnthin. Information on factors that may influence macular pigment will 
be assessed.
Description: Surveys will be used to gather information on dietary and lifestyle practices. A  fasting blood test will 
be required of participants in the comprehensive study' in order to determine circulating levels of cholesterol and 
carotenoids. Screening tests to determine basic vision functioning will be administered, such as looking at w  eye 
chart. For the macular pigment test, you will be asked to look into the macular pigment instrument .and make die 
flickering light stop flickering. This is done by manually atjjusting a knob. H is  task will be repeated at five- 
different retinal sites. Some diet survey forms will be completed on the day of your visit to the lab: other diet forms 
m y  be completed at home. For idea! results for our research, it is hoped that you will be able to complete both the 
assessments conducted on the day of your visit, as well as return diet recall forms that you may complete at home.
For some subjects, during an additional vision test, you may be asked to provide feedback on the appearance 
and /or disappearance of the flickering light. Y on will be given oral instructions and an. opportunity to practice the 
required tastes. Same subjects may be asked to provide urine or-additional blood samples used for other research 
projects. Results from the cholesterol, vision screening tests, and diet analysis will be provided to the subjects.
PLEASE READ THE FOLLOWING STATEMENTS .AND RESPOND AS TO WHETHER. OR 
NOT YOU ARE WILLING TO PARTICIPATE: - ■
1. 1 understand that the use o f human subjects in this project has been approved by the UNH Institutional 
Review Board for the Protection o f Human Subjects in 'Research.
2. I understand the scope, aims, and purpose o f this research project and the procedure to be followed 
(including identification of any treatments or procedures which are experimental) and the expected 
duration of my participation.
3. I have received information stating that there are no known significant risks or benefits associated with this 
research experiment.
4. I understand that if  I have ever had a seizure I should not participate in the since flickering lights may 
increase the risk of seizure and flickering lights arc used in this research project.
5. I understand that the confidentiality of all data and records associated with my participation in this research, 
including my identity, trill be fully maintained
6. I understand, that my consent to participate in this research is entirely voluntary, and feat my
refusal to participate m il involve no prejudice, penalty or loss of benefits to which I would otherwise be 
entitled.
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I farther understand that if  I consent to participate, I may discontinue my participation at any time without 
prejudice-, penalty or loss o f benefits to which I would otherwise be entitled.
I confirm that no coercion of any kind was used in seeking my participation .in this research project.
I understand that if  I have any questions pertaining to the research or any research related injury I can call 
Joanne Burke at 862-2573 and be given die opportunity to discuss them in confidence, i f  I have questions 
. pertaining to my rights as a research subject I can call The Office of Sponsored Research at 862-2003 and 
be given the opportunity to discuss them in confidence.
I understand that I will receive $35.00 for partial compensation for my time and travel related to 
participation in the study. In addition, while fallowing confidentiality guidelines, niy participation also 
makes me eligible to win donated goods/services to be raffled at the completion of the study.
I understand that any information gained about me as a result o f my participation will be provided to me at 
the conclusion o f  my involvement in this research project.
I certify that I have read and fully understand the purpose o f tins research project and its risks and 
benefits for me as stated, above.
I, CONSEHT/AGREE to participate in this research project.
(print name)
I, REFUSE/DO NOT AGREE to participate in this research project.
(print name)
Signature of Subject Date
169
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Appendix E.
Health and Vision History Survey (page 1 of 15)
Subject Number FF150-I079- } ' j
Subject Initials   |
Firsi/Middle.'Last
Health and Eye Status Questionnaire
Section A -  We would like to ask you some questions about your eyes 
Do you wear prescription glasses ox contact, lenses?
D YES Continue with A2
□ NO Go to A4
A2 Are they tinted?
□ YES
□  NO
How old were you when you began wearing correcti ve lenses?
Age (years)
Has a physician or other health professional ever told you that you had any of the 
following eye problems?




□ Crossed or lazy eye
Have you ever had eye surgery?
O YES For what condition?.______ ' __________
□  NO
Have you ever had an eye injury requiring medical attention?
O YES For what condition? ________
□  NO
A7 Has a health professional ever told any of your family members that they have 
macular degeneration?
(check all that apply) □ Mother or father
□ Brother or sister
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Appendix E.
Health and Vision History Survey (page 2 of 15)
□  Child
□  T o  m y k now ledge, n o  one in m y fam ily  has or had this 
condition
AB H as a health professional ever tc Id an o f  your fam ily m em bers that they have 
glaucom a?
(check all that apply) □  M other or father 
O  Brother or sister
□  T o  m y know ledge, no one in m y fam ily  has or had this 
condition
Section  B
N o w  w e are go in g  to ask you  som e questions about your m edical history. P lease check  
box for each condition, indicating whether you have not had it, had it in  the past, or are 
currently being treated for it.
I h vt, not that! this 1 am currently 
had this condition being treated 
condition in the past for this
condition
B1 Heart condition hkc a heart attack, angina,
con gestive heart failure, rheum atic fever  
B 2  Lung condition like em physem a, chronic bronchitis,
asthma
B3 H igh b lood pressure, hypertension
B4 H igh triglyceride or cholesterol level
B 5 M igraine or other chronic headaches
B 6 D iabetes or g lu cose intolerance
B 7 Hormonal condition iike a thyroid or adrenal
problem
B 8 A ny kind o f  cancer other than non-m elanom a skin
cancer
B 9 G allbladder disease or gallbladder rem oval
B 10 L iver d isease (including hepatitis)
B 1 1 Stom ach ulcer, peptic ulcer, or duodenal ulcer 
B.12 Heartburn, reflux, or hiatal hernia
B13 Irritable bow el, spastic bow el, or functional bow el 
problem
B 14 Crohn's d isease, u lcerative co litis, or bow el resection  
B I5  N eu ro log ic  condition  like Parkinson's, stroke, or 
seizure
B 16  Arthritis, includ ing rheum atoid arthritis 
B 37 Psychiatric condition  (including depression or 
anxiety)
B 18  B leed in g  disorder
B I 9  K idney d isease
B 2 0  Eating disorder, for instance anorexia or bulim ia
B 21 Other (P lease describe b elow )
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Please list all vitamins and other nutritional and fiber supplements that you have taken during the past month. Include brand names 
from the label if possible.










FOR OFFICE USE 
ONLY
Examples:
One A Day vitamins 1 pill 1 good health 2 years


































Please list all over the counter medications, non-prescription medication you have taken during die past month. Be sure to include tilings like 
laxatives, antacids and pain relievers. Give brand names if possible.










FOR OFFICE USE 
ONLY
Examples:
Alaalax 2 Tablets 4 antacid 2 weeks































Please list all medications prescribed by a doctor that you have taken during the past month. Don’t forget to include things like birth control pills and 
hormone replacement therapy. . . , . .
Name of prescription medication Amount 









FOR OFFICE USE 
ONLY
Examples;
JWevlen 28 Ipill 1 birth control 2 years


























Health and Vision History Survey (page 6 of 15)




Now we would like to ask you some questions about your smoking habits.
D1 Have you smoked at least 100 cigarettes in your life?
O YES Continue with D2
□  NO Go to D6
Do you smoke cigarettes now?
D YES
□  NO
How long has it been since you last smoked? Would you say;
(check one) □  Less than 1 day
□  Less than 7 days
□  Less than 1 month
□  Less than 3 months
□  Less than 6 months
□  6 months to a year
□  Greater than 1 year
About how many cigarettes do you or did you smoke on an average day?
| |.....  Cigarettes per day (1 Pack = 20 cigarettes
How many years have you smoked?
 j Number of years
Do you presently smoke any form of tobacco other than cigarettes?
Cl YES Continue with D7 
□  NO Go to D8
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Appendix E.
Health and Vision History Survey (page 7 of 15)
Indicate below which forms of tobacco you smoke other than cigarettes, and how 
many each day
(cheek all that apply) □  Cigars How many? 1 1 1 Cigars each day
□  Cigarillos How many? f f~ } Cigarilios each day
□  Pipe How many? [1111 Bowlfuls each day
How many people who live with you now smoke cigarettes inside your home?
(check one) □  None
□  1 or 2
□  3 or 4
□  5 or more
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Appendix E.
Health and Vision History Survey (page 8 of 15)
Subject Humber F P i50-1079- _______
Subject Initials    1..
l%st/Mirtdte/Last
Section E
Next we would like to ask you about your complexion and coloration, 
El What color are your eyes?






E2 What is or was the natural color of your hair (before treatments, graying, or 
balding)?
(check one) D Black
□  Dark Brown
□  Light Brown
□  Blond
□  Red
E3 Which best describes your ethnic background?
(check one) □  White or Caucasian
O Black or African-American, not of Hispanic descent
□  American Indian or Alaskan, native
□  Asian or Pacific Islander (includes Continental Indian) 
O Spanish or Hispanic
□  Multi-racial Please describe;___________________
□  Other Please describe;___________________
E4 How would you rate the color of your skin? Circle one number on the scale
below that best describes your skin color. (1= fair and 7 s  dark).
T
6 n ri
E5 When you are outside without a hat or other protective covering, how sensitive is 
your skin to the sun? Would you say you:
(check  on e) □  Always bum, never tan
□  Always burn, but sometimes tan 
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Appendix E.
Health and Vision History Survey (page 9 of 15)
□  Sometimes burn, but always tan
□  Never bum, but always tan
□  Have skin darkly pigmented before sun
178
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Appendix E.
Health and Vision History Survey (page 10 of 15)
Subject Number FP150-1079- [
Subject Initials ( 1 1 1
Hrst/M iddie/Last
Section F
Now we will ask you some questions about your lifestyle.
FI What is your occupation?
(check one) □  Fanner or farm worker
□  Service worker or laborer
□  Factory worker or mechanic
□  Clerical person, salesperson, or technician
□  Professional, administrator, executive
□  Student
O Homemaker
O Other Please describes___________
For questions P2 through F6, please check one box for the past year and one box for the 
past five years.
F2 Is your place of work:
In the past year □  Mainly outdoors In the past five years □  Mainly outdoors
□  Equally indoors/outdoors □  Equally indoors/
outdoors
^  Mainly indoors Mainly indoors
F3 During the summer, how much of your leisure time is spent outdoors?
In the past year □  Mainly outdoors In the past five years □  Mainly outdoors
□  Equally indoors/outdoors □  Equally indoors/
outdoors
^  Mainly indoors ^  Mainly indoors
F4 During the winter, how much of your leisure time is spent outdoors?
In the past year □  Less than 1/4 In the past five years q  Less than 1/4
□  1/4 to 1/2 □  1/4 to 1/2
□  1/2 to 3/4 □  1/2 to 3/4
□  More than 3/4 □  More than 3/4
F5 When you are outdoors, how much of the time do you wear sunglasses?
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Appendix E.
Health and Vision History Survey (page 11 of 15)
In the past year □  Less than 1/4 In the past five years ^  Less than 1/4
□  1/4 to 1/2 □  1/4 to 1/2
□  1/2 to 3/4 □  1/2 to 3/4
□  More than 3/4 □  More than 3/4
When you are outdoors, how much of the time do you wear a hat with a brim?
In the past year □  Less than 1/4 In the past five years D Less than 1/4
O  1/4 to 1/2 □  1/4 to 1/2
□  1/2 to 3/4 □  1/2 to 3/4
□  More than 3/4 □  More than 3/4
F7 How many times do you exercise each week?
Times/week
P8 Each time you exercise, how long do you typically exercise?
(check one) □  Less than 15 minutes
□  Between 15 and 30 minutes
□  31 to 60 minutes
□  more than 60 minutes
F9 How much of this exercise is vigorous enough to cause sweating or shortness of
breath?
□  Most of it 
O Some of it
□  Little of it
As part of your work, is there any vigorous physical acti vity on a regular basis?
O YES Continue with FI 1
□  NO Go to F12
How much of this physical activity at work is vigorous enough to cause sweating 
or shortness of breath?
□  Most of it
□  Some of it
□  Little of it
How many hours of sieep do you.typically get each night? Please round to whole 
numbers. I— i----f ,
: Hours o f sleep
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Appendix E.





The following questions are for women on] > I >ou are mat rk ase turn to Sccion H 
the next section..
Do you currently have periods or menstrual cycles?
D YES Go to G3 
C3 NO Continue with G2
What is the primary reason you are not having periods or menstrual cycles?
(check one) □  Reached menopause
□  Had a hysterectomy
□  Take medicine that stopped my period
□  Never had a menstrual cycle or period 
O Recently gave birth
□  Pregnancy How many months pregnant are you?
□  0-3 months
□  4-6 months
O 7-9 months
□ Other Please describe:___________ ________
How many times have you been pregnant?
Times/Pregnant 
Are you currently breastfeeding or lactatmg?
□ YES
□  NO
When was your last period?
Month Year
The next three questions (G6 through G8) refer to prescription birth control medications 
such as birth control pills, Norplant implants or Depo-Provera shots. These medications 
are used to prevent pregnancy and may also be used to regulate your monthly period to 
control monthly cramping, make your period more regular or reduce endometrial
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Appendix E.
Health and Vision History Survey (page 13 of 15)
symptoms. Please answer yes if you have used prescription birth control medications for 
any reason.
Have you ever taken any prescription birth control medications? This would 
include birth control pills, Norplant implants or Depo-Provera shots.
□  YES Continue with G7
□  NO Go to G9
Are you presently using prescription birth control medications? This would 
include birth control pills, Norplant implants or Depo-Provera shots.
£-j ygg Continue with G8
□  NO Go to G9
Please give us the name, amount and when you began using prescription birth 
control medications. This would include birth control pills, Norplant implants or 
Depo-Provera shots.
Name o f  medicine Month Year
Have you ever taken hormone replacement therapy, for example, after menopause 
(change of life) or hysterectomy?
0  YES Continue with G10 
Cl NO Go to next page
Are you presently taking hormone replacement therapy?
C3 YES Continue with Gl. 1 
O NO Go to next page
Please give us the name, amount and when you began taking hormone 
replacement therapy.
Name o f medicine Amount Month Year




□  Other________ __________
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Appendix E.
Health and Vision History Survey (page 14 of 15)
Health and Eye Status Questionnaire
Section I - About Yourself
What is your gender?
O Female 
□  Male
What is the date of your birth?
H3 How tall are you?
feet inches
How much do you weigh?
In the past 6 months, have you lost or gained more than 10 pounds?
(Do not include weight gain while you are pregnant)
(ch eck  one) ^  Weight stayed about the same 
Cl Lost 10 pounds or more 
^  Gained 10 pounds or more
The following information will be used for statistical purposes only.
Which of the following best describes your education level?
(ch eck  o n e ) ^  Haven’t graduated from high school 
D High school graduate or GED 
D Some college, or college graduate 
^  Professional/graduate school
Which of the following best describes your household income from all sources
before taxes?
(ch eck  o n e) ^  Less than $15,000
O Between $15,000 and $24,999 
n  Between $25,000 and $34,999 
^  Between 35,000 and $49,999
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Appendix E.
Health and Vision History Survey (page 15 of 15)
□  Between $50,000 and $74,999 
D Greater than $75,000
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Appendix F. 
Seven-Item Fruit and Vegetable Screening Tool (7-FVST) from Block
Eating Habits Screener
o a r name;  ____________   Age' Ses: M  ¥
Think about your eating habits over the past year or so. About how often do you eat each o f  the following 
foods? Remember breakfast, loach, dinner, snacks and eating out. Mark aa ‘x ’ in one column for each food.
j F ru its  an d  Vegetables
] ........
Fw it juice, like orange, apple, grape — fresh
.ftiizto’Stt j«r''dl$ur3f adwaitsiyi;;i-
Bow odea do you eat any fruit, fresh or canned
s'nst counting pace?)
Vegetable jmcedalcc lojaaiD-jtuea. V-Sj carrot ' ^
Green salad
otatoes anj load, mtiadmg baked trusted ot 
fren:* fried
Vegetable scrap, or stew with vegetables
A ry other’rcgrtafcfc,, including string beans, 
peas, corn, broccoli o r anv other ktnd
{0) 0) (23 P3 «) (5)
less tbaa. Once a 2-3 liases 4*6 times Once aIv-WEEK WEEK. aWEEK, e WEEK DAY .. DAY
0 .. . ... -(dS o I:
r-N /-%w W*
C • • v  . O
r~\ ,-s i - sw w-
x O 0 z> c
■v* w w -\J ■w
C r s.V ' o C O 'c
Score
inut/Vegetable S core *
See over to score
C  Block D ieuuy03U  Sjnfieas T o obtain more esftciyfv* dpsuny wjahrsi*. call.$10»7&4-£5 34. or c w s u lt» dieyu w..
noft «*a«T9owv fpoia >it*roiOTs r«  st'Ct isi" ee- no/ie
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Appendix G.
24hr-Carotenoid Guided Food Recall and National Food Frequency 
Resource List
24hr-Carotenoid Guided Food Recall
1. 24hr-Carotenoid Guided Food Recall 
Cancer Prevention Research Program 
1100 Fairview Avenue N. MP-702 
Seattle, WA 98109-1024 
(206) 667-4797
Contact: Marian Neuhouser at mneuhou@fhcrc.org
National Food Frequency Questionnaires
2. Block Dietary Data Systems 
2634 Le Conte Avenue 
Berkeley, CA 94709 
(510) 704-8514
Contact: Torin Block at www.nutritionquest.com
3. Fred Hutchinson Cancer Research Center 
1100 Fairview Avenue North 
# MW-801
Seattle, WA 98109-1024 .
(206) 667-5283
Contact: Christie Nelson at cnelson@fhcrc.org
4. USDA Human Nutrition Center on Aging 
Tufts University 
711 Washington Street 
Boston, MA 02111 
(617) 556-3344
Contact: Katherine Tucker at tucker@hnrc.tufts.edu
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Appendix H.
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P elli-R o b s o n C o n t r a s t  S e n s it iv it y T e st
0.00 V R s K D R 0.15 0.00 V  R S K D R 0.15 0.00 V R S K D R 0.15
0.30 N H C S O K 0.45 0.30 N H C S O K 0.45 0.30 N H C S O K 0.45
0.60 S O N O Z  V 0.75 0.60 S O N O Z  V 0.75 0.60 S O N O Z  V 0.75
0.90 C N H Z  O K 1.05 0.90 C N H Z  O K 1.05 0.90 C N H Z  O K 1.05
1.20 N O D V H R 1.35 1.20 N O D V H R 1.35 1.20 N O D V H R 1.35
1.50 C D N Z  S  V 1.65 1.50 C D N Z S V 1.65 1.50 C D N Z  S  V 1.65
1.80 K C H O D K 1.95 1.80 K C H O D K 1.95 1.80 K C H O D K 1.95
2.10 R S Z H  V R 2.25 2.10 R S Z H V R 2.25 2.10 R S Z H V R 2.25
Right Eye Binocular Left Eye
Log Contrast Sensitivity: Los Contrast Sensitivity: Log Contrast Sensitivity:
Acuity: Acuity: Acuity: i
Correction: Correction: \
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Appendix K.
Amsler Grid Questionnaire (page 1 of 3)
UNH Nutrition and Vision Research Project
Subject # D a te _ _ _ _ _ _ __ „
Amsler Grid: All Questions are to be used with the Standard Chart #1
It is important to remind the subject to keep his/her gaze fixed on the central point during
the whole examination.
Cover Left. Eye
A. Do you .see the white spot in the center of the squared chart?
1. ^  Yes
2. ^  Yes, but it is blurred
3. O No, the central spot is invisible.
I see it only when I glance aside.
R. Re* ping your gaze fixed upon the white spot in the center, can you see the four 
corners of the big square?
4. ^  Yes
5. D No
Can you also see the four sides of the square?
6 . ^  Yes
7. D No
In other words, can you see the whole of the square?
8. D
9 □
C. While keeping the gaze fixed on the central fixation point, do you see the 
network intact, in the whole square? Or are there interruptions in the network 
of squares, like holes or spots? Is it blurred in any place? And if so, where?
10. D
11. □
D, Always keeping your gaze fixed on the white spot in the center do you see all the 
lines, both horizontal and vertical quite straight and parallel? In other words, is 
every small square equal in size and perfectly regular ?
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E. Do you see the white spot in the center o f the squared chart?
14. O Yes
15. □ Yes, but it is blurred
16. □ No, the central spot is invisible.
I see it only when I glance aside.
F. Keeping your gaze fixed upon the white spot in the center, can you see the four 
corners of the big square?
17. ^  Yes
18. ^  No
Can you also see the four sides of the square?
19. Yes
20. n  No
In other words, can you see the whole square?
21. ^  Yes
22. D No
G. W hile keeping the gaze fixed on the central fixation point, do you see the 
network intact, in the whole square? Or are there interruptions in the network 
of squares, like holes or spots? Is it blurred in any place? And if so, w here?
23. ^  v ‘=“:
24. D No
H. Always keeping your gaze fixed on the white spot in the center do you see all the 
lines, both horizontal and vertical quite straight and parallel? In other words, is 
every small square equal in size and perfectly regular?
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Appendix K.
Amsler Grid Questionnaire (page 3 of 3)
25. °
26. ^  No
U sing Both Eyes
1. Do you see the white spot in. the center of the squared chart?
27 °
28. ^  Yes, but it is blurred
29. ^  No, the central spot is invisible.
I see it only when I glance aside.
J. Keeping your gaze fixed upon the .white spot in the center, can you see the four 
com ers of the big square?
30. D Yes
31. D No
Can you also see the four sides o f the square?
32. D Yes
33. D
In other words, can you see the whole of the square?
34. D Yes
35. D No
K. While keeping the gaze fixed on the central fixation point, do you see the
network intact, in the whole square? Or are there Interruptions in the network, 
of squares, like holes or spots? Is it blurred in any place? And if so, where?
36. °  Yes
37. ^  No
L. Always keeping your gaze fixed on the white spot in the center do you see all the 
lines, both horizontal and vertical quite straight and parallel? In other words, is 
every small square equal in size and perfectly regular?
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Appendix L.
MPOD Assessment Record Sample (one of 5 grids used to record four foveal and 1 
parafoveal site)
Site #1:0.16? da •ccwiMettv/Hartz:
























AMD age-related macular degeneration
ARM age-related maculopathy
ATBC Alpha-T ocopherol Beta-Carotene
BC beta-carotene
BCX beta-cryptoxanthin
B-FFQ Block food frequency questionnaire
BMI body mass index
CARET beta-carotene retinol effeciency trial
cdm2 candle meters squared
CLIA Clinical Laboratory Improvement Act
CMPV Composite macular pigment value
ETDRS Early Treatment Diabetic Retinopathy Study
FFQ food frequency questionnaire
FH-FFQ Fred Hutchinson Cancer Research Center food frequency questionnaire
HDL-C high density lipoprotein cholesterol
HFP heterochromatic flicker photometry




LED light emitting diode
LDL-C low density lipoprotein cholesterol
LY lycopene
L/Z lutein and zeaxanthin
MP macular pigment
MPOD macular pigment optical density
NEL Nutrition Evaluation Laboratory
NWFVGP New Fruit and Vegetable Groups
NIST National Institute of Standards and Technology
SPNT supernatant
TC total cholesterol
T-FFQ Tufts/USD A Center for the Study of Nutrition and Aging food frequency
questionnaire
TRIG triglyceride
VLDL-C very low density lipoprotein cholesterol
XBP xanthophyll-binding protein
x g relative centrifugal force
Z zeaxanthin
7-FVST Seven item fruit and vegetable screening tool
24hr-CGFR Twenty-four hour carotenoid guided food recall
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